{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import datetime as dt\n",
    "from datetime import datetime\n",
    "from datetime import date\n",
    "import matplotlib.pyplot as plt\n",
    "import re\n",
    "import requests\n",
    "pd.options.display.max_rows = 5000 "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "https://rapidapi.com/apidojo/api/yahoo-finance1/\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"financialsTemplate\":{\"code\":\"N\",\"maxAge\":1},\"cashflowStatementHistory\":{\"cashflowStatements\":[{\"investments\":{\"raw\":2853000000,\"fmt\":\"2.85B\",\"longFmt\":\"2,853,000,000\"},\"changeToLiabilities\":{\"raw\":225000000,\"fmt\":\"225M\",\"longFmt\":\"225,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":2161000000,\"fmt\":\"2.16B\",\"longFmt\":\"2,161,000,000\"},\"netBorrowings\":{\"raw\":-4234000000,\"fmt\":\"-4.23B\",\"longFmt\":\"-4,234,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-10132000000,\"fmt\":\"-10.13B\",\"longFmt\":\"-10,132,000,000\"},\"changeToOperatingActivities\":{\"raw\":-159000000,\"fmt\":\"-159M\",\"longFmt\":\"-159,000,000\"},\"issuanceOfStock\":{\"raw\":29000000,\"fmt\":\"29M\",\"longFmt\":\"29,000,000\"},\"netIncome\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"},\"changeInCash\":{\"raw\":431000000,\"fmt\":\"431M\",\"longFmt\":\"431,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"effectOfExchangeRate\":{\"raw\":-39000000,\"fmt\":\"-39M\",\"longFmt\":\"-39,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":8441000000,\"fmt\":\"8.44B\",\"longFmt\":\"8,441,000,000\"},\"depreciation\":{\"raw\":2110000000,\"fmt\":\"2.11B\",\"longFmt\":\"2,110,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":70000000,\"fmt\":\"70M\",\"longFmt\":\"70,000,000\"},\"dividendsPaid\":{\"raw\":-3977000000,\"fmt\":\"-3.98B\",\"longFmt\":\"-3,977,000,000\"},\"changeToInventory\":{\"raw\":119000000,\"fmt\":\"119M\",\"longFmt\":\"119,000,000\"},\"changeToAccountReceivables\":{\"raw\":-224000000,\"fmt\":\"-224M\",\"longFmt\":\"-224,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-1950000000,\"fmt\":\"-1.95B\",\"longFmt\":\"-1,950,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":380000000,\"fmt\":\"380M\",\"longFmt\":\"380,000,000\"},\"capitalExpenditures\":{\"raw\":-1226000000,\"fmt\":\"-1.23B\",\"longFmt\":\"-1,226,000,000\"}},{\"investments\":{\"raw\":-199000000,\"fmt\":\"-199M\",\"longFmt\":\"-199,000,000\"},\"changeToLiabilities\":{\"raw\":263000000,\"fmt\":\"263M\",\"longFmt\":\"263,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-5354000000,\"fmt\":\"-5.35B\",\"longFmt\":\"-5,354,000,000\"},\"netBorrowings\":{\"raw\":3515000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,515,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-1840000000,\"fmt\":\"-1.84B\",\"longFmt\":\"-1,840,000,000\"},\"changeToOperatingActivities\":{\"raw\":-160000000,\"fmt\":\"-160M\",\"longFmt\":\"-160,000,000\"},\"issuanceOfStock\":{\"raw\":51000000,\"fmt\":\"51M\",\"longFmt\":\"51,000,000\"},\"netIncome\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"},\"changeInCash\":{\"raw\":744000000,\"fmt\":\"744M\",\"longFmt\":\"744,000,000\"},\"endDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"effectOfExchangeRate\":{\"raw\":-82000000,\"fmt\":\"-82M\",\"longFmt\":\"-82,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":8020000000,\"fmt\":\"8.02B\",\"longFmt\":\"8,020,000,000\"},\"depreciation\":{\"raw\":2101000000,\"fmt\":\"2.1B\",\"longFmt\":\"2,101,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":89000000,\"fmt\":\"89M\",\"longFmt\":\"89,000,000\"},\"dividendsPaid\":{\"raw\":-3953000000,\"fmt\":\"-3.95B\",\"longFmt\":\"-3,953,000,000\"},\"changeToInventory\":{\"raw\":300000000,\"fmt\":\"300M\",\"longFmt\":\"300,000,000\"},\"changeToAccountReceivables\":{\"raw\":-32000000,\"fmt\":\"-32M\",\"longFmt\":\"-32,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-1453000000,\"fmt\":\"-1.45B\",\"longFmt\":\"-1,453,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":670000000,\"fmt\":\"670M\",\"longFmt\":\"670,000,000\"},\"capitalExpenditures\":{\"raw\":-1265000000,\"fmt\":\"-1.26B\",\"longFmt\":\"-1,265,000,000\"}},{\"investments\":{\"raw\":-165000000,\"fmt\":\"-165M\",\"longFmt\":\"-165,000,000\"},\"changeToLiabilities\":{\"raw\":131000000,\"fmt\":\"131M\",\"longFmt\":\"131,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-1553000000,\"fmt\":\"-1.55B\",\"longFmt\":\"-1,553,000,000\"},\"netBorrowings\":{\"raw\":8124000000,\"fmt\":\"8.12B\",\"longFmt\":\"8,124,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-6389000000,\"fmt\":\"-6.39B\",\"longFmt\":\"-6,389,000,000\"},\"changeToOperatingActivities\":{\"raw\":18000000,\"fmt\":\"18M\",\"longFmt\":\"18,000,000\"},\"issuanceOfStock\":{\"raw\":74000000,\"fmt\":\"74M\",\"longFmt\":\"74,000,000\"},\"netIncome\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"},\"changeInCash\":{\"raw\":487000000,\"fmt\":\"487M\",\"longFmt\":\"487,000,000\"},\"endDate\":{\"raw\":1546214400,\"fmt\":\"2018-12-31\"},\"effectOfExchangeRate\":{\"raw\":8000000,\"fmt\":\"8M\",\"longFmt\":\"8,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":8421000000,\"fmt\":\"8.42B\",\"longFmt\":\"8,421,000,000\"},\"depreciation\":{\"raw\":1856000000,\"fmt\":\"1.86B\",\"longFmt\":\"1,856,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":111000000,\"fmt\":\"111M\",\"longFmt\":\"111,000,000\"},\"dividendsPaid\":{\"raw\":-3927000000,\"fmt\":\"-3.93B\",\"longFmt\":\"-3,927,000,000\"},\"changeToInventory\":{\"raw\":51000000,\"fmt\":\"51M\",\"longFmt\":\"51,000,000\"},\"changeToAccountReceivables\":{\"raw\":-429000000,\"fmt\":\"-429M\",\"longFmt\":\"-429,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-10660000000,\"fmt\":\"-10.66B\",\"longFmt\":\"-10,660,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":3171000000,\"fmt\":\"3.17B\",\"longFmt\":\"3,171,000,000\"},\"capitalExpenditures\":{\"raw\":-1344000000,\"fmt\":\"-1.34B\",\"longFmt\":\"-1,344,000,000\"}},{\"investments\":{\"raw\":169000000,\"fmt\":\"169M\",\"longFmt\":\"169,000,000\"},\"changeToLiabilities\":{\"raw\":11000000,\"fmt\":\"11M\",\"longFmt\":\"11,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-1443000000,\"fmt\":\"-1.44B\",\"longFmt\":\"-1,443,000,000\"},\"netBorrowings\":{\"raw\":-990000000,\"fmt\":\"-990M\",\"longFmt\":\"-990,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-6380000000,\"fmt\":\"-6.38B\",\"longFmt\":\"-6,380,000,000\"},\"changeToOperatingActivities\":{\"raw\":74000000,\"fmt\":\"74M\",\"longFmt\":\"74,000,000\"},\"issuanceOfStock\":{\"raw\":56000000,\"fmt\":\"56M\",\"longFmt\":\"56,000,000\"},\"netIncome\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"},\"changeInCash\":{\"raw\":-1005000000,\"fmt\":\"-1B\",\"longFmt\":\"-1,005,000,000\"},\"endDate\":{\"raw\":1514678400,\"fmt\":\"2017-12-31\"},\"repurchaseOfStock\":{\"raw\":-65000000,\"fmt\":\"-65M\",\"longFmt\":\"-65,000,000\"},\"effectOfExchangeRate\":{\"raw\":-100000000,\"fmt\":\"-100M\",\"longFmt\":\"-100,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":6918000000,\"fmt\":\"6.92B\",\"longFmt\":\"6,918,000,000\"},\"depreciation\":{\"raw\":1922000000,\"fmt\":\"1.92B\",\"longFmt\":\"1,922,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":70000000,\"fmt\":\"70M\",\"longFmt\":\"70,000,000\"},\"dividendsPaid\":{\"raw\":-3906000000,\"fmt\":\"-3.91B\",\"longFmt\":\"-3,906,000,000\"},\"changeToInventory\":{\"raw\":-461000000,\"fmt\":\"-461M\",\"longFmt\":\"-461,000,000\"},\"changeToAccountReceivables\":{\"raw\":-287000000,\"fmt\":\"-287M\",\"longFmt\":\"-287,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-1475000000,\"fmt\":\"-1.48B\",\"longFmt\":\"-1,475,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":4127000000,\"fmt\":\"4.13B\",\"longFmt\":\"4,127,000,000\"},\"capitalExpenditures\":{\"raw\":-1545000000,\"fmt\":\"-1.54B\",\"longFmt\":\"-1,545,000,000\"}}],\"maxAge\":86400},\"balanceSheetHistoryQuarterly\":{\"balanceSheetStatements\":[{\"intangibleAssets\":{\"raw\":30241000000,\"fmt\":\"30.24B\",\"longFmt\":\"30,241,000,000\"},\"capitalSurplus\":{\"raw\":3300000000,\"fmt\":\"3.3B\",\"longFmt\":\"3,300,000,000\"},\"totalLiab\":{\"raw\":56941000000,\"fmt\":\"56.94B\",\"longFmt\":\"56,941,000,000\"},\"totalStockholderEquity\":{\"raw\":15426000000,\"fmt\":\"15.43B\",\"longFmt\":\"15,426,000,000\"},\"minorityInterest\":{\"raw\":6322000000,\"fmt\":\"6.32B\",\"longFmt\":\"6,322,000,000\"},\"otherCurrentLiab\":{\"raw\":3225000000,\"fmt\":\"3.23B\",\"longFmt\":\"3,225,000,000\"},\"totalAssets\":{\"raw\":78689000000,\"fmt\":\"78.69B\",\"longFmt\":\"78,689,000,000\"},\"endDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"commonStock\":{\"raw\":1347000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,347,000,000\"},\"otherCurrentAssets\":{\"raw\":212000000,\"fmt\":\"212M\",\"longFmt\":\"212,000,000\"},\"retainedEarnings\":{\"raw\":7783000000,\"fmt\":\"7.78B\",\"longFmt\":\"7,783,000,000\"},\"otherLiab\":{\"raw\":13788000000,\"fmt\":\"13.79B\",\"longFmt\":\"13,788,000,000\"},\"goodWill\":{\"raw\":10582000000,\"fmt\":\"10.58B\",\"longFmt\":\"10,582,000,000\"},\"treasuryStock\":{\"raw\":2996000000,\"fmt\":\"3B\",\"longFmt\":\"2,996,000,000\"},\"otherAssets\":{\"raw\":6121000000,\"fmt\":\"6.12B\",\"longFmt\":\"6,121,000,000\"},\"cash\":{\"raw\":3453000000,\"fmt\":\"3.45B\",\"longFmt\":\"3,453,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22417000000,\"fmt\":\"22.42B\",\"longFmt\":\"22,417,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4876000000,\"fmt\":\"4.88B\",\"longFmt\":\"4,876,000,000\"},\"shortLongTermDebt\":{\"raw\":3100000000,\"fmt\":\"3.1B\",\"longFmt\":\"3,100,000,000\"},\"otherStockholderEquity\":{\"raw\":2996000000,\"fmt\":\"3B\",\"longFmt\":\"2,996,000,000\"},\"propertyPlantEquipment\":{\"raw\":10667000000,\"fmt\":\"10.67B\",\"longFmt\":\"10,667,000,000\"},\"totalCurrentAssets\":{\"raw\":18254000000,\"fmt\":\"18.25B\",\"longFmt\":\"18,254,000,000\"},\"longTermInvestments\":{\"raw\":2824000000,\"fmt\":\"2.82B\",\"longFmt\":\"2,824,000,000\"},\"netTangibleAssets\":{\"raw\":-25397000000,\"fmt\":\"-25.4B\",\"longFmt\":\"-25,397,000,000\"},\"shortTermInvestments\":{\"raw\":61000000,\"fmt\":\"61M\",\"longFmt\":\"61,000,000\"},\"netReceivables\":{\"raw\":8284000000,\"fmt\":\"8.28B\",\"longFmt\":\"8,284,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":20736000000,\"fmt\":\"20.74B\",\"longFmt\":\"20,736,000,000\"},\"inventory\":{\"raw\":6244000000,\"fmt\":\"6.24B\",\"longFmt\":\"6,244,000,000\"},\"accountsPayable\":{\"raw\":14323000000,\"fmt\":\"14.32B\",\"longFmt\":\"14,323,000,000\"}},{\"intangibleAssets\":{\"raw\":29333000000,\"fmt\":\"29.33B\",\"longFmt\":\"29,333,000,000\"},\"capitalSurplus\":{\"raw\":3299000000,\"fmt\":\"3.3B\",\"longFmt\":\"3,299,000,000\"},\"totalLiab\":{\"raw\":55433000000,\"fmt\":\"55.43B\",\"longFmt\":\"55,433,000,000\"},\"totalStockholderEquity\":{\"raw\":15377000000,\"fmt\":\"15.38B\",\"longFmt\":\"15,377,000,000\"},\"minorityInterest\":{\"raw\":6201000000,\"fmt\":\"6.2B\",\"longFmt\":\"6,201,000,000\"},\"otherCurrentLiab\":{\"raw\":2949000000,\"fmt\":\"2.95B\",\"longFmt\":\"2,949,000,000\"},\"totalAssets\":{\"raw\":77011000000,\"fmt\":\"77.01B\",\"longFmt\":\"77,011,000,000\"},\"endDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"commonStock\":{\"raw\":1347000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,347,000,000\"},\"otherCurrentAssets\":{\"raw\":167000000,\"fmt\":\"167M\",\"longFmt\":\"167,000,000\"},\"retainedEarnings\":{\"raw\":7379000000,\"fmt\":\"7.38B\",\"longFmt\":\"7,379,000,000\"},\"otherLiab\":{\"raw\":13604000000,\"fmt\":\"13.6B\",\"longFmt\":\"13,604,000,000\"},\"goodWill\":{\"raw\":10435000000,\"fmt\":\"10.44B\",\"longFmt\":\"10,435,000,000\"},\"treasuryStock\":{\"raw\":3352000000,\"fmt\":\"3.35B\",\"longFmt\":\"3,352,000,000\"},\"otherAssets\":{\"raw\":5847000000,\"fmt\":\"5.85B\",\"longFmt\":\"5,847,000,000\"},\"cash\":{\"raw\":3503000000,\"fmt\":\"3.5B\",\"longFmt\":\"3,503,000,000\"},\"totalCurrentLiabilities\":{\"raw\":21387000000,\"fmt\":\"21.39B\",\"longFmt\":\"21,387,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4711000000,\"fmt\":\"4.71B\",\"longFmt\":\"4,711,000,000\"},\"shortLongTermDebt\":{\"raw\":2600000000,\"fmt\":\"2.6B\",\"longFmt\":\"2,600,000,000\"},\"otherStockholderEquity\":{\"raw\":3352000000,\"fmt\":\"3.35B\",\"longFmt\":\"3,352,000,000\"},\"propertyPlantEquipment\":{\"raw\":10589000000,\"fmt\":\"10.59B\",\"longFmt\":\"10,589,000,000\"},\"totalCurrentAssets\":{\"raw\":17566000000,\"fmt\":\"17.57B\",\"longFmt\":\"17,566,000,000\"},\"longTermInvestments\":{\"raw\":3241000000,\"fmt\":\"3.24B\",\"longFmt\":\"3,241,000,000\"},\"netTangibleAssets\":{\"raw\":-24391000000,\"fmt\":\"-24.39B\",\"longFmt\":\"-24,391,000,000\"},\"shortTermInvestments\":{\"raw\":59000000,\"fmt\":\"59M\",\"longFmt\":\"59,000,000\"},\"netReceivables\":{\"raw\":7507000000,\"fmt\":\"7.51B\",\"longFmt\":\"7,507,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":20442000000,\"fmt\":\"20.44B\",\"longFmt\":\"20,442,000,000\"},\"inventory\":{\"raw\":6330000000,\"fmt\":\"6.33B\",\"longFmt\":\"6,330,000,000\"},\"accountsPayable\":{\"raw\":13397000000,\"fmt\":\"13.4B\",\"longFmt\":\"13,397,000,000\"}},{\"intangibleAssets\":{\"raw\":29418000000,\"fmt\":\"29.42B\",\"longFmt\":\"29,418,000,000\"},\"capitalSurplus\":{\"raw\":3296000000,\"fmt\":\"3.3B\",\"longFmt\":\"3,296,000,000\"},\"totalLiab\":{\"raw\":57069000000,\"fmt\":\"57.07B\",\"longFmt\":\"57,069,000,000\"},\"totalStockholderEquity\":{\"raw\":14865000000,\"fmt\":\"14.87B\",\"longFmt\":\"14,865,000,000\"},\"minorityInterest\":{\"raw\":6145000000,\"fmt\":\"6.14B\",\"longFmt\":\"6,145,000,000\"},\"otherCurrentLiab\":{\"raw\":3400000000,\"fmt\":\"3.4B\",\"longFmt\":\"3,400,000,000\"},\"totalAssets\":{\"raw\":78079000000,\"fmt\":\"78.08B\",\"longFmt\":\"78,079,000,000\"},\"endDate\":{\"raw\":1617148800,\"fmt\":\"2021-03-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":308000000,\"fmt\":\"308M\",\"longFmt\":\"308,000,000\"},\"retainedEarnings\":{\"raw\":6700000000,\"fmt\":\"6.7B\",\"longFmt\":\"6,700,000,000\"},\"otherLiab\":{\"raw\":13747000000,\"fmt\":\"13.75B\",\"longFmt\":\"13,747,000,000\"},\"goodWill\":{\"raw\":10442000000,\"fmt\":\"10.44B\",\"longFmt\":\"10,442,000,000\"},\"treasuryStock\":{\"raw\":3523000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,523,000,000\"},\"otherAssets\":{\"raw\":5301000000,\"fmt\":\"5.3B\",\"longFmt\":\"5,301,000,000\"},\"cash\":{\"raw\":4757000000,\"fmt\":\"4.76B\",\"longFmt\":\"4,757,000,000\"},\"totalCurrentLiabilities\":{\"raw\":20275000000,\"fmt\":\"20.27B\",\"longFmt\":\"20,275,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4312000000,\"fmt\":\"4.31B\",\"longFmt\":\"4,312,000,000\"},\"otherStockholderEquity\":{\"raw\":3523000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,523,000,000\"},\"propertyPlantEquipment\":{\"raw\":10633000000,\"fmt\":\"10.63B\",\"longFmt\":\"10,633,000,000\"},\"totalCurrentAssets\":{\"raw\":18524000000,\"fmt\":\"18.52B\",\"longFmt\":\"18,524,000,000\"},\"longTermInvestments\":{\"raw\":3761000000,\"fmt\":\"3.76B\",\"longFmt\":\"3,761,000,000\"},\"netTangibleAssets\":{\"raw\":-24995000000,\"fmt\":\"-25B\",\"longFmt\":\"-24,995,000,000\"},\"shortTermInvestments\":{\"raw\":60000000,\"fmt\":\"60M\",\"longFmt\":\"60,000,000\"},\"netReceivables\":{\"raw\":7183000000,\"fmt\":\"7.18B\",\"longFmt\":\"7,183,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":23047000000,\"fmt\":\"23.05B\",\"longFmt\":\"23,047,000,000\"},\"inventory\":{\"raw\":6216000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,216,000,000\"},\"accountsPayable\":{\"raw\":13703000000,\"fmt\":\"13.7B\",\"longFmt\":\"13,703,000,000\"}},{\"intangibleAssets\":{\"raw\":29824000000,\"fmt\":\"29.82B\",\"longFmt\":\"29,824,000,000\"},\"capitalSurplus\":{\"raw\":3281000000,\"fmt\":\"3.28B\",\"longFmt\":\"3,281,000,000\"},\"totalLiab\":{\"raw\":59623000000,\"fmt\":\"59.62B\",\"longFmt\":\"59,623,000,000\"},\"totalStockholderEquity\":{\"raw\":14587000000,\"fmt\":\"14.59B\",\"longFmt\":\"14,587,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"otherCurrentLiab\":{\"raw\":5338000000,\"fmt\":\"5.34B\",\"longFmt\":\"5,338,000,000\"},\"totalAssets\":{\"raw\":80431000000,\"fmt\":\"80.43B\",\"longFmt\":\"80,431,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":195000000,\"fmt\":\"195M\",\"longFmt\":\"195,000,000\"},\"retainedEarnings\":{\"raw\":7294000000,\"fmt\":\"7.29B\",\"longFmt\":\"7,294,000,000\"},\"otherLiab\":{\"raw\":14050000000,\"fmt\":\"14.05B\",\"longFmt\":\"14,050,000,000\"},\"goodWill\":{\"raw\":10597000000,\"fmt\":\"10.6B\",\"longFmt\":\"10,597,000,000\"},\"treasuryStock\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"otherAssets\":{\"raw\":5261000000,\"fmt\":\"5.26B\",\"longFmt\":\"5,261,000,000\"},\"cash\":{\"raw\":6292000000,\"fmt\":\"6.29B\",\"longFmt\":\"6,292,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22148000000,\"fmt\":\"22.15B\",\"longFmt\":\"22,148,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4287000000,\"fmt\":\"4.29B\",\"longFmt\":\"4,287,000,000\"},\"shortLongTermDebt\":{\"raw\":2449000000,\"fmt\":\"2.45B\",\"longFmt\":\"2,449,000,000\"},\"otherStockholderEquity\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"propertyPlantEquipment\":{\"raw\":11006000000,\"fmt\":\"11.01B\",\"longFmt\":\"11,006,000,000\"},\"totalCurrentAssets\":{\"raw\":20247000000,\"fmt\":\"20.25B\",\"longFmt\":\"20,247,000,000\"},\"longTermInvestments\":{\"raw\":3496000000,\"fmt\":\"3.5B\",\"longFmt\":\"3,496,000,000\"},\"netTangibleAssets\":{\"raw\":-25834000000,\"fmt\":\"-25.83B\",\"longFmt\":\"-25,834,000,000\"},\"shortTermInvestments\":{\"raw\":480000000,\"fmt\":\"480M\",\"longFmt\":\"480,000,000\"},\"netReceivables\":{\"raw\":6862000000,\"fmt\":\"6.86B\",\"longFmt\":\"6,862,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":22538000000,\"fmt\":\"22.54B\",\"longFmt\":\"22,538,000,000\"},\"inventory\":{\"raw\":5996000000,\"fmt\":\"6B\",\"longFmt\":\"5,996,000,000\"},\"accountsPayable\":{\"raw\":4357000000,\"fmt\":\"4.36B\",\"longFmt\":\"4,357,000,000\"}}],\"maxAge\":86400},\"earnings\":{\"maxAge\":86400,\"earningsChart\":{\"quarterly\":[{\"date\":\"4Q2020\",\"actual\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"estimate\":{\"raw\":0.64,\"fmt\":\"0.64\"}},{\"date\":\"1Q2021\",\"actual\":{\"raw\":0.63,\"fmt\":\"0.63\"},\"estimate\":{\"raw\":0.61,\"fmt\":\"0.61\"}},{\"date\":\"2Q2021\",\"actual\":{\"raw\":0.79,\"fmt\":\"0.79\"},\"estimate\":{\"raw\":0.51,\"fmt\":\"0.51\"}},{\"date\":\"3Q2021\",\"actual\":{\"raw\":1.01,\"fmt\":\"1.01\"},\"estimate\":{\"raw\":0.81,\"fmt\":\"0.81\"}}],\"currentQuarterEstimate\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"currentQuarterEstimateDate\":\"4Q\",\"currentQuarterEstimateYear\":2021,\"earningsDate\":[{\"raw\":1485964740,\"fmt\":\"2017-02-01\"},{\"raw\":1486400400,\"fmt\":\"2017-02-06\"}]},\"financialsChart\":{\"yearly\":[{\"date\":2017,\"revenue\":{\"raw\":30186000000,\"fmt\":\"30.19B\",\"longFmt\":\"30,186,000,000\"},\"earnings\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"}},{\"date\":2018,\"revenue\":{\"raw\":30821000000,\"fmt\":\"30.82B\",\"longFmt\":\"30,821,000,000\"},\"earnings\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"}},{\"date\":2019,\"revenue\":{\"raw\":33754000000,\"fmt\":\"33.75B\",\"longFmt\":\"33,754,000,000\"},\"earnings\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"}},{\"date\":2020,\"revenue\":{\"raw\":34099000000,\"fmt\":\"34.1B\",\"longFmt\":\"34,099,000,000\"},\"earnings\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"}}],\"quarterly\":[{\"date\":\"4Q2020\",\"revenue\":{\"raw\":8739000000,\"fmt\":\"8.74B\",\"longFmt\":\"8,739,000,000\"},\"earnings\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"}},{\"date\":\"1Q2021\",\"revenue\":{\"raw\":7418000000,\"fmt\":\"7.42B\",\"longFmt\":\"7,418,000,000\"},\"earnings\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"}},{\"date\":\"2Q2021\",\"revenue\":{\"raw\":8092000000,\"fmt\":\"8.09B\",\"longFmt\":\"8,092,000,000\"},\"earnings\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"}},{\"date\":\"3Q2021\",\"revenue\":{\"raw\":9077000000,\"fmt\":\"9.08B\",\"longFmt\":\"9,077,000,000\"},\"earnings\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"}}]},\"financialCurrency\":\"GBP\"},\"price\":{\"quoteSourceName\":\"Nasdaq Real Time Price\",\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"averageDailyVolume3Month\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"exchange\":\"NYQ\",\"regularMarketTime\":1637168964,\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"shortName\":\"GlaxoSmithKline PLC\",\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"longName\":\"GlaxoSmithKline plc\",\"regularMarketChange\":{\"raw\":0.17499924,\"fmt\":\"0.17\"},\"currencySymbol\":\"$\",\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"preMarketPrice\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"preMarketTime\":1637159399,\"exchangeDataDelayedBy\":0,\"toCurrency\":null,\"postMarketChange\":{},\"postMarketPrice\":{},\"exchangeName\":\"NYSE\",\"preMarketChange\":{\"raw\":-0.190002,\"fmt\":\"-0.19\"},\"circulatingSupply\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"regularMarketPrice\":{\"raw\":42.625,\"fmt\":\"42.62\"},\"regularMarketVolume\":{\"raw\":2359284,\"fmt\":\"2.36M\",\"longFmt\":\"2,359,284.00\"},\"lastMarket\":null,\"regularMarketSource\":\"FREE_REALTIME\",\"openInterest\":{},\"marketState\":\"REGULAR\",\"underlyingSymbol\":null,\"marketCap\":{\"raw\":107239383040,\"fmt\":\"107.24B\",\"longFmt\":\"107,239,383,040.00\"},\"quoteType\":\"EQUITY\",\"preMarketChangePercent\":{\"raw\":-0.00447591,\"fmt\":\"-0.45%\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"symbol\":\"GSK\",\"preMarketSource\":\"FREE_REALTIME\",\"maxAge\":1,\"fromCurrency\":null,\"regularMarketChangePercent\":{\"raw\":0.004122479,\"fmt\":\"0.41%\"}},\"incomeStatementHistoryQuarterly\":{\"incomeStatementHistory\":[{\"researchDevelopment\":{\"raw\":1196000000,\"fmt\":\"1.2B\",\"longFmt\":\"1,196,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":1748000000,\"fmt\":\"1.75B\",\"longFmt\":\"1,748,000,000\"},\"minorityInterest\":{\"raw\":6322000000,\"fmt\":\"6.32B\",\"longFmt\":\"6,322,000,000\"},\"netIncome\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2517000000,\"fmt\":\"2.52B\",\"longFmt\":\"2,517,000,000\"},\"grossProfit\":{\"raw\":6255000000,\"fmt\":\"6.25B\",\"longFmt\":\"6,255,000,000\"},\"ebit\":{\"raw\":2658000000,\"fmt\":\"2.66B\",\"longFmt\":\"2,658,000,000\"},\"endDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"operatingIncome\":{\"raw\":2658000000,\"fmt\":\"2.66B\",\"longFmt\":\"2,658,000,000\"},\"otherOperatingExpenses\":{\"raw\":-116000000,\"fmt\":\"-116M\",\"longFmt\":\"-116,000,000\"},\"interestExpense\":{\"raw\":-199000000,\"fmt\":\"-199M\",\"longFmt\":\"-199,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":380000000,\"fmt\":\"380M\",\"longFmt\":\"380,000,000\"},\"totalRevenue\":{\"raw\":9077000000,\"fmt\":\"9.08B\",\"longFmt\":\"9,077,000,000\"},\"totalOperatingExpenses\":{\"raw\":6419000000,\"fmt\":\"6.42B\",\"longFmt\":\"6,419,000,000\"},\"costOfRevenue\":{\"raw\":2822000000,\"fmt\":\"2.82B\",\"longFmt\":\"2,822,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-910000000,\"fmt\":\"-910M\",\"longFmt\":\"-910,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":1368000000,\"fmt\":\"1.37B\",\"longFmt\":\"1,368,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"}},{\"researchDevelopment\":{\"raw\":1190000000,\"fmt\":\"1.19B\",\"longFmt\":\"1,190,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":1470000000,\"fmt\":\"1.47B\",\"longFmt\":\"1,470,000,000\"},\"minorityInterest\":{\"raw\":6201000000,\"fmt\":\"6.2B\",\"longFmt\":\"6,201,000,000\"},\"netIncome\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2496000000,\"fmt\":\"2.5B\",\"longFmt\":\"2,496,000,000\"},\"grossProfit\":{\"raw\":5573000000,\"fmt\":\"5.57B\",\"longFmt\":\"5,573,000,000\"},\"ebit\":{\"raw\":1979000000,\"fmt\":\"1.98B\",\"longFmt\":\"1,979,000,000\"},\"endDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"operatingIncome\":{\"raw\":1979000000,\"fmt\":\"1.98B\",\"longFmt\":\"1,979,000,000\"},\"otherOperatingExpenses\":{\"raw\":-92000000,\"fmt\":\"-92M\",\"longFmt\":\"-92,000,000\"},\"interestExpense\":{\"raw\":-192000000,\"fmt\":\"-192M\",\"longFmt\":\"-192,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":-68000000,\"fmt\":\"-68M\",\"longFmt\":\"-68,000,000\"},\"totalRevenue\":{\"raw\":8092000000,\"fmt\":\"8.09B\",\"longFmt\":\"8,092,000,000\"},\"totalOperatingExpenses\":{\"raw\":6113000000,\"fmt\":\"6.11B\",\"longFmt\":\"6,113,000,000\"},\"costOfRevenue\":{\"raw\":2519000000,\"fmt\":\"2.52B\",\"longFmt\":\"2,519,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-509000000,\"fmt\":\"-509M\",\"longFmt\":\"-509,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":1538000000,\"fmt\":\"1.54B\",\"longFmt\":\"1,538,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"}},{\"researchDevelopment\":{\"raw\":1103000000,\"fmt\":\"1.1B\",\"longFmt\":\"1,103,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":1518000000,\"fmt\":\"1.52B\",\"longFmt\":\"1,518,000,000\"},\"minorityInterest\":{\"raw\":6145000000,\"fmt\":\"6.14B\",\"longFmt\":\"6,145,000,000\"},\"netIncome\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2318000000,\"fmt\":\"2.32B\",\"longFmt\":\"2,318,000,000\"},\"grossProfit\":{\"raw\":4980000000,\"fmt\":\"4.98B\",\"longFmt\":\"4,980,000,000\"},\"ebit\":{\"raw\":1609000000,\"fmt\":\"1.61B\",\"longFmt\":\"1,609,000,000\"},\"endDate\":{\"raw\":1617148800,\"fmt\":\"2021-03-31\"},\"operatingIncome\":{\"raw\":1609000000,\"fmt\":\"1.61B\",\"longFmt\":\"1,609,000,000\"},\"otherOperatingExpenses\":{\"raw\":-50000000,\"fmt\":\"-50M\",\"longFmt\":\"-50,000,000\"},\"interestExpense\":{\"raw\":-200000000,\"fmt\":\"-200M\",\"longFmt\":\"-200,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":258000000,\"fmt\":\"258M\",\"longFmt\":\"258,000,000\"},\"totalRevenue\":{\"raw\":7418000000,\"fmt\":\"7.42B\",\"longFmt\":\"7,418,000,000\"},\"totalOperatingExpenses\":{\"raw\":5809000000,\"fmt\":\"5.81B\",\"longFmt\":\"5,809,000,000\"},\"costOfRevenue\":{\"raw\":2438000000,\"fmt\":\"2.44B\",\"longFmt\":\"2,438,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-91000000,\"fmt\":\"-91M\",\"longFmt\":\"-91,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":1260000000,\"fmt\":\"1.26B\",\"longFmt\":\"1,260,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"}},{\"researchDevelopment\":{\"raw\":1322000000,\"fmt\":\"1.32B\",\"longFmt\":\"1,322,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":821000000,\"fmt\":\"821M\",\"longFmt\":\"821,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"netIncome\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2692000000,\"fmt\":\"2.69B\",\"longFmt\":\"2,692,000,000\"},\"grossProfit\":{\"raw\":5777000000,\"fmt\":\"5.78B\",\"longFmt\":\"5,777,000,000\"},\"ebit\":{\"raw\":1991000000,\"fmt\":\"1.99B\",\"longFmt\":\"1,991,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"operatingIncome\":{\"raw\":1991000000,\"fmt\":\"1.99B\",\"longFmt\":\"1,991,000,000\"},\"otherOperatingExpenses\":{\"raw\":-228000000,\"fmt\":\"-228M\",\"longFmt\":\"-228,000,000\"},\"interestExpense\":{\"raw\":-210000000,\"fmt\":\"-210M\",\"longFmt\":\"-210,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":-18000000,\"fmt\":\"-18M\",\"longFmt\":\"-18,000,000\"},\"totalRevenue\":{\"raw\":8739000000,\"fmt\":\"8.74B\",\"longFmt\":\"8,739,000,000\"},\"totalOperatingExpenses\":{\"raw\":6748000000,\"fmt\":\"6.75B\",\"longFmt\":\"6,748,000,000\"},\"costOfRevenue\":{\"raw\":2962000000,\"fmt\":\"2.96B\",\"longFmt\":\"2,962,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-1170000000,\"fmt\":\"-1.17B\",\"longFmt\":\"-1,170,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":839000000,\"fmt\":\"839M\",\"longFmt\":\"839,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"}}],\"maxAge\":86400},\"incomeStatementHistory\":{\"incomeStatementHistory\":[{\"researchDevelopment\":{\"raw\":4678000000,\"fmt\":\"4.68B\",\"longFmt\":\"4,678,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":6968000000,\"fmt\":\"6.97B\",\"longFmt\":\"6,968,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"netIncome\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":10503000000,\"fmt\":\"10.5B\",\"longFmt\":\"10,503,000,000\"},\"grossProfit\":{\"raw\":23209000000,\"fmt\":\"23.21B\",\"longFmt\":\"23,209,000,000\"},\"ebit\":{\"raw\":8483000000,\"fmt\":\"8.48B\",\"longFmt\":\"8,483,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"operatingIncome\":{\"raw\":8483000000,\"fmt\":\"8.48B\",\"longFmt\":\"8,483,000,000\"},\"otherOperatingExpenses\":{\"raw\":-455000000,\"fmt\":\"-455M\",\"longFmt\":\"-455,000,000\"},\"interestExpense\":{\"raw\":-860000000,\"fmt\":\"-860M\",\"longFmt\":\"-860,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":580000000,\"fmt\":\"580M\",\"longFmt\":\"580,000,000\"},\"totalRevenue\":{\"raw\":34099000000,\"fmt\":\"34.1B\",\"longFmt\":\"34,099,000,000\"},\"totalOperatingExpenses\":{\"raw\":25616000000,\"fmt\":\"25.62B\",\"longFmt\":\"25,616,000,000\"},\"costOfRevenue\":{\"raw\":10890000000,\"fmt\":\"10.89B\",\"longFmt\":\"10,890,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-1515000000,\"fmt\":\"-1.51B\",\"longFmt\":\"-1,515,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":6388000000,\"fmt\":\"6.39B\",\"longFmt\":\"6,388,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"}},{\"researchDevelopment\":{\"raw\":4405000000,\"fmt\":\"4.41B\",\"longFmt\":\"4,405,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"minorityInterest\":{\"raw\":6952000000,\"fmt\":\"6.95B\",\"longFmt\":\"6,952,000,000\"},\"netIncome\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":10599000000,\"fmt\":\"10.6B\",\"longFmt\":\"10,599,000,000\"},\"grossProfit\":{\"raw\":22962000000,\"fmt\":\"22.96B\",\"longFmt\":\"22,962,000,000\"},\"ebit\":{\"raw\":8564000000,\"fmt\":\"8.56B\",\"longFmt\":\"8,564,000,000\"},\"endDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"operatingIncome\":{\"raw\":8564000000,\"fmt\":\"8.56B\",\"longFmt\":\"8,564,000,000\"},\"otherOperatingExpenses\":{\"raw\":-606000000,\"fmt\":\"-606M\",\"longFmt\":\"-606,000,000\"},\"interestExpense\":{\"raw\":-877000000,\"fmt\":\"-877M\",\"longFmt\":\"-877,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":953000000,\"fmt\":\"953M\",\"longFmt\":\"953,000,000\"},\"totalRevenue\":{\"raw\":33754000000,\"fmt\":\"33.75B\",\"longFmt\":\"33,754,000,000\"},\"totalOperatingExpenses\":{\"raw\":25190000000,\"fmt\":\"25.19B\",\"longFmt\":\"25,190,000,000\"},\"costOfRevenue\":{\"raw\":10792000000,\"fmt\":\"10.79B\",\"longFmt\":\"10,792,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-2343000000,\"fmt\":\"-2.34B\",\"longFmt\":\"-2,343,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":5268000000,\"fmt\":\"5.27B\",\"longFmt\":\"5,268,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"}},{\"researchDevelopment\":{\"raw\":3799000000,\"fmt\":\"3.8B\",\"longFmt\":\"3,799,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":4800000000,\"fmt\":\"4.8B\",\"longFmt\":\"4,800,000,000\"},\"minorityInterest\":{\"raw\":-109000000,\"fmt\":\"-109M\",\"longFmt\":\"-109,000,000\"},\"netIncome\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":9500000000,\"fmt\":\"9.5B\",\"longFmt\":\"9,500,000,000\"},\"grossProfit\":{\"raw\":21107000000,\"fmt\":\"21.11B\",\"longFmt\":\"21,107,000,000\"},\"ebit\":{\"raw\":7495000000,\"fmt\":\"7.5B\",\"longFmt\":\"7,495,000,000\"},\"endDate\":{\"raw\":1546214400,\"fmt\":\"2018-12-31\"},\"operatingIncome\":{\"raw\":7495000000,\"fmt\":\"7.5B\",\"longFmt\":\"7,495,000,000\"},\"otherOperatingExpenses\":{\"raw\":313000000,\"fmt\":\"313M\",\"longFmt\":\"313,000,000\"},\"interestExpense\":{\"raw\":-756000000,\"fmt\":\"-756M\",\"longFmt\":\"-756,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":754000000,\"fmt\":\"754M\",\"longFmt\":\"754,000,000\"},\"totalRevenue\":{\"raw\":30821000000,\"fmt\":\"30.82B\",\"longFmt\":\"30,821,000,000\"},\"totalOperatingExpenses\":{\"raw\":23326000000,\"fmt\":\"23.33B\",\"longFmt\":\"23,326,000,000\"},\"costOfRevenue\":{\"raw\":9714000000,\"fmt\":\"9.71B\",\"longFmt\":\"9,714,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-2695000000,\"fmt\":\"-2.69B\",\"longFmt\":\"-2,695,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":4046000000,\"fmt\":\"4.05B\",\"longFmt\":\"4,046,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"}},{\"researchDevelopment\":{\"raw\":3925000000,\"fmt\":\"3.92B\",\"longFmt\":\"3,925,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":3525000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,525,000,000\"},\"minorityInterest\":{\"raw\":3557000000,\"fmt\":\"3.56B\",\"longFmt\":\"3,557,000,000\"},\"netIncome\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":9424000000,\"fmt\":\"9.42B\",\"longFmt\":\"9,424,000,000\"},\"grossProfit\":{\"raw\":20869000000,\"fmt\":\"20.87B\",\"longFmt\":\"20,869,000,000\"},\"ebit\":{\"raw\":6721000000,\"fmt\":\"6.72B\",\"longFmt\":\"6,721,000,000\"},\"endDate\":{\"raw\":1514678400,\"fmt\":\"2017-12-31\"},\"operatingIncome\":{\"raw\":6721000000,\"fmt\":\"6.72B\",\"longFmt\":\"6,721,000,000\"},\"otherOperatingExpenses\":{\"raw\":799000000,\"fmt\":\"799M\",\"longFmt\":\"799,000,000\"},\"interestExpense\":{\"raw\":-721000000,\"fmt\":\"-721M\",\"longFmt\":\"-721,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":1356000000,\"fmt\":\"1.36B\",\"longFmt\":\"1,356,000,000\"},\"totalRevenue\":{\"raw\":30186000000,\"fmt\":\"30.19B\",\"longFmt\":\"30,186,000,000\"},\"totalOperatingExpenses\":{\"raw\":23465000000,\"fmt\":\"23.46B\",\"longFmt\":\"23,465,000,000\"},\"costOfRevenue\":{\"raw\":9317000000,\"fmt\":\"9.32B\",\"longFmt\":\"9,317,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-3196000000,\"fmt\":\"-3.2B\",\"longFmt\":\"-3,196,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":2169000000,\"fmt\":\"2.17B\",\"longFmt\":\"2,169,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"}}],\"maxAge\":86400},\"balanceSheetHistory\":{\"balanceSheetStatements\":[{\"intangibleAssets\":{\"raw\":29824000000,\"fmt\":\"29.82B\",\"longFmt\":\"29,824,000,000\"},\"capitalSurplus\":{\"raw\":3281000000,\"fmt\":\"3.28B\",\"longFmt\":\"3,281,000,000\"},\"totalLiab\":{\"raw\":59623000000,\"fmt\":\"59.62B\",\"longFmt\":\"59,623,000,000\"},\"totalStockholderEquity\":{\"raw\":14587000000,\"fmt\":\"14.59B\",\"longFmt\":\"14,587,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"otherCurrentLiab\":{\"raw\":5338000000,\"fmt\":\"5.34B\",\"longFmt\":\"5,338,000,000\"},\"totalAssets\":{\"raw\":80431000000,\"fmt\":\"80.43B\",\"longFmt\":\"80,431,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":195000000,\"fmt\":\"195M\",\"longFmt\":\"195,000,000\"},\"retainedEarnings\":{\"raw\":7294000000,\"fmt\":\"7.29B\",\"longFmt\":\"7,294,000,000\"},\"otherLiab\":{\"raw\":14050000000,\"fmt\":\"14.05B\",\"longFmt\":\"14,050,000,000\"},\"goodWill\":{\"raw\":10597000000,\"fmt\":\"10.6B\",\"longFmt\":\"10,597,000,000\"},\"treasuryStock\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"otherAssets\":{\"raw\":5261000000,\"fmt\":\"5.26B\",\"longFmt\":\"5,261,000,000\"},\"cash\":{\"raw\":6292000000,\"fmt\":\"6.29B\",\"longFmt\":\"6,292,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22148000000,\"fmt\":\"22.15B\",\"longFmt\":\"22,148,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4287000000,\"fmt\":\"4.29B\",\"longFmt\":\"4,287,000,000\"},\"shortLongTermDebt\":{\"raw\":2449000000,\"fmt\":\"2.45B\",\"longFmt\":\"2,449,000,000\"},\"otherStockholderEquity\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"propertyPlantEquipment\":{\"raw\":11006000000,\"fmt\":\"11.01B\",\"longFmt\":\"11,006,000,000\"},\"totalCurrentAssets\":{\"raw\":20247000000,\"fmt\":\"20.25B\",\"longFmt\":\"20,247,000,000\"},\"longTermInvestments\":{\"raw\":3496000000,\"fmt\":\"3.5B\",\"longFmt\":\"3,496,000,000\"},\"netTangibleAssets\":{\"raw\":-25834000000,\"fmt\":\"-25.83B\",\"longFmt\":\"-25,834,000,000\"},\"shortTermInvestments\":{\"raw\":480000000,\"fmt\":\"480M\",\"longFmt\":\"480,000,000\"},\"netReceivables\":{\"raw\":6862000000,\"fmt\":\"6.86B\",\"longFmt\":\"6,862,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":22538000000,\"fmt\":\"22.54B\",\"longFmt\":\"22,538,000,000\"},\"inventory\":{\"raw\":5996000000,\"fmt\":\"6B\",\"longFmt\":\"5,996,000,000\"},\"accountsPayable\":{\"raw\":4357000000,\"fmt\":\"4.36B\",\"longFmt\":\"4,357,000,000\"}},{\"intangibleAssets\":{\"raw\":30955000000,\"fmt\":\"30.95B\",\"longFmt\":\"30,955,000,000\"},\"capitalSurplus\":{\"raw\":3174000000,\"fmt\":\"3.17B\",\"longFmt\":\"3,174,000,000\"},\"totalLiab\":{\"raw\":61335000000,\"fmt\":\"61.34B\",\"longFmt\":\"61,335,000,000\"},\"totalStockholderEquity\":{\"raw\":11405000000,\"fmt\":\"11.4B\",\"longFmt\":\"11,405,000,000\"},\"minorityInterest\":{\"raw\":6952000000,\"fmt\":\"6.95B\",\"longFmt\":\"6,952,000,000\"},\"otherCurrentLiab\":{\"raw\":4784000000,\"fmt\":\"4.78B\",\"longFmt\":\"4,784,000,000\"},\"totalAssets\":{\"raw\":79692000000,\"fmt\":\"79.69B\",\"longFmt\":\"79,692,000,000\"},\"endDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":941000000,\"fmt\":\"941M\",\"longFmt\":\"941,000,000\"},\"retainedEarnings\":{\"raw\":5054000000,\"fmt\":\"5.05B\",\"longFmt\":\"5,054,000,000\"},\"otherLiab\":{\"raw\":13695000000,\"fmt\":\"13.7B\",\"longFmt\":\"13,695,000,000\"},\"goodWill\":{\"raw\":10562000000,\"fmt\":\"10.56B\",\"longFmt\":\"10,562,000,000\"},\"treasuryStock\":{\"raw\":1831000000,\"fmt\":\"1.83B\",\"longFmt\":\"1,831,000,000\"},\"otherAssets\":{\"raw\":5094000000,\"fmt\":\"5.09B\",\"longFmt\":\"5,094,000,000\"},\"cash\":{\"raw\":4707000000,\"fmt\":\"4.71B\",\"longFmt\":\"4,707,000,000\"},\"totalCurrentLiabilities\":{\"raw\":24050000000,\"fmt\":\"24.05B\",\"longFmt\":\"24,050,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4096000000,\"fmt\":\"4.1B\",\"longFmt\":\"4,096,000,000\"},\"shortLongTermDebt\":{\"raw\":1710000000,\"fmt\":\"1.71B\",\"longFmt\":\"1,710,000,000\"},\"otherStockholderEquity\":{\"raw\":1831000000,\"fmt\":\"1.83B\",\"longFmt\":\"1,831,000,000\"},\"propertyPlantEquipment\":{\"raw\":11314000000,\"fmt\":\"11.31B\",\"longFmt\":\"11,314,000,000\"},\"totalCurrentAssets\":{\"raw\":19491000000,\"fmt\":\"19.49B\",\"longFmt\":\"19,491,000,000\"},\"longTermInvestments\":{\"raw\":2276000000,\"fmt\":\"2.28B\",\"longFmt\":\"2,276,000,000\"},\"netTangibleAssets\":{\"raw\":-30112000000,\"fmt\":\"-30.11B\",\"longFmt\":\"-30,112,000,000\"},\"shortTermInvestments\":{\"raw\":786000000,\"fmt\":\"786M\",\"longFmt\":\"786,000,000\"},\"netReceivables\":{\"raw\":6441000000,\"fmt\":\"6.44B\",\"longFmt\":\"6,441,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":22580000000,\"fmt\":\"22.58B\",\"longFmt\":\"22,580,000,000\"},\"inventory\":{\"raw\":5947000000,\"fmt\":\"5.95B\",\"longFmt\":\"5,947,000,000\"},\"accountsPayable\":{\"raw\":4144000000,\"fmt\":\"4.14B\",\"longFmt\":\"4,144,000,000\"}},{\"intangibleAssets\":{\"raw\":17202000000,\"fmt\":\"17.2B\",\"longFmt\":\"17,202,000,000\"},\"capitalSurplus\":{\"raw\":3091000000,\"fmt\":\"3.09B\",\"longFmt\":\"3,091,000,000\"},\"totalLiab\":{\"raw\":54394000000,\"fmt\":\"54.39B\",\"longFmt\":\"54,394,000,000\"},\"totalStockholderEquity\":{\"raw\":3781000000,\"fmt\":\"3.78B\",\"longFmt\":\"3,781,000,000\"},\"minorityInterest\":{\"raw\":-109000000,\"fmt\":\"-109M\",\"longFmt\":\"-109,000,000\"},\"otherCurrentLiab\":{\"raw\":5226000000,\"fmt\":\"5.23B\",\"longFmt\":\"5,226,000,000\"},\"totalAssets\":{\"raw\":58066000000,\"fmt\":\"58.07B\",\"longFmt\":\"58,066,000,000\"},\"endDate\":{\"raw\":1546214400,\"fmt\":\"2018-12-31\"},\"commonStock\":{\"raw\":1345000000,\"fmt\":\"1.34B\",\"longFmt\":\"1,345,000,000\"},\"otherCurrentAssets\":{\"raw\":658000000,\"fmt\":\"658M\",\"longFmt\":\"658,000,000\"},\"retainedEarnings\":{\"raw\":-2701000000,\"fmt\":\"-2.7B\",\"longFmt\":\"-2,701,000,000\"},\"otherLiab\":{\"raw\":11632000000,\"fmt\":\"11.63B\",\"longFmt\":\"11,632,000,000\"},\"goodWill\":{\"raw\":5789000000,\"fmt\":\"5.79B\",\"longFmt\":\"5,789,000,000\"},\"treasuryStock\":{\"raw\":2046000000,\"fmt\":\"2.05B\",\"longFmt\":\"2,046,000,000\"},\"otherAssets\":{\"raw\":5527000000,\"fmt\":\"5.53B\",\"longFmt\":\"5,527,000,000\"},\"cash\":{\"raw\":3874000000,\"fmt\":\"3.87B\",\"longFmt\":\"3,874,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22491000000,\"fmt\":\"22.49B\",\"longFmt\":\"22,491,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":3887000000,\"fmt\":\"3.89B\",\"longFmt\":\"3,887,000,000\"},\"shortLongTermDebt\":{\"raw\":1367000000,\"fmt\":\"1.37B\",\"longFmt\":\"1,367,000,000\"},\"otherStockholderEquity\":{\"raw\":2046000000,\"fmt\":\"2.05B\",\"longFmt\":\"2,046,000,000\"},\"propertyPlantEquipment\":{\"raw\":11058000000,\"fmt\":\"11.06B\",\"longFmt\":\"11,058,000,000\"},\"totalCurrentAssets\":{\"raw\":16927000000,\"fmt\":\"16.93B\",\"longFmt\":\"16,927,000,000\"},\"longTermInvestments\":{\"raw\":1563000000,\"fmt\":\"1.56B\",\"longFmt\":\"1,563,000,000\"},\"netTangibleAssets\":{\"raw\":-19210000000,\"fmt\":\"-19.21B\",\"longFmt\":\"-19,210,000,000\"},\"shortTermInvestments\":{\"raw\":419000000,\"fmt\":\"419M\",\"longFmt\":\"419,000,000\"},\"netReceivables\":{\"raw\":5946000000,\"fmt\":\"5.95B\",\"longFmt\":\"5,946,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":20227000000,\"fmt\":\"20.23B\",\"longFmt\":\"20,227,000,000\"},\"inventory\":{\"raw\":5476000000,\"fmt\":\"5.48B\",\"longFmt\":\"5,476,000,000\"},\"accountsPayable\":{\"raw\":3645000000,\"fmt\":\"3.65B\",\"longFmt\":\"3,645,000,000\"}},{\"intangibleAssets\":{\"raw\":17562000000,\"fmt\":\"17.56B\",\"longFmt\":\"17,562,000,000\"},\"capitalSurplus\":{\"raw\":3019000000,\"fmt\":\"3.02B\",\"longFmt\":\"3,019,000,000\"},\"totalLiab\":{\"raw\":52892000000,\"fmt\":\"52.89B\",\"longFmt\":\"52,892,000,000\"},\"totalStockholderEquity\":{\"raw\":-68000000,\"fmt\":\"-68M\",\"longFmt\":\"-68,000,000\"},\"minorityInterest\":{\"raw\":3557000000,\"fmt\":\"3.56B\",\"longFmt\":\"3,557,000,000\"},\"otherCurrentLiab\":{\"raw\":13913000000,\"fmt\":\"13.91B\",\"longFmt\":\"13,913,000,000\"},\"totalAssets\":{\"raw\":56381000000,\"fmt\":\"56.38B\",\"longFmt\":\"56,381,000,000\"},\"endDate\":{\"raw\":1514678400,\"fmt\":\"2017-12-31\"},\"commonStock\":{\"raw\":1343000000,\"fmt\":\"1.34B\",\"longFmt\":\"1,343,000,000\"},\"otherCurrentAssets\":{\"raw\":118000000,\"fmt\":\"118M\",\"longFmt\":\"118,000,000\"},\"retainedEarnings\":{\"raw\":-6920000000,\"fmt\":\"-6.92B\",\"longFmt\":\"-6,920,000,000\"},\"otherLiab\":{\"raw\":12059000000,\"fmt\":\"12.06B\",\"longFmt\":\"12,059,000,000\"},\"goodWill\":{\"raw\":5734000000,\"fmt\":\"5.73B\",\"longFmt\":\"5,734,000,000\"},\"treasuryStock\":{\"raw\":2490000000,\"fmt\":\"2.49B\",\"longFmt\":\"2,490,000,000\"},\"otherAssets\":{\"raw\":5209000000,\"fmt\":\"5.21B\",\"longFmt\":\"5,209,000,000\"},\"cash\":{\"raw\":3833000000,\"fmt\":\"3.83B\",\"longFmt\":\"3,833,000,000\"},\"totalCurrentLiabilities\":{\"raw\":26569000000,\"fmt\":\"26.57B\",\"longFmt\":\"26,569,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":3796000000,\"fmt\":\"3.8B\",\"longFmt\":\"3,796,000,000\"},\"shortLongTermDebt\":{\"raw\":2040000000,\"fmt\":\"2.04B\",\"longFmt\":\"2,040,000,000\"},\"otherStockholderEquity\":{\"raw\":2490000000,\"fmt\":\"2.49B\",\"longFmt\":\"2,490,000,000\"},\"propertyPlantEquipment\":{\"raw\":10860000000,\"fmt\":\"10.86B\",\"longFmt\":\"10,860,000,000\"},\"totalCurrentAssets\":{\"raw\":15907000000,\"fmt\":\"15.91B\",\"longFmt\":\"15,907,000,000\"},\"longTermInvestments\":{\"raw\":1109000000,\"fmt\":\"1.11B\",\"longFmt\":\"1,109,000,000\"},\"netTangibleAssets\":{\"raw\":-23364000000,\"fmt\":\"-23.36B\",\"longFmt\":\"-23,364,000,000\"},\"shortTermInvestments\":{\"raw\":78000000,\"fmt\":\"78M\",\"longFmt\":\"78,000,000\"},\"netReceivables\":{\"raw\":5950000000,\"fmt\":\"5.95B\",\"longFmt\":\"5,950,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":14221000000,\"fmt\":\"14.22B\",\"longFmt\":\"14,221,000,000\"},\"inventory\":{\"raw\":5557000000,\"fmt\":\"5.56B\",\"longFmt\":\"5,557,000,000\"},\"accountsPayable\":{\"raw\":3528000000,\"fmt\":\"3.53B\",\"longFmt\":\"3,528,000,000\"}}],\"maxAge\":86400},\"cashflowStatementHistoryQuarterly\":{\"cashflowStatements\":[{\"changeToLiabilities\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-1183000000,\"fmt\":\"-1.18B\",\"longFmt\":\"-1,183,000,000\"},\"netBorrowings\":{\"raw\":-275000000,\"fmt\":\"-275M\",\"longFmt\":\"-275,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-1394000000,\"fmt\":\"-1.39B\",\"longFmt\":\"-1,394,000,000\"},\"changeToOperatingActivities\":{\"raw\":-28000000,\"fmt\":\"-28M\",\"longFmt\":\"-28,000,000\"},\"issuanceOfStock\":{\"raw\":1000000,\"fmt\":\"1M\",\"longFmt\":\"1,000,000\"},\"netIncome\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"},\"changeInCash\":{\"raw\":-2000000,\"fmt\":\"-2M\",\"longFmt\":\"-2,000,000\"},\"endDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"effectOfExchangeRate\":{\"raw\":13000000,\"fmt\":\"13M\",\"longFmt\":\"13,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":2562000000,\"fmt\":\"2.56B\",\"longFmt\":\"2,562,000,000\"},\"depreciation\":{\"raw\":986000000,\"fmt\":\"986M\",\"longFmt\":\"986,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":7000000,\"fmt\":\"7M\",\"longFmt\":\"7,000,000\"},\"dividendsPaid\":{\"raw\":-951000000,\"fmt\":\"-951M\",\"longFmt\":\"-951,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-169000000,\"fmt\":\"-169M\",\"longFmt\":\"-169,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":436000000,\"fmt\":\"436M\",\"longFmt\":\"436,000,000\"},\"capitalExpenditures\":{\"raw\":-279000000,\"fmt\":\"-279M\",\"longFmt\":\"-279,000,000\"}},{\"investments\":{\"raw\":384000000,\"fmt\":\"384M\",\"longFmt\":\"384,000,000\"},\"changeToLiabilities\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-185000000,\"fmt\":\"-185M\",\"longFmt\":\"-185,000,000\"},\"netBorrowings\":{\"raw\":-406000000,\"fmt\":\"-406M\",\"longFmt\":\"-406,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-2045000000,\"fmt\":\"-2.04B\",\"longFmt\":\"-2,045,000,000\"},\"changeToOperatingActivities\":{\"raw\":-323000000,\"fmt\":\"-323M\",\"longFmt\":\"-323,000,000\"},\"issuanceOfStock\":{\"raw\":4000000,\"fmt\":\"4M\",\"longFmt\":\"4,000,000\"},\"netIncome\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"},\"changeInCash\":{\"raw\":-937000000,\"fmt\":\"-937M\",\"longFmt\":\"-937,000,000\"},\"endDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"effectOfExchangeRate\":{\"raw\":1000000,\"fmt\":\"1M\",\"longFmt\":\"1,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":1292000000,\"fmt\":\"1.29B\",\"longFmt\":\"1,292,000,000\"},\"depreciation\":{\"raw\":664000000,\"fmt\":\"664M\",\"longFmt\":\"664,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":18000000,\"fmt\":\"18M\",\"longFmt\":\"18,000,000\"},\"dividendsPaid\":{\"raw\":-1151000000,\"fmt\":\"-1.15B\",\"longFmt\":\"-1,151,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-492000000,\"fmt\":\"-492M\",\"longFmt\":\"-492,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":-444000000,\"fmt\":\"-444M\",\"longFmt\":\"-444,000,000\"},\"capitalExpenditures\":{\"raw\":-239000000,\"fmt\":\"-239M\",\"longFmt\":\"-239,000,000\"}},{\"investments\":{\"raw\":-41000000,\"fmt\":\"-41M\",\"longFmt\":\"-41,000,000\"},\"changeToLiabilities\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-48000000,\"fmt\":\"-48M\",\"longFmt\":\"-48,000,000\"},\"netBorrowings\":{\"raw\":-54000000,\"fmt\":\"-54M\",\"longFmt\":\"-54,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-1376000000,\"fmt\":\"-1.38B\",\"longFmt\":\"-1,376,000,000\"},\"changeToOperatingActivities\":{\"raw\":-1376000000,\"fmt\":\"-1.38B\",\"longFmt\":\"-1,376,000,000\"},\"issuanceOfStock\":{\"raw\":15000000,\"fmt\":\"15M\",\"longFmt\":\"15,000,000\"},\"netIncome\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"},\"changeInCash\":{\"raw\":-1128000000,\"fmt\":\"-1.13B\",\"longFmt\":\"-1,128,000,000\"},\"endDate\":{\"raw\":1617148800,\"fmt\":\"2021-03-31\"},\"effectOfExchangeRate\":{\"raw\":-35000000,\"fmt\":\"-35M\",\"longFmt\":\"-35,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":331000000,\"fmt\":\"331M\",\"longFmt\":\"331,000,000\"},\"depreciation\":{\"raw\":361000000,\"fmt\":\"361M\",\"longFmt\":\"361,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":8000000,\"fmt\":\"8M\",\"longFmt\":\"8,000,000\"},\"dividendsPaid\":{\"raw\":-946000000,\"fmt\":\"-946M\",\"longFmt\":\"-946,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-391000000,\"fmt\":\"-391M\",\"longFmt\":\"-391,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":273000000,\"fmt\":\"273M\",\"longFmt\":\"273,000,000\"},\"capitalExpenditures\":{\"raw\":-201000000,\"fmt\":\"-201M\",\"longFmt\":\"-201,000,000\"}},{\"investments\":{\"raw\":117000000,\"fmt\":\"117M\",\"longFmt\":\"117,000,000\"},\"changeToLiabilities\":{\"raw\":225000000,\"fmt\":\"225M\",\"longFmt\":\"225,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-52000000,\"fmt\":\"-52M\",\"longFmt\":\"-52,000,000\"},\"netBorrowings\":{\"raw\":-577000000,\"fmt\":\"-577M\",\"longFmt\":\"-577,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-2175000000,\"fmt\":\"-2.17B\",\"longFmt\":\"-2,175,000,000\"},\"changeToOperatingActivities\":{\"raw\":-262000000,\"fmt\":\"-262M\",\"longFmt\":\"-262,000,000\"},\"issuanceOfStock\":{\"raw\":1000000,\"fmt\":\"1M\",\"longFmt\":\"1,000,000\"},\"netIncome\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"},\"changeInCash\":{\"raw\":1606000000,\"fmt\":\"1.61B\",\"longFmt\":\"1,606,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"effectOfExchangeRate\":{\"raw\":-22000000,\"fmt\":\"-22M\",\"longFmt\":\"-22,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":3855000000,\"fmt\":\"3.85B\",\"longFmt\":\"3,855,000,000\"},\"depreciation\":{\"raw\":2440000000,\"fmt\":\"2.44B\",\"longFmt\":\"2,440,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":23000000,\"fmt\":\"23M\",\"longFmt\":\"23,000,000\"},\"dividendsPaid\":{\"raw\":-946000000,\"fmt\":\"-946M\",\"longFmt\":\"-946,000,000\"},\"changeToInventory\":{\"raw\":119000000,\"fmt\":\"119M\",\"longFmt\":\"119,000,000\"},\"changeToAccountReceivables\":{\"raw\":-224000000,\"fmt\":\"-224M\",\"longFmt\":\"-224,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-653000000,\"fmt\":\"-653M\",\"longFmt\":\"-653,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":639000000,\"fmt\":\"639M\",\"longFmt\":\"639,000,000\"},\"capitalExpenditures\":{\"raw\":-514000000,\"fmt\":\"-514M\",\"longFmt\":\"-514,000,000\"}}],\"maxAge\":86400},\"quoteType\":{\"exchange\":\"NYQ\",\"shortName\":\"GlaxoSmithKline PLC\",\"longName\":\"GlaxoSmithKline plc\",\"exchangeTimezoneName\":\"America/New_York\",\"exchangeTimezoneShortName\":\"EST\",\"isEsgPopulated\":false,\"gmtOffSetMilliseconds\":\"-18000000\",\"quoteType\":\"EQUITY\",\"symbol\":\"GSK\",\"messageBoardId\":\"finmb_275442\",\"market\":\"us_market\"},\"summaryDetail\":{\"previousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"twoHundredDayAverage\":{\"raw\":39.97489,\"fmt\":\"39.97\"},\"trailingAnnualDividendYield\":{\"raw\":0.018845702,\"fmt\":\"1.88%\"},\"payoutRatio\":{\"raw\":0.935,\"fmt\":\"93.50%\"},\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"navPrice\":{},\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"totalAssets\":{},\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"fiftyDayAverage\":{\"raw\":40.445,\"fmt\":\"40.44\"},\"trailingAnnualDividendRate\":{\"raw\":0.8,\"fmt\":\"0.80\"},\"open\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"toCurrency\":null,\"averageVolume10days\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"expireDate\":{},\"yield\":{},\"algorithm\":null,\"dividendRate\":{\"raw\":2.2,\"fmt\":\"2.20\"},\"exDividendDate\":{\"raw\":1637193600,\"fmt\":\"2021-11-18\"},\"beta\":{\"raw\":0.402824,\"fmt\":\"0.40\"},\"circulatingSupply\":{},\"startDate\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"trailingPE\":{\"raw\":18.629807,\"fmt\":\"18.63\"},\"regularMarketVolume\":{\"raw\":2359284,\"fmt\":\"2.36M\",\"longFmt\":\"2,359,284\"},\"lastMarket\":null,\"maxSupply\":{},\"openInterest\":{},\"marketCap\":{\"raw\":107239383040,\"fmt\":\"107.24B\",\"longFmt\":\"107,239,383,040\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"averageVolume\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"priceToSalesTrailing12Months\":{\"raw\":3.2178893,\"fmt\":\"3.22\"},\"dayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"ask\":{\"raw\":0,\"fmt\":\"0.00\"},\"ytdReturn\":{},\"askSize\":{\"raw\":4000,\"fmt\":\"4k\",\"longFmt\":\"4,000\"},\"volume\":{\"raw\":2359284,\"fmt\":\"2.36M\",\"longFmt\":\"2,359,284\"},\"fiftyTwoWeekHigh\":{\"raw\":43.61,\"fmt\":\"43.61\"},\"forwardPE\":{\"raw\":13.3203125,\"fmt\":\"13.32\"},\"maxAge\":1,\"fromCurrency\":null,\"fiveYearAvgDividendYield\":{\"raw\":5.24,\"fmt\":\"5.24\"},\"fiftyTwoWeekLow\":{\"raw\":33.53,\"fmt\":\"33.53\"},\"bid\":{\"raw\":0,\"fmt\":\"0.00\"},\"tradeable\":false,\"dividendYield\":{\"raw\":0.051,\"fmt\":\"5.10%\"},\"bidSize\":{\"raw\":1400,\"fmt\":\"1.4k\",\"longFmt\":\"1,400\"},\"dayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"}},\"symbol\":\"GSK\",\"pageViews\":{\"shortTermTrend\":\"UP\",\"midTermTrend\":\"UP\",\"longTermTrend\":\"UP\",\"maxAge\":1},\"timeSeries\":{\"annualBasicAverageShares\":[{\"dataId\":29010,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2443000000,\"fmt\":\"2.44B\"}},{\"dataId\":29010,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2457000000,\"fmt\":\"2.46B\"}},{\"dataId\":29010,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2473500000,\"fmt\":\"2.47B\"}},{\"dataId\":29010,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2488000000,\"fmt\":\"2.49B\"}}],\"annualInterestExpense\":[{\"dataId\":20057,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":736000000,\"fmt\":\"736.00M\"}},{\"dataId\":20057,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":771000000,\"fmt\":\"771.00M\"}},{\"dataId\":20057,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":885000000,\"fmt\":\"885.00M\"}},{\"dataId\":20057,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":856000000,\"fmt\":\"856.00M\"}}],\"annualPretaxIncome\":[{\"dataId\":20136,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3525000000,\"fmt\":\"3.52B\"}},{\"dataId\":20136,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4800000000,\"fmt\":\"4.80B\"}},{\"dataId\":20136,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6221000000,\"fmt\":\"6.22B\"}},{\"dataId\":20136,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6968000000,\"fmt\":\"6.97B\"}}],\"trailingInterestExpense\":[{\"dataId\":20057,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":796000000,\"fmt\":\"796.00M\"}}],\"trailingCostOfRevenue\":[{\"dataId\":20013,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11094000000,\"fmt\":\"11.09B\"}}],\"annualEbitda\":[{\"dataId\":20190,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6183000000,\"fmt\":\"6.18B\"}},{\"dataId\":20190,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":7427000000,\"fmt\":\"7.43B\"}},{\"dataId\":20190,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":9440000000,\"fmt\":\"9.44B\"}},{\"dataId\":20190,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10175000000,\"fmt\":\"10.18B\"}}],\"annualCostOfRevenue\":[{\"dataId\":20013,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10342000000,\"fmt\":\"10.34B\"}},{\"dataId\":20013,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10241000000,\"fmt\":\"10.24B\"}},{\"dataId\":20013,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11863000000,\"fmt\":\"11.86B\"}},{\"dataId\":20013,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11704000000,\"fmt\":\"11.70B\"}}],\"annualNetIncomeContinuousOperations\":[{\"dataId\":20094,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2169000000,\"fmt\":\"2.17B\"}},{\"dataId\":20094,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4046000000,\"fmt\":\"4.05B\"}},{\"dataId\":20094,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5268000000,\"fmt\":\"5.27B\"}},{\"dataId\":20094,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6388000000,\"fmt\":\"6.39B\"}}],\"annualDilutedAverageShares\":[{\"dataId\":29011,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2470500000,\"fmt\":\"2.47B\"}},{\"dataId\":29011,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2485500000,\"fmt\":\"2.49B\"}},{\"dataId\":29011,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2508000000,\"fmt\":\"2.51B\"}},{\"dataId\":29011,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2519000000,\"fmt\":\"2.52B\"}}],\"annualTotalRevenue\":[{\"dataId\":20100,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":30186000000,\"fmt\":\"30.19B\"}},{\"dataId\":20100,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":30821000000,\"fmt\":\"30.82B\"}},{\"dataId\":20100,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":33754000000,\"fmt\":\"33.75B\"}},{\"dataId\":20100,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":34099000000,\"fmt\":\"34.10B\"}}],\"trailingTotalRevenue\":[{\"dataId\":20100,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":33326000000,\"fmt\":\"33.33B\"}}],\"trailingResearchAndDevelopment\":[{\"dataId\":20151,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5300000000,\"fmt\":\"5.30B\"}}],\"annualNetIncome\":[{\"dataId\":20091,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1532000000,\"fmt\":\"1.53B\"}},{\"dataId\":20091,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3623000000,\"fmt\":\"3.62B\"}},{\"dataId\":20091,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4645000000,\"fmt\":\"4.64B\"}},{\"dataId\":20091,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5749000000,\"fmt\":\"5.75B\"}}],\"annualOperatingIncome\":[{\"dataId\":20109,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6061000000,\"fmt\":\"6.06B\"}},{\"dataId\":20109,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":7064000000,\"fmt\":\"7.06B\"}},{\"dataId\":20109,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6292000000,\"fmt\":\"6.29B\"}},{\"dataId\":20109,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6224000000,\"fmt\":\"6.22B\"}}],\"trailingNetIncomeContinuousOperations\":[{\"dataId\":20094,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5005000000,\"fmt\":\"5.00B\"}}],\"trailingOperatingExpense\":[{\"dataId\":20108,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":17424000000,\"fmt\":\"17.42B\"}}],\"annualDilutedEPS\":[{\"dataId\":29009,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":0.62,\"fmt\":\"0.62\"}},{\"dataId\":29009,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1.458,\"fmt\":\"1.46\"}},{\"dataId\":29009,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1.852,\"fmt\":\"1.85\"}},{\"dataId\":29009,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2.282,\"fmt\":\"2.28\"}}],\"trailingSellingGeneralAndAdministration\":[{\"dataId\":20159,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10877000000,\"fmt\":\"10.88B\"}}],\"annualBasicEPS\":[{\"dataId\":29004,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":0.628,\"fmt\":\"0.63\"}},{\"dataId\":29004,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1.474,\"fmt\":\"1.47\"}},{\"dataId\":29004,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1.878,\"fmt\":\"1.88\"}},{\"dataId\":29004,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2.31,\"fmt\":\"2.31\"}}],\"trailingGrossProfit\":[{\"dataId\":20046,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22232000000,\"fmt\":\"22.23B\"}}],\"annualGrossProfit\":[{\"dataId\":20046,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":19844000000,\"fmt\":\"19.84B\"}},{\"dataId\":20046,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":20580000000,\"fmt\":\"20.58B\"}},{\"dataId\":20046,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":21891000000,\"fmt\":\"21.89B\"}},{\"dataId\":20046,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22395000000,\"fmt\":\"22.39B\"}}],\"annualOperatingExpense\":[{\"dataId\":20108,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":13783000000,\"fmt\":\"13.78B\"}},{\"dataId\":20108,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":13516000000,\"fmt\":\"13.52B\"}},{\"dataId\":20108,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":15599000000,\"fmt\":\"15.60B\"}},{\"dataId\":20108,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":16171000000,\"fmt\":\"16.17B\"}}],\"annualResearchAndDevelopment\":[{\"dataId\":20151,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4476000000,\"fmt\":\"4.48B\"}},{\"dataId\":20151,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3893000000,\"fmt\":\"3.89B\"}},{\"dataId\":20151,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4568000000,\"fmt\":\"4.57B\"}},{\"dataId\":20151,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5098000000,\"fmt\":\"5.10B\"}}],\"trailingNetIncomeCommonStockholders\":[{\"dataId\":20093,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4313000000,\"fmt\":\"4.31B\"}}],\"trailingOperatingIncome\":[{\"dataId\":20109,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4808000000,\"fmt\":\"4.81B\"}}],\"trailingNetIncome\":[{\"dataId\":20091,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4313000000,\"fmt\":\"4.31B\"}}],\"trailingTaxProvision\":[{\"dataId\":20145,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":552000000,\"fmt\":\"552.00M\"}}],\"annualSellingGeneralAndAdministration\":[{\"dataId\":20159,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":9672000000,\"fmt\":\"9.67B\"}},{\"dataId\":20159,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":9915000000,\"fmt\":\"9.91B\"}},{\"dataId\":20159,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11402000000,\"fmt\":\"11.40B\"}},{\"dataId\":20159,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11456000000,\"fmt\":\"11.46B\"}}],\"annualTaxProvision\":[{\"dataId\":20145,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1356000000,\"fmt\":\"1.36B\"}},{\"dataId\":20145,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":754000000,\"fmt\":\"754.00M\"}},{\"dataId\":20145,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":953000000,\"fmt\":\"953.00M\"}},{\"dataId\":20145,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":580000000,\"fmt\":\"580.00M\"}}],\"annualNetIncomeCommonStockholders\":[{\"dataId\":20093,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1532000000,\"fmt\":\"1.53B\"}},{\"dataId\":20093,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3623000000,\"fmt\":\"3.62B\"}},{\"dataId\":20093,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4645000000,\"fmt\":\"4.64B\"}},{\"dataId\":20093,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5749000000,\"fmt\":\"5.75B\"}}],\"trailingPretaxIncome\":[{\"dataId\":20136,\"asOfDate\":\"2021-09-30\",\"periodType\":\"TTM\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5557000000,\"fmt\":\"5.56B\"}}],\"trailingOtherIncomeExpense\":[],\"trailingDilutedEPS\":[],\"trailingDilutedAverageShares\":[],\"trailingBasicAverageShares\":[],\"annualOtherIncomeExpense\":[],\"trailingBasicEPS\":[],\"timestamp\":[1514678400,1546214400,1577750400,1609372800]},\"meta\":{\"symbol\":\"GSK\",\"start\":493590046,\"end\":1637168969,\"timeUnit\":\"annual\"},\"loading\":false,\"errorList\":[]}\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "\n",
    "url = \"https://apidojo-yahoo-finance-v1.p.rapidapi.com/stock/v2/get-financials\"\n",
    "\n",
    "querystring = {\"symbol\":\"gsk\",\"region\":\"uk\"}\n",
    "\n",
    "headers = {\n",
    "    'x-rapidapi-host': \"apidojo-yahoo-finance-v1.p.rapidapi.com\",\n",
    "    'x-rapidapi-key': \"9cd97ba3camsh244cbd2e3e420a4p1e83c0jsne0fdd0787f8e\"\n",
    "    }\n",
    "\n",
    "response = requests.request(\"GET\", url, headers=headers, params=querystring)\n",
    "\n",
    "print(response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"financialsTemplate\":{\"code\":\"N\",\"maxAge\":1},\"price\":{\"quoteSourceName\":\"Nasdaq Real Time Price\",\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"averageDailyVolume3Month\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"exchange\":\"NYQ\",\"regularMarketTime\":1637169158,\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"shortName\":\"GlaxoSmithKline PLC\",\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"longName\":\"GlaxoSmithKline plc\",\"regularMarketChange\":{\"raw\":0.17710114,\"fmt\":\"0.18\"},\"currencySymbol\":\"$\",\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"preMarketPrice\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"preMarketTime\":1637159399,\"exchangeDataDelayedBy\":0,\"toCurrency\":null,\"postMarketChange\":{},\"postMarketPrice\":{},\"exchangeName\":\"NYSE\",\"preMarketChange\":{\"raw\":-0.190002,\"fmt\":\"-0.19\"},\"circulatingSupply\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"regularMarketPrice\":{\"raw\":42.6271,\"fmt\":\"42.63\"},\"regularMarketVolume\":{\"raw\":2379143,\"fmt\":\"2.38M\",\"longFmt\":\"2,379,143.00\"},\"lastMarket\":null,\"regularMarketSource\":\"FREE_REALTIME\",\"openInterest\":{},\"marketState\":\"REGULAR\",\"underlyingSymbol\":null,\"marketCap\":{\"raw\":107244666880,\"fmt\":\"107.24B\",\"longFmt\":\"107,244,666,880.00\"},\"quoteType\":\"EQUITY\",\"preMarketChangePercent\":{\"raw\":-0.00447591,\"fmt\":\"-0.45%\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"symbol\":\"GSK\",\"preMarketSource\":\"FREE_REALTIME\",\"maxAge\":1,\"fromCurrency\":null,\"regularMarketChangePercent\":{\"raw\":0.0041719936,\"fmt\":\"0.42%\"}},\"secFilings\":{},\"quoteType\":{\"exchange\":\"NYQ\",\"shortName\":\"GlaxoSmithKline PLC\",\"longName\":\"GlaxoSmithKline plc\",\"exchangeTimezoneName\":\"America/New_York\",\"exchangeTimezoneShortName\":\"EST\",\"isEsgPopulated\":false,\"gmtOffSetMilliseconds\":\"-18000000\",\"quoteType\":\"EQUITY\",\"symbol\":\"GSK\",\"messageBoardId\":\"finmb_275442\",\"market\":\"us_market\"},\"calendarEvents\":{\"maxAge\":1,\"earnings\":{\"earningsDate\":[{\"raw\":1485964740,\"fmt\":\"2017-02-01\"},{\"raw\":1486400400,\"fmt\":\"2017-02-06\"}],\"earningsAverage\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"earningsLow\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"earningsHigh\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"revenueAverage\":{\"raw\":12587600000,\"fmt\":\"12.59B\",\"longFmt\":\"12,587,600,000\"},\"revenueLow\":{\"raw\":12350200000,\"fmt\":\"12.35B\",\"longFmt\":\"12,350,200,000\"},\"revenueHigh\":{\"raw\":12755600000,\"fmt\":\"12.76B\",\"longFmt\":\"12,755,600,000\"}},\"exDividendDate\":{\"raw\":1637193600,\"fmt\":\"2021-11-18\"},\"dividendDate\":{\"raw\":1642032000,\"fmt\":\"2022-01-13\"}},\"summaryDetail\":{\"previousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"twoHundredDayAverage\":{\"raw\":39.97489,\"fmt\":\"39.97\"},\"trailingAnnualDividendYield\":{\"raw\":0.018845702,\"fmt\":\"1.88%\"},\"payoutRatio\":{\"raw\":0.935,\"fmt\":\"93.50%\"},\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"navPrice\":{},\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"totalAssets\":{},\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"fiftyDayAverage\":{\"raw\":40.445,\"fmt\":\"40.44\"},\"trailingAnnualDividendRate\":{\"raw\":0.8,\"fmt\":\"0.80\"},\"open\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"toCurrency\":null,\"averageVolume10days\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"expireDate\":{},\"yield\":{},\"algorithm\":null,\"dividendRate\":{\"raw\":2.2,\"fmt\":\"2.20\"},\"exDividendDate\":{\"raw\":1637193600,\"fmt\":\"2021-11-18\"},\"beta\":{\"raw\":0.402824,\"fmt\":\"0.40\"},\"circulatingSupply\":{},\"startDate\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"trailingPE\":{\"raw\":18.630726,\"fmt\":\"18.63\"},\"regularMarketVolume\":{\"raw\":2379143,\"fmt\":\"2.38M\",\"longFmt\":\"2,379,143\"},\"lastMarket\":null,\"maxSupply\":{},\"openInterest\":{},\"marketCap\":{\"raw\":107244666880,\"fmt\":\"107.24B\",\"longFmt\":\"107,244,666,880\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"averageVolume\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"priceToSalesTrailing12Months\":{\"raw\":3.2180479,\"fmt\":\"3.22\"},\"dayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"ask\":{\"raw\":0,\"fmt\":\"0.00\"},\"ytdReturn\":{},\"askSize\":{\"raw\":4000,\"fmt\":\"4k\",\"longFmt\":\"4,000\"},\"volume\":{\"raw\":2379143,\"fmt\":\"2.38M\",\"longFmt\":\"2,379,143\"},\"fiftyTwoWeekHigh\":{\"raw\":43.61,\"fmt\":\"43.61\"},\"forwardPE\":{\"raw\":13.32097,\"fmt\":\"13.32\"},\"maxAge\":1,\"fromCurrency\":null,\"fiveYearAvgDividendYield\":{\"raw\":5.24,\"fmt\":\"5.24\"},\"fiftyTwoWeekLow\":{\"raw\":33.53,\"fmt\":\"33.53\"},\"bid\":{\"raw\":0,\"fmt\":\"0.00\"},\"tradeable\":false,\"dividendYield\":{\"raw\":0.051,\"fmt\":\"5.10%\"},\"bidSize\":{\"raw\":1400,\"fmt\":\"1.4k\",\"longFmt\":\"1,400\"},\"dayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"}},\"symbol\":\"GSK\",\"assetProfile\":{\"zip\":\"TW8 9GS\",\"sector\":\"Healthcare\",\"fullTimeEmployees\":94066,\"compensationRisk\":8,\"auditRisk\":1,\"longBusinessSummary\":\"GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.\",\"city\":\"Brentford\",\"phone\":\"44 20 8047 5000\",\"shareHolderRightsRisk\":1,\"compensationAsOfEpochDate\":1609372800,\"governanceEpochDate\":1632614400,\"boardRisk\":3,\"country\":\"United Kingdom\",\"companyOfficers\":[{\"totalPay\":{\"raw\":3694573,\"fmt\":\"3.69M\",\"longFmt\":\"3,694,573\"},\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"yearBorn\":1970,\"name\":\"Ms. Emma N. Walmsley\",\"title\":\"CEO & Director\",\"maxAge\":1,\"fiscalYear\":2020,\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"age\":50},{\"totalPay\":{\"raw\":2697816,\"fmt\":\"2.7M\",\"longFmt\":\"2,697,816\"},\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"yearBorn\":1962,\"name\":\"Mr. Iain James Mackay\",\"title\":\"CFO & Exec. Director\",\"maxAge\":1,\"fiscalYear\":2020,\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"age\":58},{\"totalPay\":{\"raw\":4832000,\"fmt\":\"4.83M\",\"longFmt\":\"4,832,000\"},\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"yearBorn\":1963,\"name\":\"Dr. Hal V. Barron F.A.C.C., M.D.\",\"title\":\"Chief Scientific Officer, Pres of R&D and Director\",\"maxAge\":1,\"fiscalYear\":2020,\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"age\":57},{\"maxAge\":1,\"name\":\"Ms. Karenann K. Terrell\",\"age\":58,\"title\":\"Chief Digital & Technology Officer\",\"yearBorn\":1962,\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},{\"maxAge\":1,\"name\":\"Ms. Sarah  Elton-Farr\",\"title\":\"Head of Investor Relations\",\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},{\"maxAge\":1,\"name\":\"Mr. James  Ford\",\"title\":\"Sr. VP & Gen. Counsel\",\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},{\"maxAge\":1,\"name\":\"Ms. Sally  Jackson\",\"title\":\"Sr. VP of Global Communications & CEO Office\",\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},{\"maxAge\":1,\"name\":\"Ms. Diana  Conrad\",\"title\":\"Sr. VP of HR\",\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},{\"maxAge\":1,\"name\":\"Mr. David Simon Redfern\",\"age\":54,\"title\":\"Chief Strategy Officer\",\"yearBorn\":1966,\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},{\"maxAge\":1,\"name\":\"Mr. Herve  Gisserot\",\"title\":\"Head of Pharmaceuticals for Asia-Pacific\",\"exercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"unexercisedValue\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}}],\"website\":\"http://www.gsk.com\",\"maxAge\":86400,\"overallRisk\":5,\"address1\":\"980 Great West Road\",\"industry\":\"Drug ManufacturersGeneral\"},\"pageViews\":{\"shortTermTrend\":\"UP\",\"midTermTrend\":\"UP\",\"longTermTrend\":\"UP\",\"maxAge\":1}}\n"
     ]
    }
   ],
   "source": [
    "url = \"https://apidojo-yahoo-finance-v1.p.rapidapi.com/stock/v2/get-profile\"\n",
    "\n",
    "querystring = {\"symbol\":\"gsk\",\"region\":\"uk\"}\n",
    "\n",
    "headers = {\n",
    "    'x-rapidapi-host': \"apidojo-yahoo-finance-v1.p.rapidapi.com\",\n",
    "    'x-rapidapi-key': \"9cd97ba3camsh244cbd2e3e420a4p1e83c0jsne0fdd0787f8e\"\n",
    "    }\n",
    "\n",
    "response = requests.request(\"GET\", url, headers=headers, params=querystring)\n",
    "\n",
    "print(response.text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"financialsTemplate\":{\"code\":\"N\",\"maxAge\":1},\"cashflowStatementHistory\":{\"cashflowStatements\":[{\"investments\":{\"raw\":2853000000,\"fmt\":\"2.85B\",\"longFmt\":\"2,853,000,000\"},\"changeToLiabilities\":{\"raw\":225000000,\"fmt\":\"225M\",\"longFmt\":\"225,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":2161000000,\"fmt\":\"2.16B\",\"longFmt\":\"2,161,000,000\"},\"netBorrowings\":{\"raw\":-4234000000,\"fmt\":\"-4.23B\",\"longFmt\":\"-4,234,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-10132000000,\"fmt\":\"-10.13B\",\"longFmt\":\"-10,132,000,000\"},\"changeToOperatingActivities\":{\"raw\":-159000000,\"fmt\":\"-159M\",\"longFmt\":\"-159,000,000\"},\"issuanceOfStock\":{\"raw\":29000000,\"fmt\":\"29M\",\"longFmt\":\"29,000,000\"},\"netIncome\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"},\"changeInCash\":{\"raw\":431000000,\"fmt\":\"431M\",\"longFmt\":\"431,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"effectOfExchangeRate\":{\"raw\":-39000000,\"fmt\":\"-39M\",\"longFmt\":\"-39,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":8441000000,\"fmt\":\"8.44B\",\"longFmt\":\"8,441,000,000\"},\"depreciation\":{\"raw\":2110000000,\"fmt\":\"2.11B\",\"longFmt\":\"2,110,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":70000000,\"fmt\":\"70M\",\"longFmt\":\"70,000,000\"},\"dividendsPaid\":{\"raw\":-3977000000,\"fmt\":\"-3.98B\",\"longFmt\":\"-3,977,000,000\"},\"changeToInventory\":{\"raw\":119000000,\"fmt\":\"119M\",\"longFmt\":\"119,000,000\"},\"changeToAccountReceivables\":{\"raw\":-224000000,\"fmt\":\"-224M\",\"longFmt\":\"-224,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-1950000000,\"fmt\":\"-1.95B\",\"longFmt\":\"-1,950,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":380000000,\"fmt\":\"380M\",\"longFmt\":\"380,000,000\"},\"capitalExpenditures\":{\"raw\":-1226000000,\"fmt\":\"-1.23B\",\"longFmt\":\"-1,226,000,000\"}},{\"investments\":{\"raw\":-199000000,\"fmt\":\"-199M\",\"longFmt\":\"-199,000,000\"},\"changeToLiabilities\":{\"raw\":263000000,\"fmt\":\"263M\",\"longFmt\":\"263,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-5354000000,\"fmt\":\"-5.35B\",\"longFmt\":\"-5,354,000,000\"},\"netBorrowings\":{\"raw\":3515000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,515,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-1840000000,\"fmt\":\"-1.84B\",\"longFmt\":\"-1,840,000,000\"},\"changeToOperatingActivities\":{\"raw\":-160000000,\"fmt\":\"-160M\",\"longFmt\":\"-160,000,000\"},\"issuanceOfStock\":{\"raw\":51000000,\"fmt\":\"51M\",\"longFmt\":\"51,000,000\"},\"netIncome\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"},\"changeInCash\":{\"raw\":744000000,\"fmt\":\"744M\",\"longFmt\":\"744,000,000\"},\"endDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"effectOfExchangeRate\":{\"raw\":-82000000,\"fmt\":\"-82M\",\"longFmt\":\"-82,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":8020000000,\"fmt\":\"8.02B\",\"longFmt\":\"8,020,000,000\"},\"depreciation\":{\"raw\":2101000000,\"fmt\":\"2.1B\",\"longFmt\":\"2,101,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":89000000,\"fmt\":\"89M\",\"longFmt\":\"89,000,000\"},\"dividendsPaid\":{\"raw\":-3953000000,\"fmt\":\"-3.95B\",\"longFmt\":\"-3,953,000,000\"},\"changeToInventory\":{\"raw\":300000000,\"fmt\":\"300M\",\"longFmt\":\"300,000,000\"},\"changeToAccountReceivables\":{\"raw\":-32000000,\"fmt\":\"-32M\",\"longFmt\":\"-32,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-1453000000,\"fmt\":\"-1.45B\",\"longFmt\":\"-1,453,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":670000000,\"fmt\":\"670M\",\"longFmt\":\"670,000,000\"},\"capitalExpenditures\":{\"raw\":-1265000000,\"fmt\":\"-1.26B\",\"longFmt\":\"-1,265,000,000\"}},{\"investments\":{\"raw\":-165000000,\"fmt\":\"-165M\",\"longFmt\":\"-165,000,000\"},\"changeToLiabilities\":{\"raw\":131000000,\"fmt\":\"131M\",\"longFmt\":\"131,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-1553000000,\"fmt\":\"-1.55B\",\"longFmt\":\"-1,553,000,000\"},\"netBorrowings\":{\"raw\":8124000000,\"fmt\":\"8.12B\",\"longFmt\":\"8,124,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-6389000000,\"fmt\":\"-6.39B\",\"longFmt\":\"-6,389,000,000\"},\"changeToOperatingActivities\":{\"raw\":18000000,\"fmt\":\"18M\",\"longFmt\":\"18,000,000\"},\"issuanceOfStock\":{\"raw\":74000000,\"fmt\":\"74M\",\"longFmt\":\"74,000,000\"},\"netIncome\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"},\"changeInCash\":{\"raw\":487000000,\"fmt\":\"487M\",\"longFmt\":\"487,000,000\"},\"endDate\":{\"raw\":1546214400,\"fmt\":\"2018-12-31\"},\"effectOfExchangeRate\":{\"raw\":8000000,\"fmt\":\"8M\",\"longFmt\":\"8,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":8421000000,\"fmt\":\"8.42B\",\"longFmt\":\"8,421,000,000\"},\"depreciation\":{\"raw\":1856000000,\"fmt\":\"1.86B\",\"longFmt\":\"1,856,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":111000000,\"fmt\":\"111M\",\"longFmt\":\"111,000,000\"},\"dividendsPaid\":{\"raw\":-3927000000,\"fmt\":\"-3.93B\",\"longFmt\":\"-3,927,000,000\"},\"changeToInventory\":{\"raw\":51000000,\"fmt\":\"51M\",\"longFmt\":\"51,000,000\"},\"changeToAccountReceivables\":{\"raw\":-429000000,\"fmt\":\"-429M\",\"longFmt\":\"-429,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-10660000000,\"fmt\":\"-10.66B\",\"longFmt\":\"-10,660,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":3171000000,\"fmt\":\"3.17B\",\"longFmt\":\"3,171,000,000\"},\"capitalExpenditures\":{\"raw\":-1344000000,\"fmt\":\"-1.34B\",\"longFmt\":\"-1,344,000,000\"}},{\"investments\":{\"raw\":169000000,\"fmt\":\"169M\",\"longFmt\":\"169,000,000\"},\"changeToLiabilities\":{\"raw\":11000000,\"fmt\":\"11M\",\"longFmt\":\"11,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-1443000000,\"fmt\":\"-1.44B\",\"longFmt\":\"-1,443,000,000\"},\"netBorrowings\":{\"raw\":-990000000,\"fmt\":\"-990M\",\"longFmt\":\"-990,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-6380000000,\"fmt\":\"-6.38B\",\"longFmt\":\"-6,380,000,000\"},\"changeToOperatingActivities\":{\"raw\":74000000,\"fmt\":\"74M\",\"longFmt\":\"74,000,000\"},\"issuanceOfStock\":{\"raw\":56000000,\"fmt\":\"56M\",\"longFmt\":\"56,000,000\"},\"netIncome\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"},\"changeInCash\":{\"raw\":-1005000000,\"fmt\":\"-1B\",\"longFmt\":\"-1,005,000,000\"},\"endDate\":{\"raw\":1514678400,\"fmt\":\"2017-12-31\"},\"repurchaseOfStock\":{\"raw\":-65000000,\"fmt\":\"-65M\",\"longFmt\":\"-65,000,000\"},\"effectOfExchangeRate\":{\"raw\":-100000000,\"fmt\":\"-100M\",\"longFmt\":\"-100,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":6918000000,\"fmt\":\"6.92B\",\"longFmt\":\"6,918,000,000\"},\"depreciation\":{\"raw\":1922000000,\"fmt\":\"1.92B\",\"longFmt\":\"1,922,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":70000000,\"fmt\":\"70M\",\"longFmt\":\"70,000,000\"},\"dividendsPaid\":{\"raw\":-3906000000,\"fmt\":\"-3.91B\",\"longFmt\":\"-3,906,000,000\"},\"changeToInventory\":{\"raw\":-461000000,\"fmt\":\"-461M\",\"longFmt\":\"-461,000,000\"},\"changeToAccountReceivables\":{\"raw\":-287000000,\"fmt\":\"-287M\",\"longFmt\":\"-287,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-1475000000,\"fmt\":\"-1.48B\",\"longFmt\":\"-1,475,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":4127000000,\"fmt\":\"4.13B\",\"longFmt\":\"4,127,000,000\"},\"capitalExpenditures\":{\"raw\":-1545000000,\"fmt\":\"-1.54B\",\"longFmt\":\"-1,545,000,000\"}}],\"maxAge\":86400},\"balanceSheetHistoryQuarterly\":{\"balanceSheetStatements\":[{\"intangibleAssets\":{\"raw\":30241000000,\"fmt\":\"30.24B\",\"longFmt\":\"30,241,000,000\"},\"capitalSurplus\":{\"raw\":3300000000,\"fmt\":\"3.3B\",\"longFmt\":\"3,300,000,000\"},\"totalLiab\":{\"raw\":56941000000,\"fmt\":\"56.94B\",\"longFmt\":\"56,941,000,000\"},\"totalStockholderEquity\":{\"raw\":15426000000,\"fmt\":\"15.43B\",\"longFmt\":\"15,426,000,000\"},\"minorityInterest\":{\"raw\":6322000000,\"fmt\":\"6.32B\",\"longFmt\":\"6,322,000,000\"},\"otherCurrentLiab\":{\"raw\":3225000000,\"fmt\":\"3.23B\",\"longFmt\":\"3,225,000,000\"},\"totalAssets\":{\"raw\":78689000000,\"fmt\":\"78.69B\",\"longFmt\":\"78,689,000,000\"},\"endDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"commonStock\":{\"raw\":1347000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,347,000,000\"},\"otherCurrentAssets\":{\"raw\":212000000,\"fmt\":\"212M\",\"longFmt\":\"212,000,000\"},\"retainedEarnings\":{\"raw\":7783000000,\"fmt\":\"7.78B\",\"longFmt\":\"7,783,000,000\"},\"otherLiab\":{\"raw\":13788000000,\"fmt\":\"13.79B\",\"longFmt\":\"13,788,000,000\"},\"goodWill\":{\"raw\":10582000000,\"fmt\":\"10.58B\",\"longFmt\":\"10,582,000,000\"},\"treasuryStock\":{\"raw\":2996000000,\"fmt\":\"3B\",\"longFmt\":\"2,996,000,000\"},\"otherAssets\":{\"raw\":6121000000,\"fmt\":\"6.12B\",\"longFmt\":\"6,121,000,000\"},\"cash\":{\"raw\":3453000000,\"fmt\":\"3.45B\",\"longFmt\":\"3,453,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22417000000,\"fmt\":\"22.42B\",\"longFmt\":\"22,417,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4876000000,\"fmt\":\"4.88B\",\"longFmt\":\"4,876,000,000\"},\"shortLongTermDebt\":{\"raw\":3100000000,\"fmt\":\"3.1B\",\"longFmt\":\"3,100,000,000\"},\"otherStockholderEquity\":{\"raw\":2996000000,\"fmt\":\"3B\",\"longFmt\":\"2,996,000,000\"},\"propertyPlantEquipment\":{\"raw\":10667000000,\"fmt\":\"10.67B\",\"longFmt\":\"10,667,000,000\"},\"totalCurrentAssets\":{\"raw\":18254000000,\"fmt\":\"18.25B\",\"longFmt\":\"18,254,000,000\"},\"longTermInvestments\":{\"raw\":2824000000,\"fmt\":\"2.82B\",\"longFmt\":\"2,824,000,000\"},\"netTangibleAssets\":{\"raw\":-25397000000,\"fmt\":\"-25.4B\",\"longFmt\":\"-25,397,000,000\"},\"shortTermInvestments\":{\"raw\":61000000,\"fmt\":\"61M\",\"longFmt\":\"61,000,000\"},\"netReceivables\":{\"raw\":8284000000,\"fmt\":\"8.28B\",\"longFmt\":\"8,284,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":20736000000,\"fmt\":\"20.74B\",\"longFmt\":\"20,736,000,000\"},\"inventory\":{\"raw\":6244000000,\"fmt\":\"6.24B\",\"longFmt\":\"6,244,000,000\"},\"accountsPayable\":{\"raw\":14323000000,\"fmt\":\"14.32B\",\"longFmt\":\"14,323,000,000\"}},{\"intangibleAssets\":{\"raw\":29333000000,\"fmt\":\"29.33B\",\"longFmt\":\"29,333,000,000\"},\"capitalSurplus\":{\"raw\":3299000000,\"fmt\":\"3.3B\",\"longFmt\":\"3,299,000,000\"},\"totalLiab\":{\"raw\":55433000000,\"fmt\":\"55.43B\",\"longFmt\":\"55,433,000,000\"},\"totalStockholderEquity\":{\"raw\":15377000000,\"fmt\":\"15.38B\",\"longFmt\":\"15,377,000,000\"},\"minorityInterest\":{\"raw\":6201000000,\"fmt\":\"6.2B\",\"longFmt\":\"6,201,000,000\"},\"otherCurrentLiab\":{\"raw\":2949000000,\"fmt\":\"2.95B\",\"longFmt\":\"2,949,000,000\"},\"totalAssets\":{\"raw\":77011000000,\"fmt\":\"77.01B\",\"longFmt\":\"77,011,000,000\"},\"endDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"commonStock\":{\"raw\":1347000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,347,000,000\"},\"otherCurrentAssets\":{\"raw\":167000000,\"fmt\":\"167M\",\"longFmt\":\"167,000,000\"},\"retainedEarnings\":{\"raw\":7379000000,\"fmt\":\"7.38B\",\"longFmt\":\"7,379,000,000\"},\"otherLiab\":{\"raw\":13604000000,\"fmt\":\"13.6B\",\"longFmt\":\"13,604,000,000\"},\"goodWill\":{\"raw\":10435000000,\"fmt\":\"10.44B\",\"longFmt\":\"10,435,000,000\"},\"treasuryStock\":{\"raw\":3352000000,\"fmt\":\"3.35B\",\"longFmt\":\"3,352,000,000\"},\"otherAssets\":{\"raw\":5847000000,\"fmt\":\"5.85B\",\"longFmt\":\"5,847,000,000\"},\"cash\":{\"raw\":3503000000,\"fmt\":\"3.5B\",\"longFmt\":\"3,503,000,000\"},\"totalCurrentLiabilities\":{\"raw\":21387000000,\"fmt\":\"21.39B\",\"longFmt\":\"21,387,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4711000000,\"fmt\":\"4.71B\",\"longFmt\":\"4,711,000,000\"},\"shortLongTermDebt\":{\"raw\":2600000000,\"fmt\":\"2.6B\",\"longFmt\":\"2,600,000,000\"},\"otherStockholderEquity\":{\"raw\":3352000000,\"fmt\":\"3.35B\",\"longFmt\":\"3,352,000,000\"},\"propertyPlantEquipment\":{\"raw\":10589000000,\"fmt\":\"10.59B\",\"longFmt\":\"10,589,000,000\"},\"totalCurrentAssets\":{\"raw\":17566000000,\"fmt\":\"17.57B\",\"longFmt\":\"17,566,000,000\"},\"longTermInvestments\":{\"raw\":3241000000,\"fmt\":\"3.24B\",\"longFmt\":\"3,241,000,000\"},\"netTangibleAssets\":{\"raw\":-24391000000,\"fmt\":\"-24.39B\",\"longFmt\":\"-24,391,000,000\"},\"shortTermInvestments\":{\"raw\":59000000,\"fmt\":\"59M\",\"longFmt\":\"59,000,000\"},\"netReceivables\":{\"raw\":7507000000,\"fmt\":\"7.51B\",\"longFmt\":\"7,507,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":20442000000,\"fmt\":\"20.44B\",\"longFmt\":\"20,442,000,000\"},\"inventory\":{\"raw\":6330000000,\"fmt\":\"6.33B\",\"longFmt\":\"6,330,000,000\"},\"accountsPayable\":{\"raw\":13397000000,\"fmt\":\"13.4B\",\"longFmt\":\"13,397,000,000\"}},{\"intangibleAssets\":{\"raw\":29418000000,\"fmt\":\"29.42B\",\"longFmt\":\"29,418,000,000\"},\"capitalSurplus\":{\"raw\":3296000000,\"fmt\":\"3.3B\",\"longFmt\":\"3,296,000,000\"},\"totalLiab\":{\"raw\":57069000000,\"fmt\":\"57.07B\",\"longFmt\":\"57,069,000,000\"},\"totalStockholderEquity\":{\"raw\":14865000000,\"fmt\":\"14.87B\",\"longFmt\":\"14,865,000,000\"},\"minorityInterest\":{\"raw\":6145000000,\"fmt\":\"6.14B\",\"longFmt\":\"6,145,000,000\"},\"otherCurrentLiab\":{\"raw\":3400000000,\"fmt\":\"3.4B\",\"longFmt\":\"3,400,000,000\"},\"totalAssets\":{\"raw\":78079000000,\"fmt\":\"78.08B\",\"longFmt\":\"78,079,000,000\"},\"endDate\":{\"raw\":1617148800,\"fmt\":\"2021-03-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":308000000,\"fmt\":\"308M\",\"longFmt\":\"308,000,000\"},\"retainedEarnings\":{\"raw\":6700000000,\"fmt\":\"6.7B\",\"longFmt\":\"6,700,000,000\"},\"otherLiab\":{\"raw\":13747000000,\"fmt\":\"13.75B\",\"longFmt\":\"13,747,000,000\"},\"goodWill\":{\"raw\":10442000000,\"fmt\":\"10.44B\",\"longFmt\":\"10,442,000,000\"},\"treasuryStock\":{\"raw\":3523000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,523,000,000\"},\"otherAssets\":{\"raw\":5301000000,\"fmt\":\"5.3B\",\"longFmt\":\"5,301,000,000\"},\"cash\":{\"raw\":4757000000,\"fmt\":\"4.76B\",\"longFmt\":\"4,757,000,000\"},\"totalCurrentLiabilities\":{\"raw\":20275000000,\"fmt\":\"20.27B\",\"longFmt\":\"20,275,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4312000000,\"fmt\":\"4.31B\",\"longFmt\":\"4,312,000,000\"},\"otherStockholderEquity\":{\"raw\":3523000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,523,000,000\"},\"propertyPlantEquipment\":{\"raw\":10633000000,\"fmt\":\"10.63B\",\"longFmt\":\"10,633,000,000\"},\"totalCurrentAssets\":{\"raw\":18524000000,\"fmt\":\"18.52B\",\"longFmt\":\"18,524,000,000\"},\"longTermInvestments\":{\"raw\":3761000000,\"fmt\":\"3.76B\",\"longFmt\":\"3,761,000,000\"},\"netTangibleAssets\":{\"raw\":-24995000000,\"fmt\":\"-25B\",\"longFmt\":\"-24,995,000,000\"},\"shortTermInvestments\":{\"raw\":60000000,\"fmt\":\"60M\",\"longFmt\":\"60,000,000\"},\"netReceivables\":{\"raw\":7183000000,\"fmt\":\"7.18B\",\"longFmt\":\"7,183,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":23047000000,\"fmt\":\"23.05B\",\"longFmt\":\"23,047,000,000\"},\"inventory\":{\"raw\":6216000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,216,000,000\"},\"accountsPayable\":{\"raw\":13703000000,\"fmt\":\"13.7B\",\"longFmt\":\"13,703,000,000\"}},{\"intangibleAssets\":{\"raw\":29824000000,\"fmt\":\"29.82B\",\"longFmt\":\"29,824,000,000\"},\"capitalSurplus\":{\"raw\":3281000000,\"fmt\":\"3.28B\",\"longFmt\":\"3,281,000,000\"},\"totalLiab\":{\"raw\":59623000000,\"fmt\":\"59.62B\",\"longFmt\":\"59,623,000,000\"},\"totalStockholderEquity\":{\"raw\":14587000000,\"fmt\":\"14.59B\",\"longFmt\":\"14,587,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"otherCurrentLiab\":{\"raw\":5338000000,\"fmt\":\"5.34B\",\"longFmt\":\"5,338,000,000\"},\"totalAssets\":{\"raw\":80431000000,\"fmt\":\"80.43B\",\"longFmt\":\"80,431,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":195000000,\"fmt\":\"195M\",\"longFmt\":\"195,000,000\"},\"retainedEarnings\":{\"raw\":7294000000,\"fmt\":\"7.29B\",\"longFmt\":\"7,294,000,000\"},\"otherLiab\":{\"raw\":14050000000,\"fmt\":\"14.05B\",\"longFmt\":\"14,050,000,000\"},\"goodWill\":{\"raw\":10597000000,\"fmt\":\"10.6B\",\"longFmt\":\"10,597,000,000\"},\"treasuryStock\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"otherAssets\":{\"raw\":5261000000,\"fmt\":\"5.26B\",\"longFmt\":\"5,261,000,000\"},\"cash\":{\"raw\":6292000000,\"fmt\":\"6.29B\",\"longFmt\":\"6,292,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22148000000,\"fmt\":\"22.15B\",\"longFmt\":\"22,148,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4287000000,\"fmt\":\"4.29B\",\"longFmt\":\"4,287,000,000\"},\"shortLongTermDebt\":{\"raw\":2449000000,\"fmt\":\"2.45B\",\"longFmt\":\"2,449,000,000\"},\"otherStockholderEquity\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"propertyPlantEquipment\":{\"raw\":11006000000,\"fmt\":\"11.01B\",\"longFmt\":\"11,006,000,000\"},\"totalCurrentAssets\":{\"raw\":20247000000,\"fmt\":\"20.25B\",\"longFmt\":\"20,247,000,000\"},\"longTermInvestments\":{\"raw\":3496000000,\"fmt\":\"3.5B\",\"longFmt\":\"3,496,000,000\"},\"netTangibleAssets\":{\"raw\":-25834000000,\"fmt\":\"-25.83B\",\"longFmt\":\"-25,834,000,000\"},\"shortTermInvestments\":{\"raw\":480000000,\"fmt\":\"480M\",\"longFmt\":\"480,000,000\"},\"netReceivables\":{\"raw\":6862000000,\"fmt\":\"6.86B\",\"longFmt\":\"6,862,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":22538000000,\"fmt\":\"22.54B\",\"longFmt\":\"22,538,000,000\"},\"inventory\":{\"raw\":5996000000,\"fmt\":\"6B\",\"longFmt\":\"5,996,000,000\"},\"accountsPayable\":{\"raw\":4357000000,\"fmt\":\"4.36B\",\"longFmt\":\"4,357,000,000\"}}],\"maxAge\":86400},\"earnings\":{\"maxAge\":86400,\"earningsChart\":{\"quarterly\":[{\"date\":\"4Q2020\",\"actual\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"estimate\":{\"raw\":0.64,\"fmt\":\"0.64\"}},{\"date\":\"1Q2021\",\"actual\":{\"raw\":0.63,\"fmt\":\"0.63\"},\"estimate\":{\"raw\":0.61,\"fmt\":\"0.61\"}},{\"date\":\"2Q2021\",\"actual\":{\"raw\":0.79,\"fmt\":\"0.79\"},\"estimate\":{\"raw\":0.51,\"fmt\":\"0.51\"}},{\"date\":\"3Q2021\",\"actual\":{\"raw\":1.01,\"fmt\":\"1.01\"},\"estimate\":{\"raw\":0.81,\"fmt\":\"0.81\"}}],\"currentQuarterEstimate\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"currentQuarterEstimateDate\":\"4Q\",\"currentQuarterEstimateYear\":2021,\"earningsDate\":[{\"raw\":1485964740,\"fmt\":\"2017-02-01\"},{\"raw\":1486400400,\"fmt\":\"2017-02-06\"}]},\"financialsChart\":{\"yearly\":[{\"date\":2017,\"revenue\":{\"raw\":30186000000,\"fmt\":\"30.19B\",\"longFmt\":\"30,186,000,000\"},\"earnings\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"}},{\"date\":2018,\"revenue\":{\"raw\":30821000000,\"fmt\":\"30.82B\",\"longFmt\":\"30,821,000,000\"},\"earnings\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"}},{\"date\":2019,\"revenue\":{\"raw\":33754000000,\"fmt\":\"33.75B\",\"longFmt\":\"33,754,000,000\"},\"earnings\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"}},{\"date\":2020,\"revenue\":{\"raw\":34099000000,\"fmt\":\"34.1B\",\"longFmt\":\"34,099,000,000\"},\"earnings\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"}}],\"quarterly\":[{\"date\":\"4Q2020\",\"revenue\":{\"raw\":8739000000,\"fmt\":\"8.74B\",\"longFmt\":\"8,739,000,000\"},\"earnings\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"}},{\"date\":\"1Q2021\",\"revenue\":{\"raw\":7418000000,\"fmt\":\"7.42B\",\"longFmt\":\"7,418,000,000\"},\"earnings\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"}},{\"date\":\"2Q2021\",\"revenue\":{\"raw\":8092000000,\"fmt\":\"8.09B\",\"longFmt\":\"8,092,000,000\"},\"earnings\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"}},{\"date\":\"3Q2021\",\"revenue\":{\"raw\":9077000000,\"fmt\":\"9.08B\",\"longFmt\":\"9,077,000,000\"},\"earnings\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"}}]},\"financialCurrency\":\"GBP\"},\"price\":{\"quoteSourceName\":\"Nasdaq Real Time Price\",\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"averageDailyVolume3Month\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"exchange\":\"NYQ\",\"regularMarketTime\":1637169258,\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"shortName\":\"GlaxoSmithKline PLC\",\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"longName\":\"GlaxoSmithKline plc\",\"regularMarketChange\":{\"raw\":0.16320038,\"fmt\":\"0.16\"},\"currencySymbol\":\"$\",\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"preMarketPrice\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"preMarketTime\":1637159399,\"exchangeDataDelayedBy\":0,\"toCurrency\":null,\"postMarketChange\":{},\"postMarketPrice\":{},\"exchangeName\":\"NYSE\",\"preMarketChange\":{\"raw\":-0.190002,\"fmt\":\"-0.19\"},\"circulatingSupply\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"regularMarketPrice\":{\"raw\":42.6132,\"fmt\":\"42.61\"},\"regularMarketVolume\":{\"raw\":2390686,\"fmt\":\"2.39M\",\"longFmt\":\"2,390,686.00\"},\"lastMarket\":null,\"regularMarketSource\":\"FREE_REALTIME\",\"openInterest\":{},\"marketState\":\"REGULAR\",\"underlyingSymbol\":null,\"marketCap\":{\"raw\":107209695232,\"fmt\":\"107.21B\",\"longFmt\":\"107,209,695,232.00\"},\"quoteType\":\"EQUITY\",\"preMarketChangePercent\":{\"raw\":-0.00447591,\"fmt\":\"-0.45%\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"symbol\":\"GSK\",\"preMarketSource\":\"FREE_REALTIME\",\"maxAge\":1,\"fromCurrency\":null,\"regularMarketChangePercent\":{\"raw\":0.0038445317,\"fmt\":\"0.38%\"}},\"incomeStatementHistoryQuarterly\":{\"incomeStatementHistory\":[{\"researchDevelopment\":{\"raw\":1196000000,\"fmt\":\"1.2B\",\"longFmt\":\"1,196,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":1748000000,\"fmt\":\"1.75B\",\"longFmt\":\"1,748,000,000\"},\"minorityInterest\":{\"raw\":6322000000,\"fmt\":\"6.32B\",\"longFmt\":\"6,322,000,000\"},\"netIncome\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2517000000,\"fmt\":\"2.52B\",\"longFmt\":\"2,517,000,000\"},\"grossProfit\":{\"raw\":6255000000,\"fmt\":\"6.25B\",\"longFmt\":\"6,255,000,000\"},\"ebit\":{\"raw\":2658000000,\"fmt\":\"2.66B\",\"longFmt\":\"2,658,000,000\"},\"endDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"operatingIncome\":{\"raw\":2658000000,\"fmt\":\"2.66B\",\"longFmt\":\"2,658,000,000\"},\"otherOperatingExpenses\":{\"raw\":-116000000,\"fmt\":\"-116M\",\"longFmt\":\"-116,000,000\"},\"interestExpense\":{\"raw\":-199000000,\"fmt\":\"-199M\",\"longFmt\":\"-199,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":380000000,\"fmt\":\"380M\",\"longFmt\":\"380,000,000\"},\"totalRevenue\":{\"raw\":9077000000,\"fmt\":\"9.08B\",\"longFmt\":\"9,077,000,000\"},\"totalOperatingExpenses\":{\"raw\":6419000000,\"fmt\":\"6.42B\",\"longFmt\":\"6,419,000,000\"},\"costOfRevenue\":{\"raw\":2822000000,\"fmt\":\"2.82B\",\"longFmt\":\"2,822,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-910000000,\"fmt\":\"-910M\",\"longFmt\":\"-910,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":1368000000,\"fmt\":\"1.37B\",\"longFmt\":\"1,368,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"}},{\"researchDevelopment\":{\"raw\":1190000000,\"fmt\":\"1.19B\",\"longFmt\":\"1,190,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":1470000000,\"fmt\":\"1.47B\",\"longFmt\":\"1,470,000,000\"},\"minorityInterest\":{\"raw\":6201000000,\"fmt\":\"6.2B\",\"longFmt\":\"6,201,000,000\"},\"netIncome\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2496000000,\"fmt\":\"2.5B\",\"longFmt\":\"2,496,000,000\"},\"grossProfit\":{\"raw\":5573000000,\"fmt\":\"5.57B\",\"longFmt\":\"5,573,000,000\"},\"ebit\":{\"raw\":1979000000,\"fmt\":\"1.98B\",\"longFmt\":\"1,979,000,000\"},\"endDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"operatingIncome\":{\"raw\":1979000000,\"fmt\":\"1.98B\",\"longFmt\":\"1,979,000,000\"},\"otherOperatingExpenses\":{\"raw\":-92000000,\"fmt\":\"-92M\",\"longFmt\":\"-92,000,000\"},\"interestExpense\":{\"raw\":-192000000,\"fmt\":\"-192M\",\"longFmt\":\"-192,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":-68000000,\"fmt\":\"-68M\",\"longFmt\":\"-68,000,000\"},\"totalRevenue\":{\"raw\":8092000000,\"fmt\":\"8.09B\",\"longFmt\":\"8,092,000,000\"},\"totalOperatingExpenses\":{\"raw\":6113000000,\"fmt\":\"6.11B\",\"longFmt\":\"6,113,000,000\"},\"costOfRevenue\":{\"raw\":2519000000,\"fmt\":\"2.52B\",\"longFmt\":\"2,519,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-509000000,\"fmt\":\"-509M\",\"longFmt\":\"-509,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":1538000000,\"fmt\":\"1.54B\",\"longFmt\":\"1,538,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"}},{\"researchDevelopment\":{\"raw\":1103000000,\"fmt\":\"1.1B\",\"longFmt\":\"1,103,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":1518000000,\"fmt\":\"1.52B\",\"longFmt\":\"1,518,000,000\"},\"minorityInterest\":{\"raw\":6145000000,\"fmt\":\"6.14B\",\"longFmt\":\"6,145,000,000\"},\"netIncome\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2318000000,\"fmt\":\"2.32B\",\"longFmt\":\"2,318,000,000\"},\"grossProfit\":{\"raw\":4980000000,\"fmt\":\"4.98B\",\"longFmt\":\"4,980,000,000\"},\"ebit\":{\"raw\":1609000000,\"fmt\":\"1.61B\",\"longFmt\":\"1,609,000,000\"},\"endDate\":{\"raw\":1617148800,\"fmt\":\"2021-03-31\"},\"operatingIncome\":{\"raw\":1609000000,\"fmt\":\"1.61B\",\"longFmt\":\"1,609,000,000\"},\"otherOperatingExpenses\":{\"raw\":-50000000,\"fmt\":\"-50M\",\"longFmt\":\"-50,000,000\"},\"interestExpense\":{\"raw\":-200000000,\"fmt\":\"-200M\",\"longFmt\":\"-200,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":258000000,\"fmt\":\"258M\",\"longFmt\":\"258,000,000\"},\"totalRevenue\":{\"raw\":7418000000,\"fmt\":\"7.42B\",\"longFmt\":\"7,418,000,000\"},\"totalOperatingExpenses\":{\"raw\":5809000000,\"fmt\":\"5.81B\",\"longFmt\":\"5,809,000,000\"},\"costOfRevenue\":{\"raw\":2438000000,\"fmt\":\"2.44B\",\"longFmt\":\"2,438,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-91000000,\"fmt\":\"-91M\",\"longFmt\":\"-91,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":1260000000,\"fmt\":\"1.26B\",\"longFmt\":\"1,260,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"}},{\"researchDevelopment\":{\"raw\":1322000000,\"fmt\":\"1.32B\",\"longFmt\":\"1,322,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":821000000,\"fmt\":\"821M\",\"longFmt\":\"821,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"netIncome\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":2692000000,\"fmt\":\"2.69B\",\"longFmt\":\"2,692,000,000\"},\"grossProfit\":{\"raw\":5777000000,\"fmt\":\"5.78B\",\"longFmt\":\"5,777,000,000\"},\"ebit\":{\"raw\":1991000000,\"fmt\":\"1.99B\",\"longFmt\":\"1,991,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"operatingIncome\":{\"raw\":1991000000,\"fmt\":\"1.99B\",\"longFmt\":\"1,991,000,000\"},\"otherOperatingExpenses\":{\"raw\":-228000000,\"fmt\":\"-228M\",\"longFmt\":\"-228,000,000\"},\"interestExpense\":{\"raw\":-210000000,\"fmt\":\"-210M\",\"longFmt\":\"-210,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":-18000000,\"fmt\":\"-18M\",\"longFmt\":\"-18,000,000\"},\"totalRevenue\":{\"raw\":8739000000,\"fmt\":\"8.74B\",\"longFmt\":\"8,739,000,000\"},\"totalOperatingExpenses\":{\"raw\":6748000000,\"fmt\":\"6.75B\",\"longFmt\":\"6,748,000,000\"},\"costOfRevenue\":{\"raw\":2962000000,\"fmt\":\"2.96B\",\"longFmt\":\"2,962,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-1170000000,\"fmt\":\"-1.17B\",\"longFmt\":\"-1,170,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":839000000,\"fmt\":\"839M\",\"longFmt\":\"839,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"}}],\"maxAge\":86400},\"incomeStatementHistory\":{\"incomeStatementHistory\":[{\"researchDevelopment\":{\"raw\":4678000000,\"fmt\":\"4.68B\",\"longFmt\":\"4,678,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":6968000000,\"fmt\":\"6.97B\",\"longFmt\":\"6,968,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"netIncome\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":10503000000,\"fmt\":\"10.5B\",\"longFmt\":\"10,503,000,000\"},\"grossProfit\":{\"raw\":23209000000,\"fmt\":\"23.21B\",\"longFmt\":\"23,209,000,000\"},\"ebit\":{\"raw\":8483000000,\"fmt\":\"8.48B\",\"longFmt\":\"8,483,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"operatingIncome\":{\"raw\":8483000000,\"fmt\":\"8.48B\",\"longFmt\":\"8,483,000,000\"},\"otherOperatingExpenses\":{\"raw\":-455000000,\"fmt\":\"-455M\",\"longFmt\":\"-455,000,000\"},\"interestExpense\":{\"raw\":-860000000,\"fmt\":\"-860M\",\"longFmt\":\"-860,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":580000000,\"fmt\":\"580M\",\"longFmt\":\"580,000,000\"},\"totalRevenue\":{\"raw\":34099000000,\"fmt\":\"34.1B\",\"longFmt\":\"34,099,000,000\"},\"totalOperatingExpenses\":{\"raw\":25616000000,\"fmt\":\"25.62B\",\"longFmt\":\"25,616,000,000\"},\"costOfRevenue\":{\"raw\":10890000000,\"fmt\":\"10.89B\",\"longFmt\":\"10,890,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-1515000000,\"fmt\":\"-1.51B\",\"longFmt\":\"-1,515,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":6388000000,\"fmt\":\"6.39B\",\"longFmt\":\"6,388,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"}},{\"researchDevelopment\":{\"raw\":4405000000,\"fmt\":\"4.41B\",\"longFmt\":\"4,405,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"minorityInterest\":{\"raw\":6952000000,\"fmt\":\"6.95B\",\"longFmt\":\"6,952,000,000\"},\"netIncome\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":10599000000,\"fmt\":\"10.6B\",\"longFmt\":\"10,599,000,000\"},\"grossProfit\":{\"raw\":22962000000,\"fmt\":\"22.96B\",\"longFmt\":\"22,962,000,000\"},\"ebit\":{\"raw\":8564000000,\"fmt\":\"8.56B\",\"longFmt\":\"8,564,000,000\"},\"endDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"operatingIncome\":{\"raw\":8564000000,\"fmt\":\"8.56B\",\"longFmt\":\"8,564,000,000\"},\"otherOperatingExpenses\":{\"raw\":-606000000,\"fmt\":\"-606M\",\"longFmt\":\"-606,000,000\"},\"interestExpense\":{\"raw\":-877000000,\"fmt\":\"-877M\",\"longFmt\":\"-877,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":953000000,\"fmt\":\"953M\",\"longFmt\":\"953,000,000\"},\"totalRevenue\":{\"raw\":33754000000,\"fmt\":\"33.75B\",\"longFmt\":\"33,754,000,000\"},\"totalOperatingExpenses\":{\"raw\":25190000000,\"fmt\":\"25.19B\",\"longFmt\":\"25,190,000,000\"},\"costOfRevenue\":{\"raw\":10792000000,\"fmt\":\"10.79B\",\"longFmt\":\"10,792,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-2343000000,\"fmt\":\"-2.34B\",\"longFmt\":\"-2,343,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":5268000000,\"fmt\":\"5.27B\",\"longFmt\":\"5,268,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"}},{\"researchDevelopment\":{\"raw\":3799000000,\"fmt\":\"3.8B\",\"longFmt\":\"3,799,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":4800000000,\"fmt\":\"4.8B\",\"longFmt\":\"4,800,000,000\"},\"minorityInterest\":{\"raw\":-109000000,\"fmt\":\"-109M\",\"longFmt\":\"-109,000,000\"},\"netIncome\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":9500000000,\"fmt\":\"9.5B\",\"longFmt\":\"9,500,000,000\"},\"grossProfit\":{\"raw\":21107000000,\"fmt\":\"21.11B\",\"longFmt\":\"21,107,000,000\"},\"ebit\":{\"raw\":7495000000,\"fmt\":\"7.5B\",\"longFmt\":\"7,495,000,000\"},\"endDate\":{\"raw\":1546214400,\"fmt\":\"2018-12-31\"},\"operatingIncome\":{\"raw\":7495000000,\"fmt\":\"7.5B\",\"longFmt\":\"7,495,000,000\"},\"otherOperatingExpenses\":{\"raw\":313000000,\"fmt\":\"313M\",\"longFmt\":\"313,000,000\"},\"interestExpense\":{\"raw\":-756000000,\"fmt\":\"-756M\",\"longFmt\":\"-756,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":754000000,\"fmt\":\"754M\",\"longFmt\":\"754,000,000\"},\"totalRevenue\":{\"raw\":30821000000,\"fmt\":\"30.82B\",\"longFmt\":\"30,821,000,000\"},\"totalOperatingExpenses\":{\"raw\":23326000000,\"fmt\":\"23.33B\",\"longFmt\":\"23,326,000,000\"},\"costOfRevenue\":{\"raw\":9714000000,\"fmt\":\"9.71B\",\"longFmt\":\"9,714,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-2695000000,\"fmt\":\"-2.69B\",\"longFmt\":\"-2,695,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":4046000000,\"fmt\":\"4.05B\",\"longFmt\":\"4,046,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"}},{\"researchDevelopment\":{\"raw\":3925000000,\"fmt\":\"3.92B\",\"longFmt\":\"3,925,000,000\"},\"effectOfAccountingCharges\":{},\"incomeBeforeTax\":{\"raw\":3525000000,\"fmt\":\"3.52B\",\"longFmt\":\"3,525,000,000\"},\"minorityInterest\":{\"raw\":3557000000,\"fmt\":\"3.56B\",\"longFmt\":\"3,557,000,000\"},\"netIncome\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"},\"sellingGeneralAdministrative\":{\"raw\":9424000000,\"fmt\":\"9.42B\",\"longFmt\":\"9,424,000,000\"},\"grossProfit\":{\"raw\":20869000000,\"fmt\":\"20.87B\",\"longFmt\":\"20,869,000,000\"},\"ebit\":{\"raw\":6721000000,\"fmt\":\"6.72B\",\"longFmt\":\"6,721,000,000\"},\"endDate\":{\"raw\":1514678400,\"fmt\":\"2017-12-31\"},\"operatingIncome\":{\"raw\":6721000000,\"fmt\":\"6.72B\",\"longFmt\":\"6,721,000,000\"},\"otherOperatingExpenses\":{\"raw\":799000000,\"fmt\":\"799M\",\"longFmt\":\"799,000,000\"},\"interestExpense\":{\"raw\":-721000000,\"fmt\":\"-721M\",\"longFmt\":\"-721,000,000\"},\"extraordinaryItems\":{},\"nonRecurring\":{},\"otherItems\":{},\"incomeTaxExpense\":{\"raw\":1356000000,\"fmt\":\"1.36B\",\"longFmt\":\"1,356,000,000\"},\"totalRevenue\":{\"raw\":30186000000,\"fmt\":\"30.19B\",\"longFmt\":\"30,186,000,000\"},\"totalOperatingExpenses\":{\"raw\":23465000000,\"fmt\":\"23.46B\",\"longFmt\":\"23,465,000,000\"},\"costOfRevenue\":{\"raw\":9317000000,\"fmt\":\"9.32B\",\"longFmt\":\"9,317,000,000\"},\"totalOtherIncomeExpenseNet\":{\"raw\":-3196000000,\"fmt\":\"-3.2B\",\"longFmt\":\"-3,196,000,000\"},\"maxAge\":1,\"discontinuedOperations\":{},\"netIncomeFromContinuingOps\":{\"raw\":2169000000,\"fmt\":\"2.17B\",\"longFmt\":\"2,169,000,000\"},\"netIncomeApplicableToCommonShares\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"}}],\"maxAge\":86400},\"balanceSheetHistory\":{\"balanceSheetStatements\":[{\"intangibleAssets\":{\"raw\":29824000000,\"fmt\":\"29.82B\",\"longFmt\":\"29,824,000,000\"},\"capitalSurplus\":{\"raw\":3281000000,\"fmt\":\"3.28B\",\"longFmt\":\"3,281,000,000\"},\"totalLiab\":{\"raw\":59623000000,\"fmt\":\"59.62B\",\"longFmt\":\"59,623,000,000\"},\"totalStockholderEquity\":{\"raw\":14587000000,\"fmt\":\"14.59B\",\"longFmt\":\"14,587,000,000\"},\"minorityInterest\":{\"raw\":6221000000,\"fmt\":\"6.22B\",\"longFmt\":\"6,221,000,000\"},\"otherCurrentLiab\":{\"raw\":5338000000,\"fmt\":\"5.34B\",\"longFmt\":\"5,338,000,000\"},\"totalAssets\":{\"raw\":80431000000,\"fmt\":\"80.43B\",\"longFmt\":\"80,431,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":195000000,\"fmt\":\"195M\",\"longFmt\":\"195,000,000\"},\"retainedEarnings\":{\"raw\":7294000000,\"fmt\":\"7.29B\",\"longFmt\":\"7,294,000,000\"},\"otherLiab\":{\"raw\":14050000000,\"fmt\":\"14.05B\",\"longFmt\":\"14,050,000,000\"},\"goodWill\":{\"raw\":10597000000,\"fmt\":\"10.6B\",\"longFmt\":\"10,597,000,000\"},\"treasuryStock\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"otherAssets\":{\"raw\":5261000000,\"fmt\":\"5.26B\",\"longFmt\":\"5,261,000,000\"},\"cash\":{\"raw\":6292000000,\"fmt\":\"6.29B\",\"longFmt\":\"6,292,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22148000000,\"fmt\":\"22.15B\",\"longFmt\":\"22,148,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4287000000,\"fmt\":\"4.29B\",\"longFmt\":\"4,287,000,000\"},\"shortLongTermDebt\":{\"raw\":2449000000,\"fmt\":\"2.45B\",\"longFmt\":\"2,449,000,000\"},\"otherStockholderEquity\":{\"raw\":2666000000,\"fmt\":\"2.67B\",\"longFmt\":\"2,666,000,000\"},\"propertyPlantEquipment\":{\"raw\":11006000000,\"fmt\":\"11.01B\",\"longFmt\":\"11,006,000,000\"},\"totalCurrentAssets\":{\"raw\":20247000000,\"fmt\":\"20.25B\",\"longFmt\":\"20,247,000,000\"},\"longTermInvestments\":{\"raw\":3496000000,\"fmt\":\"3.5B\",\"longFmt\":\"3,496,000,000\"},\"netTangibleAssets\":{\"raw\":-25834000000,\"fmt\":\"-25.83B\",\"longFmt\":\"-25,834,000,000\"},\"shortTermInvestments\":{\"raw\":480000000,\"fmt\":\"480M\",\"longFmt\":\"480,000,000\"},\"netReceivables\":{\"raw\":6862000000,\"fmt\":\"6.86B\",\"longFmt\":\"6,862,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":22538000000,\"fmt\":\"22.54B\",\"longFmt\":\"22,538,000,000\"},\"inventory\":{\"raw\":5996000000,\"fmt\":\"6B\",\"longFmt\":\"5,996,000,000\"},\"accountsPayable\":{\"raw\":4357000000,\"fmt\":\"4.36B\",\"longFmt\":\"4,357,000,000\"}},{\"intangibleAssets\":{\"raw\":30955000000,\"fmt\":\"30.95B\",\"longFmt\":\"30,955,000,000\"},\"capitalSurplus\":{\"raw\":3174000000,\"fmt\":\"3.17B\",\"longFmt\":\"3,174,000,000\"},\"totalLiab\":{\"raw\":61335000000,\"fmt\":\"61.34B\",\"longFmt\":\"61,335,000,000\"},\"totalStockholderEquity\":{\"raw\":11405000000,\"fmt\":\"11.4B\",\"longFmt\":\"11,405,000,000\"},\"minorityInterest\":{\"raw\":6952000000,\"fmt\":\"6.95B\",\"longFmt\":\"6,952,000,000\"},\"otherCurrentLiab\":{\"raw\":4784000000,\"fmt\":\"4.78B\",\"longFmt\":\"4,784,000,000\"},\"totalAssets\":{\"raw\":79692000000,\"fmt\":\"79.69B\",\"longFmt\":\"79,692,000,000\"},\"endDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"commonStock\":{\"raw\":1346000000,\"fmt\":\"1.35B\",\"longFmt\":\"1,346,000,000\"},\"otherCurrentAssets\":{\"raw\":941000000,\"fmt\":\"941M\",\"longFmt\":\"941,000,000\"},\"retainedEarnings\":{\"raw\":5054000000,\"fmt\":\"5.05B\",\"longFmt\":\"5,054,000,000\"},\"otherLiab\":{\"raw\":13695000000,\"fmt\":\"13.7B\",\"longFmt\":\"13,695,000,000\"},\"goodWill\":{\"raw\":10562000000,\"fmt\":\"10.56B\",\"longFmt\":\"10,562,000,000\"},\"treasuryStock\":{\"raw\":1831000000,\"fmt\":\"1.83B\",\"longFmt\":\"1,831,000,000\"},\"otherAssets\":{\"raw\":5094000000,\"fmt\":\"5.09B\",\"longFmt\":\"5,094,000,000\"},\"cash\":{\"raw\":4707000000,\"fmt\":\"4.71B\",\"longFmt\":\"4,707,000,000\"},\"totalCurrentLiabilities\":{\"raw\":24050000000,\"fmt\":\"24.05B\",\"longFmt\":\"24,050,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":4096000000,\"fmt\":\"4.1B\",\"longFmt\":\"4,096,000,000\"},\"shortLongTermDebt\":{\"raw\":1710000000,\"fmt\":\"1.71B\",\"longFmt\":\"1,710,000,000\"},\"otherStockholderEquity\":{\"raw\":1831000000,\"fmt\":\"1.83B\",\"longFmt\":\"1,831,000,000\"},\"propertyPlantEquipment\":{\"raw\":11314000000,\"fmt\":\"11.31B\",\"longFmt\":\"11,314,000,000\"},\"totalCurrentAssets\":{\"raw\":19491000000,\"fmt\":\"19.49B\",\"longFmt\":\"19,491,000,000\"},\"longTermInvestments\":{\"raw\":2276000000,\"fmt\":\"2.28B\",\"longFmt\":\"2,276,000,000\"},\"netTangibleAssets\":{\"raw\":-30112000000,\"fmt\":\"-30.11B\",\"longFmt\":\"-30,112,000,000\"},\"shortTermInvestments\":{\"raw\":786000000,\"fmt\":\"786M\",\"longFmt\":\"786,000,000\"},\"netReceivables\":{\"raw\":6441000000,\"fmt\":\"6.44B\",\"longFmt\":\"6,441,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":22580000000,\"fmt\":\"22.58B\",\"longFmt\":\"22,580,000,000\"},\"inventory\":{\"raw\":5947000000,\"fmt\":\"5.95B\",\"longFmt\":\"5,947,000,000\"},\"accountsPayable\":{\"raw\":4144000000,\"fmt\":\"4.14B\",\"longFmt\":\"4,144,000,000\"}},{\"intangibleAssets\":{\"raw\":17202000000,\"fmt\":\"17.2B\",\"longFmt\":\"17,202,000,000\"},\"capitalSurplus\":{\"raw\":3091000000,\"fmt\":\"3.09B\",\"longFmt\":\"3,091,000,000\"},\"totalLiab\":{\"raw\":54394000000,\"fmt\":\"54.39B\",\"longFmt\":\"54,394,000,000\"},\"totalStockholderEquity\":{\"raw\":3781000000,\"fmt\":\"3.78B\",\"longFmt\":\"3,781,000,000\"},\"minorityInterest\":{\"raw\":-109000000,\"fmt\":\"-109M\",\"longFmt\":\"-109,000,000\"},\"otherCurrentLiab\":{\"raw\":5226000000,\"fmt\":\"5.23B\",\"longFmt\":\"5,226,000,000\"},\"totalAssets\":{\"raw\":58066000000,\"fmt\":\"58.07B\",\"longFmt\":\"58,066,000,000\"},\"endDate\":{\"raw\":1546214400,\"fmt\":\"2018-12-31\"},\"commonStock\":{\"raw\":1345000000,\"fmt\":\"1.34B\",\"longFmt\":\"1,345,000,000\"},\"otherCurrentAssets\":{\"raw\":658000000,\"fmt\":\"658M\",\"longFmt\":\"658,000,000\"},\"retainedEarnings\":{\"raw\":-2701000000,\"fmt\":\"-2.7B\",\"longFmt\":\"-2,701,000,000\"},\"otherLiab\":{\"raw\":11632000000,\"fmt\":\"11.63B\",\"longFmt\":\"11,632,000,000\"},\"goodWill\":{\"raw\":5789000000,\"fmt\":\"5.79B\",\"longFmt\":\"5,789,000,000\"},\"treasuryStock\":{\"raw\":2046000000,\"fmt\":\"2.05B\",\"longFmt\":\"2,046,000,000\"},\"otherAssets\":{\"raw\":5527000000,\"fmt\":\"5.53B\",\"longFmt\":\"5,527,000,000\"},\"cash\":{\"raw\":3874000000,\"fmt\":\"3.87B\",\"longFmt\":\"3,874,000,000\"},\"totalCurrentLiabilities\":{\"raw\":22491000000,\"fmt\":\"22.49B\",\"longFmt\":\"22,491,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":3887000000,\"fmt\":\"3.89B\",\"longFmt\":\"3,887,000,000\"},\"shortLongTermDebt\":{\"raw\":1367000000,\"fmt\":\"1.37B\",\"longFmt\":\"1,367,000,000\"},\"otherStockholderEquity\":{\"raw\":2046000000,\"fmt\":\"2.05B\",\"longFmt\":\"2,046,000,000\"},\"propertyPlantEquipment\":{\"raw\":11058000000,\"fmt\":\"11.06B\",\"longFmt\":\"11,058,000,000\"},\"totalCurrentAssets\":{\"raw\":16927000000,\"fmt\":\"16.93B\",\"longFmt\":\"16,927,000,000\"},\"longTermInvestments\":{\"raw\":1563000000,\"fmt\":\"1.56B\",\"longFmt\":\"1,563,000,000\"},\"netTangibleAssets\":{\"raw\":-19210000000,\"fmt\":\"-19.21B\",\"longFmt\":\"-19,210,000,000\"},\"shortTermInvestments\":{\"raw\":419000000,\"fmt\":\"419M\",\"longFmt\":\"419,000,000\"},\"netReceivables\":{\"raw\":5946000000,\"fmt\":\"5.95B\",\"longFmt\":\"5,946,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":20227000000,\"fmt\":\"20.23B\",\"longFmt\":\"20,227,000,000\"},\"inventory\":{\"raw\":5476000000,\"fmt\":\"5.48B\",\"longFmt\":\"5,476,000,000\"},\"accountsPayable\":{\"raw\":3645000000,\"fmt\":\"3.65B\",\"longFmt\":\"3,645,000,000\"}},{\"intangibleAssets\":{\"raw\":17562000000,\"fmt\":\"17.56B\",\"longFmt\":\"17,562,000,000\"},\"capitalSurplus\":{\"raw\":3019000000,\"fmt\":\"3.02B\",\"longFmt\":\"3,019,000,000\"},\"totalLiab\":{\"raw\":52892000000,\"fmt\":\"52.89B\",\"longFmt\":\"52,892,000,000\"},\"totalStockholderEquity\":{\"raw\":-68000000,\"fmt\":\"-68M\",\"longFmt\":\"-68,000,000\"},\"minorityInterest\":{\"raw\":3557000000,\"fmt\":\"3.56B\",\"longFmt\":\"3,557,000,000\"},\"otherCurrentLiab\":{\"raw\":13913000000,\"fmt\":\"13.91B\",\"longFmt\":\"13,913,000,000\"},\"totalAssets\":{\"raw\":56381000000,\"fmt\":\"56.38B\",\"longFmt\":\"56,381,000,000\"},\"endDate\":{\"raw\":1514678400,\"fmt\":\"2017-12-31\"},\"commonStock\":{\"raw\":1343000000,\"fmt\":\"1.34B\",\"longFmt\":\"1,343,000,000\"},\"otherCurrentAssets\":{\"raw\":118000000,\"fmt\":\"118M\",\"longFmt\":\"118,000,000\"},\"retainedEarnings\":{\"raw\":-6920000000,\"fmt\":\"-6.92B\",\"longFmt\":\"-6,920,000,000\"},\"otherLiab\":{\"raw\":12059000000,\"fmt\":\"12.06B\",\"longFmt\":\"12,059,000,000\"},\"goodWill\":{\"raw\":5734000000,\"fmt\":\"5.73B\",\"longFmt\":\"5,734,000,000\"},\"treasuryStock\":{\"raw\":2490000000,\"fmt\":\"2.49B\",\"longFmt\":\"2,490,000,000\"},\"otherAssets\":{\"raw\":5209000000,\"fmt\":\"5.21B\",\"longFmt\":\"5,209,000,000\"},\"cash\":{\"raw\":3833000000,\"fmt\":\"3.83B\",\"longFmt\":\"3,833,000,000\"},\"totalCurrentLiabilities\":{\"raw\":26569000000,\"fmt\":\"26.57B\",\"longFmt\":\"26,569,000,000\"},\"deferredLongTermAssetCharges\":{\"raw\":3796000000,\"fmt\":\"3.8B\",\"longFmt\":\"3,796,000,000\"},\"shortLongTermDebt\":{\"raw\":2040000000,\"fmt\":\"2.04B\",\"longFmt\":\"2,040,000,000\"},\"otherStockholderEquity\":{\"raw\":2490000000,\"fmt\":\"2.49B\",\"longFmt\":\"2,490,000,000\"},\"propertyPlantEquipment\":{\"raw\":10860000000,\"fmt\":\"10.86B\",\"longFmt\":\"10,860,000,000\"},\"totalCurrentAssets\":{\"raw\":15907000000,\"fmt\":\"15.91B\",\"longFmt\":\"15,907,000,000\"},\"longTermInvestments\":{\"raw\":1109000000,\"fmt\":\"1.11B\",\"longFmt\":\"1,109,000,000\"},\"netTangibleAssets\":{\"raw\":-23364000000,\"fmt\":\"-23.36B\",\"longFmt\":\"-23,364,000,000\"},\"shortTermInvestments\":{\"raw\":78000000,\"fmt\":\"78M\",\"longFmt\":\"78,000,000\"},\"netReceivables\":{\"raw\":5950000000,\"fmt\":\"5.95B\",\"longFmt\":\"5,950,000,000\"},\"maxAge\":1,\"longTermDebt\":{\"raw\":14221000000,\"fmt\":\"14.22B\",\"longFmt\":\"14,221,000,000\"},\"inventory\":{\"raw\":5557000000,\"fmt\":\"5.56B\",\"longFmt\":\"5,557,000,000\"},\"accountsPayable\":{\"raw\":3528000000,\"fmt\":\"3.53B\",\"longFmt\":\"3,528,000,000\"}}],\"maxAge\":86400},\"cashflowStatementHistoryQuarterly\":{\"cashflowStatements\":[{\"changeToLiabilities\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-1183000000,\"fmt\":\"-1.18B\",\"longFmt\":\"-1,183,000,000\"},\"netBorrowings\":{\"raw\":-275000000,\"fmt\":\"-275M\",\"longFmt\":\"-275,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-1394000000,\"fmt\":\"-1.39B\",\"longFmt\":\"-1,394,000,000\"},\"changeToOperatingActivities\":{\"raw\":-28000000,\"fmt\":\"-28M\",\"longFmt\":\"-28,000,000\"},\"issuanceOfStock\":{\"raw\":1000000,\"fmt\":\"1M\",\"longFmt\":\"1,000,000\"},\"netIncome\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"},\"changeInCash\":{\"raw\":-2000000,\"fmt\":\"-2M\",\"longFmt\":\"-2,000,000\"},\"endDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"effectOfExchangeRate\":{\"raw\":13000000,\"fmt\":\"13M\",\"longFmt\":\"13,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":2562000000,\"fmt\":\"2.56B\",\"longFmt\":\"2,562,000,000\"},\"depreciation\":{\"raw\":986000000,\"fmt\":\"986M\",\"longFmt\":\"986,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":7000000,\"fmt\":\"7M\",\"longFmt\":\"7,000,000\"},\"dividendsPaid\":{\"raw\":-951000000,\"fmt\":\"-951M\",\"longFmt\":\"-951,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-169000000,\"fmt\":\"-169M\",\"longFmt\":\"-169,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":436000000,\"fmt\":\"436M\",\"longFmt\":\"436,000,000\"},\"capitalExpenditures\":{\"raw\":-279000000,\"fmt\":\"-279M\",\"longFmt\":\"-279,000,000\"}},{\"investments\":{\"raw\":384000000,\"fmt\":\"384M\",\"longFmt\":\"384,000,000\"},\"changeToLiabilities\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-185000000,\"fmt\":\"-185M\",\"longFmt\":\"-185,000,000\"},\"netBorrowings\":{\"raw\":-406000000,\"fmt\":\"-406M\",\"longFmt\":\"-406,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-2045000000,\"fmt\":\"-2.04B\",\"longFmt\":\"-2,045,000,000\"},\"changeToOperatingActivities\":{\"raw\":-323000000,\"fmt\":\"-323M\",\"longFmt\":\"-323,000,000\"},\"issuanceOfStock\":{\"raw\":4000000,\"fmt\":\"4M\",\"longFmt\":\"4,000,000\"},\"netIncome\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"},\"changeInCash\":{\"raw\":-937000000,\"fmt\":\"-937M\",\"longFmt\":\"-937,000,000\"},\"endDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"effectOfExchangeRate\":{\"raw\":1000000,\"fmt\":\"1M\",\"longFmt\":\"1,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":1292000000,\"fmt\":\"1.29B\",\"longFmt\":\"1,292,000,000\"},\"depreciation\":{\"raw\":664000000,\"fmt\":\"664M\",\"longFmt\":\"664,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":18000000,\"fmt\":\"18M\",\"longFmt\":\"18,000,000\"},\"dividendsPaid\":{\"raw\":-1151000000,\"fmt\":\"-1.15B\",\"longFmt\":\"-1,151,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-492000000,\"fmt\":\"-492M\",\"longFmt\":\"-492,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":-444000000,\"fmt\":\"-444M\",\"longFmt\":\"-444,000,000\"},\"capitalExpenditures\":{\"raw\":-239000000,\"fmt\":\"-239M\",\"longFmt\":\"-239,000,000\"}},{\"investments\":{\"raw\":-41000000,\"fmt\":\"-41M\",\"longFmt\":\"-41,000,000\"},\"changeToLiabilities\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-48000000,\"fmt\":\"-48M\",\"longFmt\":\"-48,000,000\"},\"netBorrowings\":{\"raw\":-54000000,\"fmt\":\"-54M\",\"longFmt\":\"-54,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-1376000000,\"fmt\":\"-1.38B\",\"longFmt\":\"-1,376,000,000\"},\"changeToOperatingActivities\":{\"raw\":-1376000000,\"fmt\":\"-1.38B\",\"longFmt\":\"-1,376,000,000\"},\"issuanceOfStock\":{\"raw\":15000000,\"fmt\":\"15M\",\"longFmt\":\"15,000,000\"},\"netIncome\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"},\"changeInCash\":{\"raw\":-1128000000,\"fmt\":\"-1.13B\",\"longFmt\":\"-1,128,000,000\"},\"endDate\":{\"raw\":1617148800,\"fmt\":\"2021-03-31\"},\"effectOfExchangeRate\":{\"raw\":-35000000,\"fmt\":\"-35M\",\"longFmt\":\"-35,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":331000000,\"fmt\":\"331M\",\"longFmt\":\"331,000,000\"},\"depreciation\":{\"raw\":361000000,\"fmt\":\"361M\",\"longFmt\":\"361,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":8000000,\"fmt\":\"8M\",\"longFmt\":\"8,000,000\"},\"dividendsPaid\":{\"raw\":-946000000,\"fmt\":\"-946M\",\"longFmt\":\"-946,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-391000000,\"fmt\":\"-391M\",\"longFmt\":\"-391,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":273000000,\"fmt\":\"273M\",\"longFmt\":\"273,000,000\"},\"capitalExpenditures\":{\"raw\":-201000000,\"fmt\":\"-201M\",\"longFmt\":\"-201,000,000\"}},{\"investments\":{\"raw\":117000000,\"fmt\":\"117M\",\"longFmt\":\"117,000,000\"},\"changeToLiabilities\":{\"raw\":225000000,\"fmt\":\"225M\",\"longFmt\":\"225,000,000\"},\"totalCashflowsFromInvestingActivities\":{\"raw\":-52000000,\"fmt\":\"-52M\",\"longFmt\":\"-52,000,000\"},\"netBorrowings\":{\"raw\":-577000000,\"fmt\":\"-577M\",\"longFmt\":\"-577,000,000\"},\"totalCashFromFinancingActivities\":{\"raw\":-2175000000,\"fmt\":\"-2.17B\",\"longFmt\":\"-2,175,000,000\"},\"changeToOperatingActivities\":{\"raw\":-262000000,\"fmt\":\"-262M\",\"longFmt\":\"-262,000,000\"},\"issuanceOfStock\":{\"raw\":1000000,\"fmt\":\"1M\",\"longFmt\":\"1,000,000\"},\"netIncome\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"},\"changeInCash\":{\"raw\":1606000000,\"fmt\":\"1.61B\",\"longFmt\":\"1,606,000,000\"},\"endDate\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"effectOfExchangeRate\":{\"raw\":-22000000,\"fmt\":\"-22M\",\"longFmt\":\"-22,000,000\"},\"totalCashFromOperatingActivities\":{\"raw\":3855000000,\"fmt\":\"3.85B\",\"longFmt\":\"3,855,000,000\"},\"depreciation\":{\"raw\":2440000000,\"fmt\":\"2.44B\",\"longFmt\":\"2,440,000,000\"},\"otherCashflowsFromInvestingActivities\":{\"raw\":23000000,\"fmt\":\"23M\",\"longFmt\":\"23,000,000\"},\"dividendsPaid\":{\"raw\":-946000000,\"fmt\":\"-946M\",\"longFmt\":\"-946,000,000\"},\"changeToInventory\":{\"raw\":119000000,\"fmt\":\"119M\",\"longFmt\":\"119,000,000\"},\"changeToAccountReceivables\":{\"raw\":-224000000,\"fmt\":\"-224M\",\"longFmt\":\"-224,000,000\"},\"otherCashflowsFromFinancingActivities\":{\"raw\":-653000000,\"fmt\":\"-653M\",\"longFmt\":\"-653,000,000\"},\"maxAge\":1,\"changeToNetincome\":{\"raw\":639000000,\"fmt\":\"639M\",\"longFmt\":\"639,000,000\"},\"capitalExpenditures\":{\"raw\":-514000000,\"fmt\":\"-514M\",\"longFmt\":\"-514,000,000\"}}],\"maxAge\":86400},\"quoteType\":{\"exchange\":\"NYQ\",\"shortName\":\"GlaxoSmithKline PLC\",\"longName\":\"GlaxoSmithKline plc\",\"exchangeTimezoneName\":\"America/New_York\",\"exchangeTimezoneShortName\":\"EST\",\"isEsgPopulated\":false,\"gmtOffSetMilliseconds\":\"-18000000\",\"quoteType\":\"EQUITY\",\"symbol\":\"GSK\",\"messageBoardId\":\"finmb_275442\",\"market\":\"us_market\"},\"summaryDetail\":{\"previousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"twoHundredDayAverage\":{\"raw\":39.97489,\"fmt\":\"39.97\"},\"trailingAnnualDividendYield\":{\"raw\":0.018845702,\"fmt\":\"1.88%\"},\"payoutRatio\":{\"raw\":0.935,\"fmt\":\"93.50%\"},\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"navPrice\":{},\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"totalAssets\":{},\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"fiftyDayAverage\":{\"raw\":40.445,\"fmt\":\"40.44\"},\"trailingAnnualDividendRate\":{\"raw\":0.8,\"fmt\":\"0.80\"},\"open\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"toCurrency\":null,\"averageVolume10days\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"expireDate\":{},\"yield\":{},\"algorithm\":null,\"dividendRate\":{\"raw\":2.2,\"fmt\":\"2.20\"},\"exDividendDate\":{\"raw\":1637193600,\"fmt\":\"2021-11-18\"},\"beta\":{\"raw\":0.402824,\"fmt\":\"0.40\"},\"circulatingSupply\":{},\"startDate\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"trailingPE\":{\"raw\":18.62465,\"fmt\":\"18.62\"},\"regularMarketVolume\":{\"raw\":2390686,\"fmt\":\"2.39M\",\"longFmt\":\"2,390,686\"},\"lastMarket\":null,\"maxSupply\":{},\"openInterest\":{},\"marketCap\":{\"raw\":107209695232,\"fmt\":\"107.21B\",\"longFmt\":\"107,209,695,232\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"averageVolume\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"priceToSalesTrailing12Months\":{\"raw\":3.2169986,\"fmt\":\"3.22\"},\"dayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"ask\":{\"raw\":0,\"fmt\":\"0.00\"},\"ytdReturn\":{},\"askSize\":{\"raw\":4000,\"fmt\":\"4k\",\"longFmt\":\"4,000\"},\"volume\":{\"raw\":2390686,\"fmt\":\"2.39M\",\"longFmt\":\"2,390,686\"},\"fiftyTwoWeekHigh\":{\"raw\":43.61,\"fmt\":\"43.61\"},\"forwardPE\":{\"raw\":13.316626,\"fmt\":\"13.32\"},\"maxAge\":1,\"fromCurrency\":null,\"fiveYearAvgDividendYield\":{\"raw\":5.24,\"fmt\":\"5.24\"},\"fiftyTwoWeekLow\":{\"raw\":33.53,\"fmt\":\"33.53\"},\"bid\":{\"raw\":0,\"fmt\":\"0.00\"},\"tradeable\":false,\"dividendYield\":{\"raw\":0.051,\"fmt\":\"5.10%\"},\"bidSize\":{\"raw\":1400,\"fmt\":\"1.4k\",\"longFmt\":\"1,400\"},\"dayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"}},\"symbol\":\"GSK\",\"pageViews\":{\"shortTermTrend\":\"UP\",\"midTermTrend\":\"UP\",\"longTermTrend\":\"UP\",\"maxAge\":1},\"timeSeries\":{\"annualCurrentDebt\":[{\"dataId\":23045,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":2802000000,\"fmt\":\"2.80B\"}},{\"dataId\":23045,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5769000000,\"fmt\":\"5.77B\"}},{\"dataId\":23045,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6678000000,\"fmt\":\"6.68B\"}},{\"dataId\":23045,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3495000000,\"fmt\":\"3.50B\"}}],\"annualStockholdersEquity\":[{\"dataId\":23215,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-68000000,\"fmt\":\"-68.00M\"}},{\"dataId\":23215,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4360000000,\"fmt\":\"4.36B\"}},{\"dataId\":23215,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11405000000,\"fmt\":\"11.40B\"}},{\"dataId\":23215,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":14587000000,\"fmt\":\"14.59B\"}}],\"annualOtherCurrentAssets\":[],\"annualNonCurrentDeferredRevenue\":[null,{\"dataId\":23062,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":19000000,\"fmt\":\"19.00M\"}},{\"dataId\":23062,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":24000000,\"fmt\":\"24.00M\"}},{\"dataId\":23062,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":21000000,\"fmt\":\"21.00M\"}}],\"annualCurrentAssets\":[{\"dataId\":23044,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":15907000000,\"fmt\":\"15.91B\"}},{\"dataId\":23044,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":16927000000,\"fmt\":\"16.93B\"}},{\"dataId\":23044,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":19491000000,\"fmt\":\"19.49B\"}},{\"dataId\":23044,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":20247000000,\"fmt\":\"20.25B\"}}],\"annualAccountsReceivable\":[{\"dataId\":23001,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4672000000,\"fmt\":\"4.67B\"}},{\"dataId\":23001,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5161000000,\"fmt\":\"5.16B\"}},{\"dataId\":23001,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5487000000,\"fmt\":\"5.49B\"}},{\"dataId\":23001,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5549000000,\"fmt\":\"5.55B\"}}],\"annualLongTermDebt\":[{\"dataId\":23123,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":14221000000,\"fmt\":\"14.22B\"}},{\"dataId\":23123,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":20227000000,\"fmt\":\"20.23B\"}},{\"dataId\":23123,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22580000000,\"fmt\":\"22.58B\"}},{\"dataId\":23123,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22538000000,\"fmt\":\"22.54B\"}}],\"annualOtherNonCurrentLiabilities\":[{\"dataId\":23379,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5096000000,\"fmt\":\"5.10B\"}},{\"dataId\":23379,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5449000000,\"fmt\":\"5.45B\"}},{\"dataId\":23379,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4724000000,\"fmt\":\"4.72B\"}},{\"dataId\":23379,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5104000000,\"fmt\":\"5.10B\"}}],\"annualCapitalStock\":[{\"dataId\":23027,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1343000000,\"fmt\":\"1.34B\"}},{\"dataId\":23027,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1345000000,\"fmt\":\"1.34B\"}},{\"dataId\":23027,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1346000000,\"fmt\":\"1.35B\"}},{\"dataId\":23027,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1346000000,\"fmt\":\"1.35B\"}}],\"annualNetPPE\":[{\"dataId\":23139,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10860000000,\"fmt\":\"10.86B\"}},{\"dataId\":23139,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11058000000,\"fmt\":\"11.06B\"}},{\"dataId\":23139,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11314000000,\"fmt\":\"11.31B\"}},{\"dataId\":23139,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":11006000000,\"fmt\":\"11.01B\"}}],\"annualCurrentLiabilities\":[{\"dataId\":23047,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":26569000000,\"fmt\":\"26.57B\"}},{\"dataId\":23047,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22491000000,\"fmt\":\"22.49B\"}},{\"dataId\":23047,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":24050000000,\"fmt\":\"24.05B\"}},{\"dataId\":23047,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22148000000,\"fmt\":\"22.15B\"}}],\"annualRetainedEarnings\":[{\"dataId\":23204,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-6477000000,\"fmt\":\"-6.48B\"}},{\"dataId\":23204,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-2137000000,\"fmt\":\"-2.14B\"}},{\"dataId\":23204,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4530000000,\"fmt\":\"4.53B\"}},{\"dataId\":23204,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6755000000,\"fmt\":\"6.75B\"}}],\"annualAccountsPayable\":[{\"dataId\":23000,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3528000000,\"fmt\":\"3.53B\"}},{\"dataId\":23000,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3645000000,\"fmt\":\"3.65B\"}},{\"dataId\":23000,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4144000000,\"fmt\":\"4.14B\"}},{\"dataId\":23000,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4357000000,\"fmt\":\"4.36B\"}}],\"annualGrossPPE\":[{\"dataId\":23100,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":21719000000,\"fmt\":\"21.72B\"}},{\"dataId\":23100,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22488000000,\"fmt\":\"22.49B\"}},{\"dataId\":23100,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22565000000,\"fmt\":\"22.57B\"}},{\"dataId\":23100,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":22313000000,\"fmt\":\"22.31B\"}}],\"annualOtherNonCurrentAssets\":[{\"dataId\":23339,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1413000000,\"fmt\":\"1.41B\"}},{\"dataId\":23339,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1576000000,\"fmt\":\"1.58B\"}},{\"dataId\":23339,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1020000000,\"fmt\":\"1.02B\"}},{\"dataId\":23339,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1041000000,\"fmt\":\"1.04B\"}}],\"annualTotalNonCurrentAssets\":[{\"dataId\":23226,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":40474000000,\"fmt\":\"40.47B\"}},{\"dataId\":23226,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":41139000000,\"fmt\":\"41.14B\"}},{\"dataId\":23226,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":60201000000,\"fmt\":\"60.20B\"}},{\"dataId\":23226,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":60184000000,\"fmt\":\"60.18B\"}}],\"annualInventory\":[{\"dataId\":23108,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5557000000,\"fmt\":\"5.56B\"}},{\"dataId\":23108,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5476000000,\"fmt\":\"5.48B\"}},{\"dataId\":23108,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5947000000,\"fmt\":\"5.95B\"}},{\"dataId\":23108,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5996000000,\"fmt\":\"6.00B\"}}],\"annualTotalAssets\":[{\"dataId\":23220,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":56381000000,\"fmt\":\"56.38B\"}},{\"dataId\":23220,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":58066000000,\"fmt\":\"58.07B\"}},{\"dataId\":23220,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":79692000000,\"fmt\":\"79.69B\"}},{\"dataId\":23220,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":80431000000,\"fmt\":\"80.43B\"}}],\"annualGoodwill\":[{\"dataId\":23097,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5734000000,\"fmt\":\"5.73B\"}},{\"dataId\":23097,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":5789000000,\"fmt\":\"5.79B\"}},{\"dataId\":23097,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10562000000,\"fmt\":\"10.56B\"}},{\"dataId\":23097,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":10597000000,\"fmt\":\"10.60B\"}}],\"annualNonCurrentDeferredTaxesLiabilities\":[{\"dataId\":23067,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1396000000,\"fmt\":\"1.40B\"}},{\"dataId\":23067,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1156000000,\"fmt\":\"1.16B\"}},{\"dataId\":23067,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3810000000,\"fmt\":\"3.81B\"}},{\"dataId\":23067,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3600000000,\"fmt\":\"3.60B\"}}],\"annualCashAndCashEquivalents\":[{\"dataId\":23030,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3833000000,\"fmt\":\"3.83B\"}},{\"dataId\":23030,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3874000000,\"fmt\":\"3.87B\"}},{\"dataId\":23030,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4707000000,\"fmt\":\"4.71B\"}},{\"dataId\":23030,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6092000000,\"fmt\":\"6.09B\"}}],\"annualCashCashEquivalentsAndShortTermInvestments\":[{\"dataId\":23033,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3911000000,\"fmt\":\"3.91B\"}},{\"dataId\":23033,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":3958000000,\"fmt\":\"3.96B\"}},{\"dataId\":23033,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":4786000000,\"fmt\":\"4.79B\"}},{\"dataId\":23033,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":6170000000,\"fmt\":\"6.17B\"}}],\"annualOtherShortTermInvestments\":[{\"dataId\":23163,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":78000000,\"fmt\":\"78.00M\"}},{\"dataId\":23163,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":84000000,\"fmt\":\"84.00M\"}},{\"dataId\":23163,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":79000000,\"fmt\":\"79.00M\"}},{\"dataId\":23163,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":78000000,\"fmt\":\"78.00M\"}}],\"annualAccumulatedDepreciation\":[{\"dataId\":23008,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-10859000000,\"fmt\":\"-10.86B\"}},{\"dataId\":23008,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-11430000000,\"fmt\":\"-11.43B\"}},{\"dataId\":23008,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-11251000000,\"fmt\":\"-11.25B\"}},{\"dataId\":23008,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":-11307000000,\"fmt\":\"-11.31B\"}}],\"annualTotalNonCurrentLiabilitiesNetMinorityInterest\":[{\"dataId\":23260,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":26323000000,\"fmt\":\"26.32B\"}},{\"dataId\":23260,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":31903000000,\"fmt\":\"31.90B\"}},{\"dataId\":23260,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":37285000000,\"fmt\":\"37.28B\"}},{\"dataId\":23260,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":37475000000,\"fmt\":\"37.48B\"}}],\"annualTotalLiabilitiesNetMinorityInterest\":[{\"dataId\":23259,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":52892000000,\"fmt\":\"52.89B\"}},{\"dataId\":23259,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":54394000000,\"fmt\":\"54.39B\"}},{\"dataId\":23259,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":61335000000,\"fmt\":\"61.34B\"}},{\"dataId\":23259,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":59623000000,\"fmt\":\"59.62B\"}}],\"annualOtherCurrentLiabilities\":[{\"dataId\":23151,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":1076000000,\"fmt\":\"1.08B\"}},{\"dataId\":23151,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":837000000,\"fmt\":\"837.00M\"}},{\"dataId\":23151,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":755000000,\"fmt\":\"755.00M\"}},{\"dataId\":23151,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":765000000,\"fmt\":\"765.00M\"}}],\"annualOtherIntangibleAssets\":[{\"dataId\":23155,\"asOfDate\":\"2017-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":17562000000,\"fmt\":\"17.56B\"}},{\"dataId\":23155,\"asOfDate\":\"2018-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":17202000000,\"fmt\":\"17.20B\"}},{\"dataId\":23155,\"asOfDate\":\"2019-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":30955000000,\"fmt\":\"30.95B\"}},{\"dataId\":23155,\"asOfDate\":\"2020-12-31\",\"periodType\":\"12M\",\"currencyCode\":\"GBP\",\"reportedValue\":{\"raw\":29824000000,\"fmt\":\"29.82B\"}}],\"annualGainsLossesNotAffectingRetainedEarnings\":[],\"annualIncomeTaxPayable\":[],\"annualCurrentDeferredRevenue\":[],\"annualInvestmentsAndAdvances\":[],\"annualCurrentAccruedExpenses\":[],\"timestamp\":[1514678400,1546214400,1577750400,1609372800]},\"meta\":{\"symbol\":\"GSK\",\"start\":493590046,\"end\":1637169265,\"timeUnit\":\"annual\"},\"loading\":false,\"errorList\":[]}\n"
     ]
    }
   ],
   "source": [
    "url = \"https://apidojo-yahoo-finance-v1.p.rapidapi.com/stock/v2/get-balance-sheet\"\n",
    "\n",
    "querystring = {\"symbol\":\"gsk\",\"region\":\"Uk\"}\n",
    "\n",
    "headers = {\n",
    "    'x-rapidapi-host': \"apidojo-yahoo-finance-v1.p.rapidapi.com\",\n",
    "    'x-rapidapi-key': \"9cd97ba3camsh244cbd2e3e420a4p1e83c0jsne0fdd0787f8e\"\n",
    "    }\n",
    "\n",
    "response = requests.request(\"GET\", url, headers=headers, params=querystring)\n",
    "\n",
    "print(response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"finance\":{\"result\":{\"symbol\":\"GSK\",\"instrumentInfo\":{\"technicalEvents\":{\"provider\":\"Trading Central\",\"shortTerm\":\"down\",\"midTerm\":\"up\",\"longTerm\":\"up\"},\"keyTechnicals\":{\"provider\":\"Trading Central\",\"support\":37.76,\"resistance\":43.45,\"stopLoss\":41.079271},\"valuation\":{\"color\":0.0,\"description\":\"Overvalued\",\"discount\":\"12%\",\"relativeValue\":\"Premium\",\"provider\":\"Trading Central\"},\"recommendation\":{\"targetPrice\":45.0,\"provider\":\"Argus Research\",\"rating\":\"BUY\"}},\"reports\":[{\"id\":\"MS_0P000002FO_AnalystReport_1636383254000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-11-08T14:54:14Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. \"},{\"id\":\"MS_0P000002FO_AnalystReport_1635353053000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-10-27T16:44:13Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. \"},{\"id\":\"MS_0P000002FO_AnalystReport_1633982688000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-10-11T20:04:48Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. \"},{\"id\":\"ARGUS_3019_AnalystReport_1633523925000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-10-06T12:38:45Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory and infectious diseases, and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care products, and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 94,000 employees.\"},{\"id\":\"ARGUS_31070_MarketUpdate_1633523025000\",\"title\":\"Market Update: GSK\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-10-06T12:23:45Z\",\"summary\":\"Stocks fell on Wednesday morning amid continued concerns about inflation, slowing economic growth, and the looming debt ceiling deadline. With less than two weeks to prevent a U.S. government default, Senate Democrats were reportedly considering dropping the filibuster rule in a new vote to raise the debt limit. Employment data was positive. Payroll provider ADP said that U.S. companies added 568,000 jobs in September, up from a revised 340,000 in August and above the Reuters consensus forecast of 428,000. The Dow fell 0.7%, the S&P 0.5%, and the Nasdaq 0.1%. Crude oil fell 2% to $77 per barrel, while gold traded near $1761 per ounce.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1631500884000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-09-13T02:41:24Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. \"},{\"id\":\"MS_0P000002FO_AnalystReport_1627523633000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-07-29T01:53:53Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_3019_AnalystReport_1625555747000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-07-06T07:15:47Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory and infectious diseases, and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care products, and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 94,000 employees.\"},{\"id\":\"ARGUS_30295_MarketSummary_1625554847000\",\"title\":\"Market Digest: GSK, VTR\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-07-06T07:00:47Z\",\"summary\":\"The stock market moved higher last week in quiet trading, as volatility decreased to a post-pandemic low and tech stocks outperformed, though blue chips were not far behind. During Friday's session, the Dow Jones Industrial Average increased 153 points, or 0.44%. The S&P 500 was up 0.75%, and the Nasdaq Composite was up 0.81%. For the week, the DJIA was up 353 points, or 1.02%, the S&P 500 was up 1.67%, and the Nasdaq Composite was up 1.94%. Year-to-date, the DJIA is up 13.66%, the S&P 500 is up 15.87%, and the Nasdaq Composite is up 13.59%. \"},{\"id\":\"ARGUS_30245_ThematicPortfolio_1624869344000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-06-28T08:35:44Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years as the endless speculation over the direction of rates has created market-timing headaches. Investors have endured wide swings in prices for rate-sensitive equity sectors such as utilities, REITs and MLPs. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to volatile U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also a number of positives in this segment for U.S. investors.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1624484650000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-06-23T21:44:10Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1624048261000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-06-18T20:31:01Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1619632367000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-04-28T17:52:47Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_3019_AnalystReport_1619076275000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-04-22T07:24:35Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 94,000 employees.\"},{\"id\":\"ARGUS_29693_MarketSummary_1619075375000\",\"title\":\"Market Digest: CMA, ERIC, GSK, KEY, NFLX, VTRS\",\"provider\":\"Argus Research\",\"publishedOn\":\"2021-04-22T07:09:35Z\",\"summary\":\"Sector Rotation Showing Signs of Reverting\"},{\"id\":\"MS_0P000002FO_AnalystReport_1618605946000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-04-16T20:45:46Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1612381136000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-02-03T19:38:56Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1609991716000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-01-07T03:55:16Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1609960247000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2021-01-06T19:10:47Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_3019_AnalystReport_1607930210000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-12-14T07:16:50Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"ARGUS_28650_MarketSummary_1607929310000\",\"title\":\"Market Digest: DVN, GSK, NFG, WTRG, LULU, AVGO\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-12-14T07:01:50Z\",\"summary\":\"Stocks fell last week, with a final drop on Friday as hopes for a stimulus plan fizzled. The details, rather than the size of the deal, are the sticking points. A troubling initial UE claims report also weighed on sentiment. On Friday, the Dow Jones Industrial Average eked out a win of 47 points, or 0.16%, as DIS shares rallied. The S&P 500 fell 4 points, or 0.13%, and the Nasdaq Composite dropped 28 points or 0.23%. Last week, the Dow was down 0.6%, the S&P 500 was down 1.0%, and the Nasdaq was down 0.7%. For the year-to-date, the DJIA is up 5.3%. The S&P is up 13.4%, and the Nasdaq remains in front with a gain of 38.0%. Over the past 52 weeks, the Dow is up 6.8%, the S&P 500 is up 15.6%, and the Nasdaq is up 41.7%.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1606150009000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-11-23T16:46:49Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1604688238000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-11-06T18:43:58Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1603910086000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-10-28T18:34:46Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_28233_ThematicPortfolio_1603271869000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-10-21T09:17:49Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to volatile U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also a number of positives in this segment for U.S. investors. One is a more robust selection of high-quality names. Yields also tend to be higher in overseas markets in general. And finally, valuations can be more attractive.\"},{\"id\":\"ARGUS_28151_StockPicks_1602506883000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-10-12T12:48:03Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the U.S. Federal Reserve embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities.  The central bank reversed course in 2019, before moving to the sidelines.  In 2020, due to the coronavirus, the Fed is back in action, cutting rates, backstopping numerous financial markets and pledging to do \\\"whatever it takes\\\" and \\\"for as long as necessary.\\\"  Also due to COVID-19, many U.S. companies have cut back or eliminated their dividends in order to preserve capital during the pandemic. The endless speculation over the timing of the Fed's next moves has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as Utilities, REITs and MLPs -- even as generally positive industry fundamentals remained largely intact.  In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geo-political turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has boosted its global coverage, adding the following BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_28151_StockPicks_1602460800000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-10-12T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the U.S. Federal Reserve embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities.  The central bank reversed course in 2019, before moving to the sidelines.  In 2020, due to the coronavirus, the Fed is back in action, cutting rates, backstopping numerous financial markets and pledging to do \\\"whatever it takes\\\" and \\\"for as long as necessary.\\\"  Also due to COVID-19, many U.S. companies have cut back or eliminated their dividends in order to preserve capital during the pandemic. The endless speculation over the timing of the Fed's next moves has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as Utilities, REITs and MLPs -- even as generally positive industry fundamentals remained largely intact.  In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geo-political turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has boosted its global coverage, adding the following BUY-rated international dividend stocks.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1601060904000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-09-25T19:08:24Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1599001057000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-09-01T22:57:37Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_3019_AnalystReport_1597153365000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-08-11T13:42:45Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"ARGUS_27653_MarketUpdate_1597152465000\",\"title\":\"Market Update: ALB, BP, GS, GSK, K, MRO, VFC, WMB\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-08-11T13:27:45Z\",\"summary\":\"Stocks were mixed on Tuesday morning as investors weighed prospects for further government stimulus measures and the approval of a coronavirus vaccine in Russia - despite the lack of standard Phase 3 testing. The Labor Department said that its producer price index rose 0.6% in July, above the Reuters consensus forecast of 0.3% and the strongest growth since October 2018. The Dow rose 0.9%, the S&P rose 0.3%, and the Nasdaq fell 0.3%. Crude oil traded near $42 per barrel, while gold dropped more than 4% to $1954 per ounce.\"},{\"id\":\"ARGUS_27653_MarketUpdate_1597104000000\",\"title\":\"Market Update: ALB, BP, GS, GSK, K, MRO, VFC, WMB\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-08-11T00:00:00Z\",\"summary\":\"Stocks were mixed on Tuesday morning as investors weighed prospects for further government stimulus measures and the approval of a coronavirus vaccine in Russia - despite the lack of standard Phase 3 testing. The Labor Department said that its producer price index rose 0.6% in July, above the Reuters consensus forecast of 0.3% and the strongest growth since October 2018. The Dow rose 0.9%, the S&P rose 0.3%, and the Nasdaq fell 0.3%. Crude oil traded near $42 per barrel, while gold dropped more than 4% to $1954 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1597104000000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-08-11T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1596043502000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-07-29T17:25:02Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_3019_AnalystReport_1588317092000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-05-01T07:11:32Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"ARGUS_26826_MarketSummary_1588316192000\",\"title\":\"Market Digest: LUV, XRX, GSK, NVS, PPG\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-05-01T06:56:32Z\",\"summary\":\"Stocks fell on Thursday, reversing some of Wednesday's gains amid weak employment and consumer spending data. First-time unemployment benefit claims fell from the prior week, but still totaled 3.839 million - bringing the six-week total to more than 30 million. Consumer spending also plunged a record 7.5% in March, greater than the consensus call for a 5.0% decline. Meanwhile, the Federal Reserve expanded its 'Main Street' lending program to help medium-sized businesses. The Dow fell 1.17%, the S&P 0.92%, and the Nasdaq 0.28%. Crude oil rose to nearly $19 per barrel, while gold fell $18 to $1695 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1588291200000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-05-01T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"ARGUS_26826_MarketSummary_1588291200000\",\"title\":\"Market Digest: LUV, XRX, GSK, NVS, PPG\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-05-01T00:00:00Z\",\"summary\":\"Stocks fell on Thursday, reversing some of Wednesday's gains amid weak employment and consumer spending data. First-time unemployment benefit claims fell from the prior week, but still totaled 3.839 million - bringing the six-week total to more than 30 million. Consumer spending also plunged a record 7.5% in March, greater than the consensus call for a 5.0% decline. Meanwhile, the Federal Reserve expanded its 'Main Street' lending program to help medium-sized businesses. The Dow fell 1.17%, the S&P 0.92%, and the Nasdaq 0.28%. Crude oil rose to nearly $19 per barrel, while gold fell $18 to $1695 per ounce.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1588284956000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-04-30T22:15:56Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory, oncology, and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1588178717000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-04-29T16:45:17Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1586909379000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-04-15T00:09:39Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1586191383000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-04-06T16:43:03Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1585927122000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-04-03T15:18:42Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_26505_StockPicks_1584987732000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-03-23T18:22:12Z\",\"summary\":\"Argus Research covers 55 leading global healthcare companies.  Many of them are working on new products, vaccines and medicals supplies and equipment to help healthcare professionals treat Covid-19 patients and prevent the outbreak from spreading even further than its current trajectory projects.  Argus Senior Analyst David Toung and Security Analyst Jasper Hellweg cited the following companies in the current battle.\"},{\"id\":\"ARGUS_26505_StockPicks_1584921600000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-03-23T00:00:00Z\",\"summary\":\"Argus Research covers 55 leading global healthcare companies.  Many of them are working on new products, vaccines and medicals supplies and equipment to help healthcare professionals treat Covid-19 patients and prevent the outbreak from spreading even further than its current trajectory projects.  Argus Senior Analyst David Toung and Security Analyst Jasper Hellweg cited the following companies in the current battle.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1584651862000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-03-19T21:04:22Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1583352570000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-03-04T20:09:30Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"MS_0P000002FO_AnalystReport_1582936433000\",\"title\":\"Analyst Report: GlaxoSmithKline plc\",\"provider\":\"Morningstar\",\"publishedOn\":\"2020-02-29T00:33:53Z\",\"summary\":\"In the pharmaceutical industry, GlaxoSmithKline ranks as one of the largest companies by total sales. The company wields its might across several therapeutic classes, including respiratory and antiviral, as well as vaccines and consumer healthcare products. Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products.\"},{\"id\":\"ARGUS_26296_ThematicPortfolio_1582786699000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-27T06:58:19Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the Federal Reserve embarked on an aggressive campaign to raise interest rates -- causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. In 2019, the Fed lowered rates, in order to restore a normal upward slope in the yield curve. And in 2020, global investors, fearing the spread of the coronavirus, have pushed rates lower still. The endless speculation over the direction of rates has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs -- even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also many positives in this asset class for U.S. investors.\"},{\"id\":\"ARGUS_26296_ThematicPortfolio_1582761600000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-27T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the Federal Reserve embarked on an aggressive campaign to raise interest rates -- causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. In 2019, the Fed lowered rates, in order to restore a normal upward slope in the yield curve. And in 2020, global investors, fearing the spread of the coronavirus, have pushed rates lower still. The endless speculation over the direction of rates has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs -- even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also many positives in this asset class for U.S. investors.\"},{\"id\":\"ARGUS_3019_AnalystReport_1581426979000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-11T13:16:19Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_26165_MarketUpdate_1581426079000\",\"title\":\"Market Update: CBOE, EA, MET, QSR, GSK, PSX, TPR\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-11T13:01:19Z\",\"summary\":\"Stocks rose on Tuesday morning as investors weighed congressional testimony from Fed Chair Jerome Powell, who emphasized the continued strength of the U.S. economy while also noting the risks posed by the coronavirus. T-Mobile shares rose 10% after a federal judge approved the company's merger with Sprint, while Under Armour fell more than 16% after issuing disappointing guidance. The Dow rose 0.1%, the S&P 0.5%, and the Nasdaq 0.8%. Crude oil traded near $50 per barrel, while gold fell $12 to $1568 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1581379200000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-11T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_26165_MarketUpdate_1581379200000\",\"title\":\"Market Update: CBOE, EA, MET, QSR, GSK, PSX, TPR\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-11T00:00:00Z\",\"summary\":\"Stocks rose on Tuesday morning as investors weighed congressional testimony from Fed Chair Jerome Powell, who emphasized the continued strength of the U.S. economy while also noting the risks posed by the coronavirus. T-Mobile shares rose 10% after a federal judge approved the company's merger with Sprint, while Under Armour fell more than 16% after issuing disappointing guidance. The Dow rose 0.1%, the S&P 0.5%, and the Nasdaq 0.8%. Crude oil traded near $50 per barrel, while gold fell $12 to $1568 per ounce.\"},{\"id\":\"ARGUS_26088_MarketOutlook_1580715896000\",\"title\":\"Daily Spotlight: Stocks Have Recovered from Health Scares\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-03T07:44:56Z\",\"summary\":\"The Dow Jones Industrial Average dropped more than 600 points on Friday, as investors expressed anxiety over the outbreak of coronavirus, its potential spread, and its ultimate impact on the global economy (already slowed by trade wars). Though the infectious disease may be new, investors do have some experience with virus outbreaks over the past decades, and the results have been favorable. We identified 12 outbreaks since the AIDS crisis in 1981, and have measured the market's return in the six- and 12-month periods after the month-end during which the virus emerged. On average, the S&P 500 rose 9.3% in the first six months, and 14.2% over the full year. The steepest decline was an 11% drop after the AIDS crisis emerged, but we note that market environment also was characterized by high interest rates and high inflation. Each health scare was different, and the coronavirus has its own challenges. But scientists and healthcare officials have been quick to respond. If history is any guide -- and assuming the virus does not mutate to become more lethal or transmissible -- stocks should recover.\"},{\"id\":\"ARGUS_26088_MarketOutlook_1580688000000\",\"title\":\"Daily Spotlight: Stocks Have Recovered from Health Scares\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-02-03T00:00:00Z\",\"summary\":\"The Dow Jones Industrial Average dropped more than 600 points on Friday, as investors expressed anxiety over the outbreak of coronavirus, its potential spread, and its ultimate impact on the global economy (already slowed by trade wars). Though the infectious disease may be new, investors do have some experience with virus outbreaks over the past decades, and the results have been favorable. We identified 12 outbreaks since the AIDS crisis in 1981, and have measured the market's return in the six- and 12-month periods after the month-end during which the virus emerged. On average, the S&P 500 rose 9.3% in the first six months, and 14.2% over the full year. The steepest decline was an 11% drop after the AIDS crisis emerged, but we note that market environment also was characterized by high interest rates and high inflation. Each health scare was different, and the coronavirus has its own challenges. But scientists and healthcare officials have been quick to respond. If history is any guide -- and assuming the virus does not mutate to become more lethal or transmissible -- stocks should recover.\"},{\"id\":\"ARGUS_26037_StockPicks_1580111325000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-01-27T07:48:45Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the U.S. Federal Reserve embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities.  Then the central bank reversed course in 2019, before moving to the sidelines (we shall see) in 2020. The endless speculation over the timing of the Fed's next moves has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact.  In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geopolitical turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has recently boosted its global coverage, adding the following BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_26037_StockPicks_1580083200000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-01-27T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the U.S. Federal Reserve embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities.  Then the central bank reversed course in 2019, before moving to the sidelines (we shall see) in 2020. The endless speculation over the timing of the Fed's next moves has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact.  In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geopolitical turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has recently boosted its global coverage, adding the following BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_25926_StockPicks_1578920264000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-01-13T12:57:44Z\",\"summary\":\"U.S. and Chinese officials are set to sign a Phase 1 trade agreement on Wednesday. The agreement should mark a cooling of the trade war between the countries, which has been percolating for almost two years. Phase 1 elements include China's agreeing to purchase $200 billion of U.S. goods over the next two years, while the U.S. will be reducing tariffs on Chinese products. In addition, both sides will meet every six months to resolve disputes. President Trump has indicated that a complete trade deal between the countries could involve two or three phases, though no meetings or timetables have been set. There is much to like about China, which continues to grow its economy at a 6% clip and is the second-largest economy in the world in terms of total GDP.  China is a $14 trillion economy and represents about 16% of the $86 trillion global economy. Thus, China is a critical contributor to overall global economic growth, even if it \\\"only\\\" grows 5%-6%. In fact, 6% growth in the Chinese economy today adds more to global output -- by our reckoning, 20% of incremental GDP growth this year -- than the 10% growth achieved five years ago, when China was growing faster but was smaller. We expect extraordinary growth -- in the 5%-7% range -- to continue in China for at least the next decade. Drilling deeper, we think it is important to note that, on a GDP per-capita basis, this mighty nation remains a fraction of the size of the United States. Thus, the growth going forward may be different from the growth experienced in the past decade. We are expecting a shift in focus of Chinese out of domestic infrastructure such as dams, roads, airports, rail systems and cities and into raising the living standards of its 1.4 billion people, spending on programs to lift citizens out of rural poverty, lengthening their lives and cleaning the air, among other initiatives.  This growth should favor business and consumer services, as well as financial services and healthcare.\"},{\"id\":\"ARGUS_25926_StockPicks_1578873600000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2020-01-13T00:00:00Z\",\"summary\":\"U.S. and Chinese officials are set to sign a Phase 1 trade agreement on Wednesday. The agreement should mark a cooling of the trade war between the countries, which has been percolating for almost two years. Phase 1 elements include China's agreeing to purchase $200 billion of U.S. goods over the next two years, while the U.S. will be reducing tariffs on Chinese products. In addition, both sides will meet every six months to resolve disputes. President Trump has indicated that a complete trade deal between the countries could involve two or three phases, though no meetings or timetables have been set. There is much to like about China, which continues to grow its economy at a 6% clip and is the second-largest economy in the world in terms of total GDP.  China is a $14 trillion economy and represents about 16% of the $86 trillion global economy. Thus, China is a critical contributor to overall global economic growth, even if it \\\"only\\\" grows 5%-6%. In fact, 6% growth in the Chinese economy today adds more to global output -- by our reckoning, 20% of incremental GDP growth this year -- than the 10% growth achieved five years ago, when China was growing faster but was smaller. We expect extraordinary growth -- in the 5%-7% range -- to continue in China for at least the next decade. Drilling deeper, we think it is important to note that, on a GDP per-capita basis, this mighty nation remains a fraction of the size of the United States. Thus, the growth going forward may be different from the growth experienced in the past decade. We are expecting a shift in focus of Chinese out of domestic infrastructure such as dams, roads, airports, rail systems and cities and into raising the living standards of its 1.4 billion people, spending on programs to lift citizens out of rural poverty, lengthening their lives and cleaning the air, among other initiatives.  This growth should favor business and consumer services, as well as financial services and healthcare.\"},{\"id\":\"ARGUS_3019_AnalystReport_1575763200000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-08T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"ARGUS_27653_MarketUpdate_1575763200000\",\"title\":\"Market Update: ALB, BP, GS, GSK, K, MRO, VFC, WMB\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-08T00:00:00Z\",\"summary\":\"Stocks were mixed on Tuesday morning as investors weighed prospects for further government stimulus measures and the approval of a coronavirus vaccine in Russia - despite the lack of standard Phase 3 testing. The Labor Department said that its producer price index rose 0.6% in July, above the Reuters consensus forecast of 0.3% and the strongest growth since October 2018. The Dow rose 0.9%, the S&P rose 0.3%, and the Nasdaq fell 0.3%. Crude oil traded near $42 per barrel, while gold dropped more than 4% to $1954 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1575504000000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-05T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne. The company has approximately 99,000 employees.\"},{\"id\":\"ARGUS_26826_MarketSummary_1575504000000\",\"title\":\"Market Digest: LUV, XRX, GSK, NVS, PPG\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-05T00:00:00Z\",\"summary\":\"Stocks fell on Thursday, reversing some of Wednesday's gains amid weak employment and consumer spending data. First-time unemployment benefit claims fell from the prior week, but still totaled 3.839 million - bringing the six-week total to more than 30 million. Consumer spending also plunged a record 7.5% in March, greater than the consensus call for a 5.0% decline. Meanwhile, the Federal Reserve expanded its 'Main Street' lending program to help medium-sized businesses. The Dow fell 1.17%, the S&P 0.92%, and the Nasdaq 0.28%. Crude oil rose to nearly $19 per barrel, while gold fell $18 to $1695 per ounce.\"},{\"id\":\"ARGUS_26505_StockPicks_1575331200000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-03T00:00:00Z\",\"summary\":\"Argus Research covers 55 leading global healthcare companies.  Many of them are working on new products, vaccines and medicals supplies and equipment to help healthcare professionals treat Covid-19 patients and prevent the outbreak from spreading even further than its current trajectory projects.  Argus Senior Analyst David Toung and Security Analyst Jasper Hellweg cited the following companies in the current battle.\"},{\"id\":\"ARGUS_26165_MarketUpdate_1575244800000\",\"title\":\"Market Update: CBOE, EA, MET, QSR, GSK, PSX, TPR\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-02T00:00:00Z\",\"summary\":\"Stocks rose on Tuesday morning as investors weighed congressional testimony from Fed Chair Jerome Powell, who emphasized the continued strength of the U.S. economy while also noting the risks posed by the coronavirus. T-Mobile shares rose 10% after a federal judge approved the company's merger with Sprint, while Under Armour fell more than 16% after issuing disappointing guidance. The Dow rose 0.1%, the S&P 0.5%, and the Nasdaq 0.8%. Crude oil traded near $50 per barrel, while gold fell $12 to $1568 per ounce.\"},{\"id\":\"ARGUS_26088_MarketOutlook_1575244800000\",\"title\":\"Daily Spotlight: Stocks Have Recovered from Health Scares\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-02T00:00:00Z\",\"summary\":\"The Dow Jones Industrial Average dropped more than 600 points on Friday, as investors expressed anxiety over the outbreak of coronavirus, its potential spread, and its ultimate impact on the global economy (already slowed by trade wars). Though the infectious disease may be new, investors do have some experience with virus outbreaks over the past decades, and the results have been favorable. We identified 12 outbreaks since the AIDS crisis in 1981, and have measured the market's return in the six- and 12-month periods after the month-end during which the virus emerged. On average, the S&P 500 rose 9.3% in the first six months, and 14.2% over the full year. The steepest decline was an 11% drop after the AIDS crisis emerged, but we note that market environment also was characterized by high interest rates and high inflation. Each health scare was different, and the coronavirus has its own challenges. But scientists and healthcare officials have been quick to respond. If history is any guide -- and assuming the virus does not mutate to become more lethal or transmissible -- stocks should recover.\"},{\"id\":\"ARGUS_26296_ThematicPortfolio_1575244800000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-02T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the Federal Reserve embarked on an aggressive campaign to raise interest rates -- causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. In 2019, the Fed lowered rates, in order to restore a normal upward slope in the yield curve. And in 2020, global investors, fearing the spread of the coronavirus, have pushed rates lower still. The endless speculation over the direction of rates has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs -- even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also many positives in this asset class for U.S. investors.\"},{\"id\":\"ARGUS_3019_AnalystReport_1575244800000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-02T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_25926_StockPicks_1575158400000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-01T00:00:00Z\",\"summary\":\"U.S. and Chinese officials are set to sign a Phase 1 trade agreement on Wednesday. The agreement should mark a cooling of the trade war between the countries, which has been percolating for almost two years. Phase 1 elements include China's agreeing to purchase $200 billion of U.S. goods over the next two years, while the U.S. will be reducing tariffs on Chinese products. In addition, both sides will meet every six months to resolve disputes. President Trump has indicated that a complete trade deal between the countries could involve two or three phases, though no meetings or timetables have been set. There is much to like about China, which continues to grow its economy at a 6% clip and is the second-largest economy in the world in terms of total GDP.  China is a $14 trillion economy and represents about 16% of the $86 trillion global economy. Thus, China is a critical contributor to overall global economic growth, even if it \\\"only\\\" grows 5%-6%. In fact, 6% growth in the Chinese economy today adds more to global output -- by our reckoning, 20% of incremental GDP growth this year -- than the 10% growth achieved five years ago, when China was growing faster but was smaller. We expect extraordinary growth -- in the 5%-7% range -- to continue in China for at least the next decade. Drilling deeper, we think it is important to note that, on a GDP per-capita basis, this mighty nation remains a fraction of the size of the United States. Thus, the growth going forward may be different from the growth experienced in the past decade. We are expecting a shift in focus of Chinese out of domestic infrastructure such as dams, roads, airports, rail systems and cities and into raising the living standards of its 1.4 billion people, spending on programs to lift citizens out of rural poverty, lengthening their lives and cleaning the air, among other initiatives.  This growth should favor business and consumer services, as well as financial services and healthcare.\"},{\"id\":\"ARGUS_26037_StockPicks_1575158400000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-12-01T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the U.S. Federal Reserve embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities.  Then the central bank reversed course in 2019, before moving to the sidelines (we shall see) in 2020. The endless speculation over the timing of the Fed's next moves has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact.  In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geopolitical turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has recently boosted its global coverage, adding the following BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_3019_AnalystReport_1573457626000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-11-11T07:33:46Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_25430_MarketSummary_1573457626000\",\"title\":\"Market Digest: W, LHX, ABBV, EL, PRU, STX, DIS, GSK, OXY, EIX\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-11-11T07:33:46Z\",\"summary\":\"Stocks finished flat to slightly higher on Friday, aided by optimism over a phase I trade deal with China and the potential delay of upcoming tariffs. The Dow Jones Industrial Average was flat, while the Nasdaq Composite rose 0.5% and the S&P 500 added 0.3%, closing at a record high. As third-quarter earnings announcements began to wind down in a better-than-expected fashion, stocks also maintained momentum for the week, leading to a fifth consecutive rise. The Dow was up 1.2%, the Nasdaq added 1.1%, and the S&P 500 rose 0.9%. Year-to-date gains are now 18.7% for the Dow, 27.7% for the Nasdaq and 23.4% for the S&P 500.  \"},{\"id\":\"ARGUS_25430_MarketSummary_1573430400000\",\"title\":\"Market Digest: W, LHX, ABBV, EL, PRU, STX, DIS, GSK, OXY, EIX\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-11-11T00:00:00Z\",\"summary\":\"Stocks finished flat to slightly higher on Friday, aided by optimism over a phase I trade deal with China and the potential delay of upcoming tariffs. The Dow Jones Industrial Average was flat, while the Nasdaq Composite rose 0.5% and the S&P 500 added 0.3%, closing at a record high. As third-quarter earnings announcements began to wind down in a better-than-expected fashion, stocks also maintained momentum for the week, leading to a fifth consecutive rise. The Dow was up 1.2%, the Nasdaq added 1.1%, and the S&P 500 rose 0.9%. Year-to-date gains are now 18.7% for the Dow, 27.7% for the Nasdaq and 23.4% for the S&P 500.  \"},{\"id\":\"ARGUS_3019_AnalystReport_1573430400000\",\"title\":\"Analyst Report: GlaxoSmithKline PLC\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-11-11T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_28151_StockPicks_1572480000000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-10-31T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In 2018, the U.S. Federal Reserve embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities.  The central bank reversed course in 2019, before moving to the sidelines.  In 2020, due to the coronavirus, the Fed is back in action, cutting rates, backstopping numerous financial markets and pledging to do \\\"whatever it takes\\\" and \\\"for as long as necessary.\\\"  Also due to COVID-19, many U.S. companies have cut back or eliminated their dividends in order to preserve capital during the pandemic. The endless speculation over the timing of the Fed's next moves has created market-timing headaches for equity income investors. They have endured wide swings in prices for rate-sensitive equity classes such as Utilities, REITs and MLPs -- even as generally positive industry fundamentals remained largely intact.  In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geo-political turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has boosted its global coverage, adding the following BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_28233_ThematicPortfolio_1572480000000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-10-31T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to volatile U.S interest rates. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also a number of positives in this segment for U.S. investors. One is a more robust selection of high-quality names. Yields also tend to be higher in overseas markets in general. And finally, valuations can be more attractive.\"},{\"id\":\"ARGUS_3019_AnalystReport_1565767145000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-08-14T07:19:05Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_24702_MarketSummary_1565766245000\",\"title\":\"Market Digest: AZN, EAT, HOLX, FOXA, GSK\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-08-14T07:04:05Z\",\"summary\":\"Forget summer somnolence. August has been the most volatile month of the year on several fronts. One of our favorite measures is daily rate of change (DRC), which examines the price movement in an index or stock regardless of its direction. To calculate DRC, we average the square roots of daily changes for a specified period, as using square roots eliminates the self-cancelling effects of averaging up with down days. \"},{\"id\":\"ARGUS_24702_MarketSummary_1565740800000\",\"title\":\"Market Digest: AZN, EAT, HOLX, FOXA, GSK\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-08-14T00:00:00Z\",\"summary\":\"Forget summer somnolence. August has been the most volatile month of the year on several fronts. One of our favorite measures is daily rate of change (DRC), which examines the price movement in an index or stock regardless of its direction. To calculate DRC, we average the square roots of daily changes for a specified period, as using square roots eliminates the self-cancelling effects of averaging up with down days. \"},{\"id\":\"ARGUS_3019_AnalystReport_1565740800000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-08-14T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include treatments for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_24482_ThematicPortfolio_1563343414000\",\"title\":\"The Argus High-Yield Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-07-17T06:03:34Z\",\"summary\":\"Growth stocks may be outperforming, again, in 2019. But in an environment of historically low interest rates (and with the Federal Reserve seemingly poised to cut again), many investors are still searching for high levels of income, which can often be found in value stocks. When we look for attractive high-yield/value stocks at Argus, we look for low valuations on metrics such as price/earnings, price/sales, price/book, yield and price/cash flow. But we also look for companies with clean balance sheets, high levels of profitability, cash-flow generation, and an experienced management teams. We seek to avoid companies in industries that are in secular decline, or with dividend yields that are so high that the payout is clearly at risk. That said, many value companies may face a substantial near-term industry problem. That might be a retailer fending off Amazon.com; or an energy company tied to the uncertain long-term outlook for demand for fossil fuels; or a newspaper company in the digital advertising age. Some value companies, such as tobacco companies, may face ongoing legal or regulatory risks. And others may be facing problems such as over-aggressive acquisitions, patent expirations or recent earnings stumbles. Based on requests from clients, we have designed a portfolio of companies followed by Argus Research that are BUY- or HOLD-rated on a long-term (five-year) basis and have an average yield of 4.0% or higher.\"},{\"id\":\"ARGUS_24482_ThematicPortfolio_1563321600000\",\"title\":\"The Argus High-Yield Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-07-17T00:00:00Z\",\"summary\":\"Growth stocks may be outperforming, again, in 2019. But in an environment of historically low interest rates (and with the Federal Reserve seemingly poised to cut again), many investors are still searching for high levels of income, which can often be found in value stocks. When we look for attractive high-yield/value stocks at Argus, we look for low valuations on metrics such as price/earnings, price/sales, price/book, yield and price/cash flow. But we also look for companies with clean balance sheets, high levels of profitability, cash-flow generation, and an experienced management teams. We seek to avoid companies in industries that are in secular decline, or with dividend yields that are so high that the payout is clearly at risk. That said, many value companies may face a substantial near-term industry problem. That might be a retailer fending off Amazon.com; or an energy company tied to the uncertain long-term outlook for demand for fossil fuels; or a newspaper company in the digital advertising age. Some value companies, such as tobacco companies, may face ongoing legal or regulatory risks. And others may be facing problems such as over-aggressive acquisitions, patent expirations or recent earnings stumbles. Based on requests from clients, we have designed a portfolio of companies followed by Argus Research that are BUY- or HOLD-rated on a long-term (five-year) basis and have an average yield of 4.0% or higher.\"},{\"id\":\"ARGUS_24320_ThematicPortfolio_1561550336000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-06-26T11:58:56Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. The Federal Reserve in 2018 embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. The endless speculation over the timing of the Fed's rate hikes created market-timing headaches for equity income investors. They endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also lots of positives in this asset class for U.S. investors.\"},{\"id\":\"ARGUS_24320_ThematicPortfolio_1561507200000\",\"title\":\"The Argus Global Dividend Model Portfolio\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-06-26T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. The Federal Reserve in 2018 embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. The endless speculation over the timing of the Fed's rate hikes created market-timing headaches for equity income investors. They endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase portfolio diversification while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, including the impact of currency exchange and geopolitical turmoil. But there are also lots of positives in this asset class for U.S. investors.\"},{\"id\":\"ARGUS_24310_StockPicks_1561475941000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-06-25T15:19:01Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. The U.S. Federal Reserve in 2018 embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. The endless speculation over the timing of the Fed's rate hikes created market-timing headaches for equity income investors. They endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geo-political turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has recently boosted its global coverage, adding BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_24310_StockPicks_1561420800000\",\"title\":\"Weekly Stock List\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-06-25T00:00:00Z\",\"summary\":\"Dividends are supposed to lend stability to a portfolio. However, U.S.-based equity income investors have experienced a high degree of volatility in recent years. The U.S. Federal Reserve in 2018 embarked on an aggressive campaign to raise interest rates, causing Treasury yields to swoop and dive, resulting in a wild ride for supposedly stable U.S. high-income equities. The endless speculation over the timing of the Fed's rate hikes created market-timing headaches for equity income investors. They endured wide swings in prices for rate-sensitive equity classes such as utilities, REITs and MLPs - even as generally positive industry fundamentals remained largely intact. In our view, investing in international income stocks is one way to increase diversity of holdings while reducing sensitivity to the Fed's head fakes on rate policy. Investing in overseas stocks carries its own set of risks, such as currency exchange and even the potential for geo-political turmoil. But there are also lots of positives in this asset class for U.S. investors, including a wide selection, robust industry diversification, higher yields and lower valuations. Argus has recently boosted its global coverage, adding BUY-rated international dividend stocks.\"},{\"id\":\"ARGUS_23938_MarketUpdate_1557496484000\",\"title\":\"Market Update: AMT, GSK, ODFL, RDS/A, VSH\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-05-10T13:54:44Z\",\"summary\":\"Stocks traded sharply lower on Friday morning on increased trade war concerns, as President Trump carried out his threat to impose additional tariffs on Chinese goods and China said that it would be forced to retaliate. Prospects for a deal between the two sides all but collapsed on Thursday, though talks were set to continue on Friday. The S&P fell 1.3%, the Dow 1.0%, and the Nasdaq 1.5%. Crude oil fell slightly to $61.50 per barrel, while gold rose $4 to $1289 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1557496484000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-05-10T13:54:44Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include Advair/Seretide for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_3019_AnalystReport_1557446400000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-05-10T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include Advair/Seretide for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_23938_MarketUpdate_1557446400000\",\"title\":\"Market Update: AMT, GSK, ODFL, RDS/A, VSH\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-05-10T00:00:00Z\",\"summary\":\"Stocks traded sharply lower on Friday morning on increased trade war concerns, as President Trump carried out his threat to impose additional tariffs on Chinese goods and China said that it would be forced to retaliate. Prospects for a deal between the two sides all but collapsed on Thursday, though talks were set to continue on Friday. The S&P fell 1.3%, the Dow 1.0%, and the Nasdaq 1.5%. Crude oil fell slightly to $61.50 per barrel, while gold rose $4 to $1289 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1549548502000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-02-07T14:08:22Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include Advair/Seretide for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_23179_MarketUpdate_1549547602000\",\"title\":\"Market Update: BBT, CL, CMG, GSK, MCHP, STI, SWKS, UTI, AGN\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-02-07T13:53:22Z\",\"summary\":\"Stocks fell sharply on Thursday morning after CNBC reported that an expected meeting between President Trump and Chinese President Xi Jinping was unlikely to take place before the two countries' trade deal deadline on March 1. In M&A news, BB&T and SunTrust agreed to combine in the largest bank merger since the financial crisis. The Dow fell 1.3%, the S&P 1.4%, and the Nasdaq 1.6%. Crude oil fell $2 to about $52 per barrel, while gold traded near $1314 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1549497600000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-02-07T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include Advair/Seretide for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_23179_MarketUpdate_1549497600000\",\"title\":\"Market Update: BBT, CL, CMG, GSK, MCHP, STI, SWKS, UTI, AGN\",\"provider\":\"Argus Research\",\"publishedOn\":\"2019-02-07T00:00:00Z\",\"summary\":\"Stocks fell sharply on Thursday morning after CNBC reported that an expected meeting between President Trump and Chinese President Xi Jinping was unlikely to take place before the two countries' trade deal deadline on March 1. In M&A news, BB&T and SunTrust agreed to combine in the largest bank merger since the financial crisis. The Dow fell 1.3%, the S&P 1.4%, and the Nasdaq 1.6%. Crude oil fell $2 to about $52 per barrel, while gold traded near $1314 per ounce.\"},{\"id\":\"ARGUS_3019_AnalystReport_1545893635000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2018-12-27T06:53:55Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include Advair/Seretide for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_22841_MarketSummary_1545893635000\",\"title\":\"Market Digest: GSK, LLY\",\"provider\":\"Argus Research\",\"publishedOn\":\"2018-12-27T06:53:55Z\",\"summary\":\"Current Correction: Similar to Past Near-Bear Phases, not Classic Bear Markets\"},{\"id\":\"ARGUS_22841_MarketSummary_1545892735000\",\"title\":\"Market Digest: GSK, LLY\",\"provider\":\"Argus Research\",\"publishedOn\":\"2018-12-27T06:38:55Z\",\"summary\":\"Current Correction: Similar to Past Near-Bear Phases, not Classic Bear Markets\"},{\"id\":\"ARGUS_3019_AnalystReport_1545868800000\",\"title\":\"High-yield opportunity\",\"provider\":\"Argus Research\",\"publishedOn\":\"2018-12-27T00:00:00Z\",\"summary\":\"GlaxoSmithKline, based in London, is a global healthcare company engaged in the discovery, development, manufacture and marketing of pharmaceutical and consumer healthcare products. The company's leading products include Advair/Seretide for asthma and COPD; products for HIV infection; and a range of vaccines. The company has an active research and development program in immuno-inflammation, neuroscience, metabolic pathways, ophthalmology, respiratory, infectious disease and biopharmaceuticals. The consumer healthcare segment includes over-the-counter medicines, oral care and nutritionals. Key brands include Aquafresh, Panadol, Nicorette, Tums and Sensodyne.\"},{\"id\":\"ARGUS_22841_MarketSummary_1545868800000\",\"title\":\"Market Digest: GSK, LLY\",\"provider\":\"Argus Research\",\"publishedOn\":\"2018-12-27T00:00:00Z\",\"summary\":\"Current Correction: Similar to Past Near-Bear Phases, not Classic Bear Markets\"}],\"companySnapshot\":{\"sectorInfo\":\"Healthcare\",\"company\":{\"innovativeness\":0.92,\"dividends\":0.9323999999999999},\"sector\":{\"innovativeness\":0.5,\"hiring\":0.5,\"sustainability\":0.5,\"insiderSentiments\":0.5,\"earningsReports\":0.5,\"dividends\":0.5}}},\"error\":null}}\n"
     ]
    }
   ],
   "source": [
    "url = \"https://apidojo-yahoo-finance-v1.p.rapidapi.com/stock/v2/get-insights\"\n",
    "\n",
    "querystring = {\"symbol\":\"gsk\",\"region\":\"Uk\"}\n",
    "\n",
    "headers = {\n",
    "    'x-rapidapi-host': \"apidojo-yahoo-finance-v1.p.rapidapi.com\",\n",
    "    'x-rapidapi-key': \"9cd97ba3camsh244cbd2e3e420a4p1e83c0jsne0fdd0787f8e\"\n",
    "    }\n",
    "\n",
    "response = requests.request(\"GET\", url, headers=headers, params=querystring)\n",
    "\n",
    "print(response.text)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "{\"defaultKeyStatistics\":{\"annualHoldingsTurnover\":{},\"enterpriseToRevenue\":{\"raw\":4.096,\"fmt\":\"4.10\"},\"beta3Year\":{},\"profitMargins\":{\"raw\":0.12942,\"fmt\":\"12.94%\"},\"enterpriseToEbitda\":{\"raw\":13.344,\"fmt\":\"13.34\"},\"52WeekChange\":{\"raw\":0.16078758,\"fmt\":\"16.08%\"},\"morningStarRiskRating\":{},\"forwardEps\":{\"raw\":3.2,\"fmt\":\"3.2\"},\"revenueQuarterlyGrowth\":{},\"sharesOutstanding\":{\"raw\":2515879936,\"fmt\":\"2.52B\",\"longFmt\":\"2,515,879,936\"},\"fundInceptionDate\":{},\"annualReportExpenseRatio\":{},\"totalAssets\":{},\"bookValue\":{\"raw\":6.16,\"fmt\":\"6.16\"},\"sharesShort\":{\"raw\":15580989,\"fmt\":\"15.58M\",\"longFmt\":\"15,580,989\"},\"sharesPercentSharesOut\":{\"raw\":0.0062,\"fmt\":\"0.62%\"},\"fundFamily\":null,\"lastFiscalYearEnd\":{\"raw\":1609372800,\"fmt\":\"2020-12-31\"},\"heldPercentInstitutions\":{\"raw\":0.13193,\"fmt\":\"13.19%\"},\"netIncomeToCommon\":{\"raw\":4312999936,\"fmt\":\"4.31B\",\"longFmt\":\"4,312,999,936\"},\"trailingEps\":{\"raw\":2.288,\"fmt\":\"2.29\"},\"lastDividendValue\":{\"raw\":0.53,\"fmt\":\"0.53\"},\"SandP52WeekChange\":{\"raw\":0.3175944,\"fmt\":\"31.76%\"},\"priceToBook\":{\"raw\":6.921185,\"fmt\":\"6.92\"},\"heldPercentInsiders\":{\"raw\":0.00014,\"fmt\":\"0.01%\"},\"nextFiscalYearEnd\":{\"raw\":1672444800,\"fmt\":\"2022-12-31\"},\"yield\":{},\"mostRecentQuarter\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"shortRatio\":{\"raw\":3.37,\"fmt\":\"3.37\"},\"sharesShortPreviousMonthDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"floatShares\":{\"raw\":2448160800,\"fmt\":\"2.45B\",\"longFmt\":\"2,448,160,800\"},\"beta\":{\"raw\":0.402824,\"fmt\":\"0.4\"},\"enterpriseValue\":{\"raw\":136510676992,\"fmt\":\"136.51B\",\"longFmt\":\"136,510,676,992\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"threeYearAverageReturn\":{},\"lastSplitDate\":{\"raw\":689904000,\"fmt\":\"1991-11-12\"},\"lastSplitFactor\":\"2:1\",\"legalType\":null,\"lastDividendDate\":{\"raw\":1629331200,\"fmt\":\"2021-08-19\"},\"morningStarOverallRating\":{},\"earningsQuarterlyGrowth\":{\"raw\":-0.061,\"fmt\":\"-6.10%\"},\"priceToSalesTrailing12Months\":{},\"dateShortInterest\":{\"raw\":1635465600,\"fmt\":\"2021-10-29\"},\"pegRatio\":{\"raw\":3.57,\"fmt\":\"3.57\"},\"ytdReturn\":{},\"forwardPE\":{\"raw\":13.32328,\"fmt\":\"13.32\"},\"maxAge\":1,\"lastCapGain\":{},\"shortPercentOfFloat\":{},\"sharesShortPriorMonth\":{\"raw\":17570661,\"fmt\":\"17.57M\",\"longFmt\":\"17,570,661\"},\"impliedSharesOutstanding\":{},\"category\":null,\"fiveYearAverageReturn\":{}},\"details\":{},\"summaryProfile\":{\"zip\":\"TW8 9GS\",\"sector\":\"Healthcare\",\"fullTimeEmployees\":94066,\"longBusinessSummary\":\"GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.\",\"city\":\"Brentford\",\"phone\":\"44 20 8047 5000\",\"country\":\"United Kingdom\",\"companyOfficers\":[],\"website\":\"http://www.gsk.com\",\"maxAge\":86400,\"address1\":\"980 Great West Road\",\"industry\":\"Drug ManufacturersGeneral\"},\"recommendationTrend\":{\"trend\":[{\"period\":\"0m\",\"strongBuy\":1,\"buy\":0,\"hold\":3,\"sell\":0,\"strongSell\":0},{\"period\":\"-1m\",\"strongBuy\":2,\"buy\":0,\"hold\":2,\"sell\":0,\"strongSell\":0},{\"period\":\"-2m\",\"strongBuy\":2,\"buy\":0,\"hold\":2,\"sell\":0,\"strongSell\":0},{\"period\":\"-3m\",\"strongBuy\":2,\"buy\":0,\"hold\":2,\"sell\":0,\"strongSell\":0}],\"maxAge\":86400},\"financialsTemplate\":{\"code\":\"N\",\"maxAge\":1},\"majorDirectHolders\":{\"holders\":[],\"maxAge\":1},\"earnings\":{\"maxAge\":86400,\"earningsChart\":{\"quarterly\":[{\"date\":\"4Q2020\",\"actual\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"estimate\":{\"raw\":0.64,\"fmt\":\"0.64\"}},{\"date\":\"1Q2021\",\"actual\":{\"raw\":0.63,\"fmt\":\"0.63\"},\"estimate\":{\"raw\":0.61,\"fmt\":\"0.61\"}},{\"date\":\"2Q2021\",\"actual\":{\"raw\":0.79,\"fmt\":\"0.79\"},\"estimate\":{\"raw\":0.51,\"fmt\":\"0.51\"}},{\"date\":\"3Q2021\",\"actual\":{\"raw\":1.01,\"fmt\":\"1.01\"},\"estimate\":{\"raw\":0.81,\"fmt\":\"0.81\"}}],\"currentQuarterEstimate\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"currentQuarterEstimateDate\":\"4Q\",\"currentQuarterEstimateYear\":2021,\"earningsDate\":[{\"raw\":1485964740,\"fmt\":\"2017-02-01\"},{\"raw\":1486400400,\"fmt\":\"2017-02-06\"}]},\"financialsChart\":{\"yearly\":[{\"date\":2017,\"revenue\":{\"raw\":30186000000,\"fmt\":\"30.19B\",\"longFmt\":\"30,186,000,000\"},\"earnings\":{\"raw\":1532000000,\"fmt\":\"1.53B\",\"longFmt\":\"1,532,000,000\"}},{\"date\":2018,\"revenue\":{\"raw\":30821000000,\"fmt\":\"30.82B\",\"longFmt\":\"30,821,000,000\"},\"earnings\":{\"raw\":3623000000,\"fmt\":\"3.62B\",\"longFmt\":\"3,623,000,000\"}},{\"date\":2019,\"revenue\":{\"raw\":33754000000,\"fmt\":\"33.75B\",\"longFmt\":\"33,754,000,000\"},\"earnings\":{\"raw\":4645000000,\"fmt\":\"4.64B\",\"longFmt\":\"4,645,000,000\"}},{\"date\":2020,\"revenue\":{\"raw\":34099000000,\"fmt\":\"34.1B\",\"longFmt\":\"34,099,000,000\"},\"earnings\":{\"raw\":5749000000,\"fmt\":\"5.75B\",\"longFmt\":\"5,749,000,000\"}}],\"quarterly\":[{\"date\":\"4Q2020\",\"revenue\":{\"raw\":8739000000,\"fmt\":\"8.74B\",\"longFmt\":\"8,739,000,000\"},\"earnings\":{\"raw\":677000000,\"fmt\":\"677M\",\"longFmt\":\"677,000,000\"}},{\"date\":\"1Q2021\",\"revenue\":{\"raw\":7418000000,\"fmt\":\"7.42B\",\"longFmt\":\"7,418,000,000\"},\"earnings\":{\"raw\":1073000000,\"fmt\":\"1.07B\",\"longFmt\":\"1,073,000,000\"}},{\"date\":\"2Q2021\",\"revenue\":{\"raw\":8092000000,\"fmt\":\"8.09B\",\"longFmt\":\"8,092,000,000\"},\"earnings\":{\"raw\":1395000000,\"fmt\":\"1.4B\",\"longFmt\":\"1,395,000,000\"}},{\"date\":\"3Q2021\",\"revenue\":{\"raw\":9077000000,\"fmt\":\"9.08B\",\"longFmt\":\"9,077,000,000\"},\"earnings\":{\"raw\":1168000000,\"fmt\":\"1.17B\",\"longFmt\":\"1,168,000,000\"}}]},\"financialCurrency\":\"GBP\"},\"price\":{\"quoteSourceName\":\"Nasdaq Real Time Price\",\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"averageDailyVolume3Month\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"exchange\":\"NYQ\",\"regularMarketTime\":1637169584,\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"shortName\":\"GlaxoSmithKline PLC\",\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"longName\":\"GlaxoSmithKline plc\",\"regularMarketChange\":{\"raw\":0.18449783,\"fmt\":\"0.18\"},\"currencySymbol\":\"$\",\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"preMarketPrice\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"preMarketTime\":1637159399,\"exchangeDataDelayedBy\":0,\"toCurrency\":null,\"postMarketChange\":{},\"postMarketPrice\":{},\"exchangeName\":\"NYSE\",\"preMarketChange\":{\"raw\":-0.190002,\"fmt\":\"-0.19\"},\"circulatingSupply\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"regularMarketPrice\":{\"raw\":42.6345,\"fmt\":\"42.63\"},\"regularMarketVolume\":{\"raw\":2414934,\"fmt\":\"2.41M\",\"longFmt\":\"2,414,934.00\"},\"lastMarket\":null,\"regularMarketSource\":\"FREE_REALTIME\",\"openInterest\":{},\"marketState\":\"REGULAR\",\"underlyingSymbol\":null,\"marketCap\":{\"raw\":107263279104,\"fmt\":\"107.26B\",\"longFmt\":\"107,263,279,104.00\"},\"quoteType\":\"EQUITY\",\"preMarketChangePercent\":{\"raw\":-0.00447591,\"fmt\":\"-0.45%\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"symbol\":\"GSK\",\"preMarketSource\":\"FREE_REALTIME\",\"maxAge\":1,\"fromCurrency\":null,\"regularMarketChangePercent\":{\"raw\":0.0043462384,\"fmt\":\"0.43%\"}},\"fundOwnership\":{\"maxAge\":1,\"ownershipList\":[{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Dodge & Cox Stock Fund\",\"pctHeld\":{\"raw\":0.0234,\"fmt\":\"2.34%\"},\"position\":{\"raw\":58806872,\"fmt\":\"58.81M\",\"longFmt\":\"58,806,872\"},\"value\":{\"raw\":2247010579,\"fmt\":\"2.25B\",\"longFmt\":\"2,247,010,579\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"American Mutual Fund Inc\",\"pctHeld\":{\"raw\":0.0069999998,\"fmt\":\"0.70%\"},\"position\":{\"raw\":17636047,\"fmt\":\"17.64M\",\"longFmt\":\"17,636,047\"},\"value\":{\"raw\":673873355,\"fmt\":\"673.87M\",\"longFmt\":\"673,873,355\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Washington Mutual Investors Fund\",\"pctHeld\":{\"raw\":0.0039,\"fmt\":\"0.39%\"},\"position\":{\"raw\":9774580,\"fmt\":\"9.77M\",\"longFmt\":\"9,774,580\"},\"value\":{\"raw\":373486701,\"fmt\":\"373.49M\",\"longFmt\":\"373,486,701\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Dodge & Cox Balanced Fund\",\"pctHeld\":{\"raw\":0.0032,\"fmt\":\"0.32%\"},\"position\":{\"raw\":8113650,\"fmt\":\"8.11M\",\"longFmt\":\"8,113,650\"},\"value\":{\"raw\":310022566,\"fmt\":\"310.02M\",\"longFmt\":\"310,022,566\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1627689600,\"fmt\":\"2021-07-31\"},\"organization\":\"Price (T.Rowe) International Value Equity Fund\",\"pctHeld\":{\"raw\":0.0017,\"fmt\":\"0.17%\"},\"position\":{\"raw\":4226642,\"fmt\":\"4.23M\",\"longFmt\":\"4,226,642\"},\"value\":{\"raw\":169657409,\"fmt\":\"169.66M\",\"longFmt\":\"169,657,409\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1627689600,\"fmt\":\"2021-07-31\"},\"organization\":\"Vanguard/Windsor II\",\"pctHeld\":{\"raw\":0.0017,\"fmt\":\"0.17%\"},\"position\":{\"raw\":4176194,\"fmt\":\"4.18M\",\"longFmt\":\"4,176,194\"},\"value\":{\"raw\":167632427,\"fmt\":\"167.63M\",\"longFmt\":\"167,632,427\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Fidelity Series Large Cap Stock Fund\",\"pctHeld\":{\"raw\":0.0016,\"fmt\":\"0.16%\"},\"position\":{\"raw\":4028536,\"fmt\":\"4.03M\",\"longFmt\":\"4,028,536\"},\"value\":{\"raw\":153930360,\"fmt\":\"153.93M\",\"longFmt\":\"153,930,360\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"organization\":\"Price (T.Rowe) International Value Equity Trust\",\"pctHeld\":{\"raw\":0.0013,\"fmt\":\"0.13%\"},\"position\":{\"raw\":3330831,\"fmt\":\"3.33M\",\"longFmt\":\"3,330,831\"},\"value\":{\"raw\":132633690,\"fmt\":\"132.63M\",\"longFmt\":\"132,633,690\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1627689600,\"fmt\":\"2021-07-31\"},\"organization\":\"Price (T.Rowe) Overseas Stock Fund\",\"pctHeld\":{\"raw\":0.0013,\"fmt\":\"0.13%\"},\"position\":{\"raw\":3284230,\"fmt\":\"3.28M\",\"longFmt\":\"3,284,230\"},\"value\":{\"raw\":131828992,\"fmt\":\"131.83M\",\"longFmt\":\"131,828,992\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Fidelity Growth & Income Portfolio\",\"pctHeld\":{\"raw\":0.00090000004,\"fmt\":\"0.09%\"},\"position\":{\"raw\":2172811,\"fmt\":\"2.17M\",\"longFmt\":\"2,172,811\"},\"value\":{\"raw\":83023108,\"fmt\":\"83.02M\",\"longFmt\":\"83,023,108\"}}]},\"insiderTransactions\":{\"transactions\":[{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 41.49 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1629676800,\"fmt\":\"2021-08-23\"},\"value\":{\"raw\":49995,\"fmt\":\"49.99k\",\"longFmt\":\"49,995\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1205,\"fmt\":\"1.21k\",\"longFmt\":\"1,205\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 41.81 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1629331200,\"fmt\":\"2021-08-19\"},\"value\":{\"raw\":107869,\"fmt\":\"107.87k\",\"longFmt\":\"107,869\"},\"filerRelation\":\"\",\"shares\":{\"raw\":2580,\"fmt\":\"2.58k\",\"longFmt\":\"2,580\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Bancroft (Charles A)\",\"transactionText\":\"Bought at price 39.35 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"value\":{\"raw\":57844,\"fmt\":\"57.84k\",\"longFmt\":\"57,844\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1470,\"fmt\":\"1.47k\",\"longFmt\":\"1,470\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"Bought at price 39.35 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"value\":{\"raw\":11136,\"fmt\":\"11.14k\",\"longFmt\":\"11,136\"},\"filerRelation\":\"\",\"shares\":{\"raw\":283,\"fmt\":\"283\",\"longFmt\":\"283\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"Bought at price 39.35 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"value\":{\"raw\":41317,\"fmt\":\"41.32k\",\"longFmt\":\"41,317\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1050,\"fmt\":\"1.05k\",\"longFmt\":\"1,050\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"Bought at price 39.35 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"value\":{\"raw\":13615,\"fmt\":\"13.62k\",\"longFmt\":\"13,615\"},\"filerRelation\":\"\",\"shares\":{\"raw\":346,\"fmt\":\"346\",\"longFmt\":\"346\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 39.23 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1626912000,\"fmt\":\"2021-07-22\"},\"value\":{\"raw\":46291,\"fmt\":\"46.29k\",\"longFmt\":\"46,291\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1180,\"fmt\":\"1.18k\",\"longFmt\":\"1,180\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 40.44 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1626134400,\"fmt\":\"2021-07-13\"},\"value\":{\"raw\":49539,\"fmt\":\"49.54k\",\"longFmt\":\"49,539\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1225,\"fmt\":\"1.23k\",\"longFmt\":\"1,225\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Conrad (D)\",\"transactionText\":\"Bought at price 39.72 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1624579200,\"fmt\":\"2021-06-25\"},\"value\":{\"raw\":202572,\"fmt\":\"202.57k\",\"longFmt\":\"202,572\"},\"filerRelation\":\"\",\"shares\":{\"raw\":5100,\"fmt\":\"5.1k\",\"longFmt\":\"5,100\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 38.75 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1623024000,\"fmt\":\"2021-06-07\"},\"value\":{\"raw\":46306,\"fmt\":\"46.31k\",\"longFmt\":\"46,306\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1195,\"fmt\":\"1.2k\",\"longFmt\":\"1,195\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 39.03 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1621468800,\"fmt\":\"2021-05-20\"},\"value\":{\"raw\":102219,\"fmt\":\"102.22k\",\"longFmt\":\"102,219\"},\"filerRelation\":\"\",\"shares\":{\"raw\":2619,\"fmt\":\"2.62k\",\"longFmt\":\"2,619\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 38.05 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1618444800,\"fmt\":\"2021-04-15\"},\"value\":{\"raw\":59129,\"fmt\":\"59.13k\",\"longFmt\":\"59,129\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1554,\"fmt\":\"1.55k\",\"longFmt\":\"1,554\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 36.46 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1618185600,\"fmt\":\"2021-04-12\"},\"value\":{\"raw\":61325,\"fmt\":\"61.33k\",\"longFmt\":\"61,325\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1682,\"fmt\":\"1.68k\",\"longFmt\":\"1,682\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 36.67 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1616371200,\"fmt\":\"2021-03-22\"},\"value\":{\"raw\":44774,\"fmt\":\"44.77k\",\"longFmt\":\"44,774\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1221,\"fmt\":\"1.22k\",\"longFmt\":\"1,221\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 35.54 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1615507200,\"fmt\":\"2021-03-12\"},\"value\":{\"raw\":824776,\"fmt\":\"824.78k\",\"longFmt\":\"824,776\"},\"filerRelation\":\"\",\"shares\":{\"raw\":23207,\"fmt\":\"23.21k\",\"longFmt\":\"23,207\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 35.54 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1615507200,\"fmt\":\"2021-03-12\"},\"value\":{\"raw\":20080,\"fmt\":\"20.08k\",\"longFmt\":\"20,080\"},\"filerRelation\":\"\",\"shares\":{\"raw\":565,\"fmt\":\"565\",\"longFmt\":\"565\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 34.97 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1615161600,\"fmt\":\"2021-03-08\"},\"value\":{\"raw\":49657,\"fmt\":\"49.66k\",\"longFmt\":\"49,657\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1420,\"fmt\":\"1.42k\",\"longFmt\":\"1,420\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 34.44 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613952000,\"fmt\":\"2021-02-22\"},\"value\":{\"raw\":42120,\"fmt\":\"42.12k\",\"longFmt\":\"42,120\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1223,\"fmt\":\"1.22k\",\"longFmt\":\"1,223\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 34.44 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613952000,\"fmt\":\"2021-02-22\"},\"value\":{\"raw\":7542,\"fmt\":\"7.54k\",\"longFmt\":\"7,542\"},\"filerRelation\":\"\",\"shares\":{\"raw\":219,\"fmt\":\"219\",\"longFmt\":\"219\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Conrad (D)\",\"transactionText\":\"Bought at price 34.53 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613692800,\"fmt\":\"2021-02-19\"},\"value\":{\"raw\":117402,\"fmt\":\"117.4k\",\"longFmt\":\"117,402\"},\"filerRelation\":\"\",\"shares\":{\"raw\":3400,\"fmt\":\"3.4k\",\"longFmt\":\"3,400\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Dodge & Cox\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613692800,\"fmt\":\"2021-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 34.70 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613606400,\"fmt\":\"2021-02-18\"},\"value\":{\"raw\":100699,\"fmt\":\"100.7k\",\"longFmt\":\"100,699\"},\"filerRelation\":\"\",\"shares\":{\"raw\":2902,\"fmt\":\"2.9k\",\"longFmt\":\"2,902\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Sold at price 35.00 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613088000,\"fmt\":\"2021-02-12\"},\"value\":{\"raw\":3039925,\"fmt\":\"3.04M\",\"longFmt\":\"3,039,925\"},\"filerRelation\":\"\",\"shares\":{\"raw\":86855,\"fmt\":\"86.86k\",\"longFmt\":\"86,855\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1613001600,\"fmt\":\"2021-02-11\"},\"filerRelation\":\"\",\"shares\":{\"raw\":180833,\"fmt\":\"180.83k\",\"longFmt\":\"180,833\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 35.46 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1612742400,\"fmt\":\"2021-02-08\"},\"value\":{\"raw\":49644,\"fmt\":\"49.64k\",\"longFmt\":\"49,644\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1400,\"fmt\":\"1.4k\",\"longFmt\":\"1,400\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 38.36 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1611273600,\"fmt\":\"2021-01-22\"},\"value\":{\"raw\":42119,\"fmt\":\"42.12k\",\"longFmt\":\"42,119\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1098,\"fmt\":\"1.1k\",\"longFmt\":\"1,098\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 38.36 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1611273600,\"fmt\":\"2021-01-22\"},\"value\":{\"raw\":7518,\"fmt\":\"7.52k\",\"longFmt\":\"7,518\"},\"filerRelation\":\"\",\"shares\":{\"raw\":196,\"fmt\":\"196\",\"longFmt\":\"196\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 38.07 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1609977600,\"fmt\":\"2021-01-07\"},\"value\":{\"raw\":7385,\"fmt\":\"7.38k\",\"longFmt\":\"7,385\"},\"filerRelation\":\"\",\"shares\":{\"raw\":194,\"fmt\":\"194\",\"longFmt\":\"194\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 38.07 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1609977600,\"fmt\":\"2021-01-07\"},\"value\":{\"raw\":41305,\"fmt\":\"41.3k\",\"longFmt\":\"41,305\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1085,\"fmt\":\"1.08k\",\"longFmt\":\"1,085\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 36.22 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1608508800,\"fmt\":\"2020-12-21\"},\"value\":{\"raw\":41689,\"fmt\":\"41.69k\",\"longFmt\":\"41,689\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1151,\"fmt\":\"1.15k\",\"longFmt\":\"1,151\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 37.56 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1607299200,\"fmt\":\"2020-12-07\"},\"value\":{\"raw\":41691,\"fmt\":\"41.69k\",\"longFmt\":\"41,691\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1110,\"fmt\":\"1.11k\",\"longFmt\":\"1,110\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 36.74 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1606089600,\"fmt\":\"2020-11-23\"},\"value\":{\"raw\":41663,\"fmt\":\"41.66k\",\"longFmt\":\"41,663\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1134,\"fmt\":\"1.13k\",\"longFmt\":\"1,134\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Capital Group Companies, Inc.\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1605571200,\"fmt\":\"2020-11-17\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1397106,\"fmt\":\"1.4M\",\"longFmt\":\"1,397,106\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 37.75 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1605139200,\"fmt\":\"2020-11-12\"},\"value\":{\"raw\":74707,\"fmt\":\"74.71k\",\"longFmt\":\"74,707\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1979,\"fmt\":\"1.98k\",\"longFmt\":\"1,979\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 37.49 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1604880000,\"fmt\":\"2020-11-09\"},\"value\":{\"raw\":41688,\"fmt\":\"41.69k\",\"longFmt\":\"41,688\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1112,\"fmt\":\"1.11k\",\"longFmt\":\"1,112\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Conrad (D)\",\"transactionText\":\"Bought at price 34.23 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1604275200,\"fmt\":\"2020-11-02\"},\"value\":{\"raw\":149927,\"fmt\":\"149.93k\",\"longFmt\":\"149,927\"},\"filerRelation\":\"\",\"shares\":{\"raw\":4380,\"fmt\":\"4.38k\",\"longFmt\":\"4,380\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 33.96 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1603929600,\"fmt\":\"2020-10-29\"},\"value\":{\"raw\":114581,\"fmt\":\"114.58k\",\"longFmt\":\"114,581\"},\"filerRelation\":\"\",\"shares\":{\"raw\":3374,\"fmt\":\"3.37k\",\"longFmt\":\"3,374\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Capital Group Companies, Inc.\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1603756800,\"fmt\":\"2020-10-27\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1266,\"fmt\":\"1.27k\",\"longFmt\":\"1,266\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Capital Group Companies, Inc.\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1603152000,\"fmt\":\"2020-10-20\"},\"filerRelation\":\"\",\"shares\":{\"raw\":514676,\"fmt\":\"514.68k\",\"longFmt\":\"514,676\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 37.16 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1602460800,\"fmt\":\"2020-10-12\"},\"value\":{\"raw\":34558,\"fmt\":\"34.56k\",\"longFmt\":\"34,558\"},\"filerRelation\":\"\",\"shares\":{\"raw\":930,\"fmt\":\"930\",\"longFmt\":\"930\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Bancroft (Charles A)\",\"transactionText\":\"Bought at price 40.82 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"},\"value\":{\"raw\":20450,\"fmt\":\"20.45k\",\"longFmt\":\"20,450\"},\"filerRelation\":\"\",\"shares\":{\"raw\":501,\"fmt\":\"501\",\"longFmt\":\"501\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"Bought at price 40.82 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"},\"value\":{\"raw\":26573,\"fmt\":\"26.57k\",\"longFmt\":\"26,573\"},\"filerRelation\":\"\",\"shares\":{\"raw\":651,\"fmt\":\"651\",\"longFmt\":\"651\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"Bought at price 40.82 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"},\"value\":{\"raw\":49882,\"fmt\":\"49.88k\",\"longFmt\":\"49,882\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1222,\"fmt\":\"1.22k\",\"longFmt\":\"1,222\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"Bought at price 40.82 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"},\"value\":{\"raw\":15674,\"fmt\":\"15.67k\",\"longFmt\":\"15,674\"},\"filerRelation\":\"\",\"shares\":{\"raw\":384,\"fmt\":\"384\",\"longFmt\":\"384\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"Bought at price 40.82 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"},\"value\":{\"raw\":16491,\"fmt\":\"16.49k\",\"longFmt\":\"16,491\"},\"filerRelation\":\"\",\"shares\":{\"raw\":404,\"fmt\":\"404\",\"longFmt\":\"404\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 40.37 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1594598400,\"fmt\":\"2020-07-13\"},\"value\":{\"raw\":32780,\"fmt\":\"32.78k\",\"longFmt\":\"32,780\"},\"filerRelation\":\"\",\"shares\":{\"raw\":812,\"fmt\":\"812\",\"longFmt\":\"812\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Capital Group Companies, Inc.\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1589328000,\"fmt\":\"2020-05-13\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Conrad (D)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1583366400,\"fmt\":\"2020-03-05\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1582502400,\"fmt\":\"2020-02-24\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1582502400,\"fmt\":\"2020-02-24\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1582502400,\"fmt\":\"2020-02-24\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1582502400,\"fmt\":\"2020-02-24\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1582502400,\"fmt\":\"2020-02-24\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1577750400,\"fmt\":\"2019-12-31\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 42.25 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1571011200,\"fmt\":\"2019-10-14\"},\"value\":{\"raw\":17449,\"fmt\":\"17.45k\",\"longFmt\":\"17,449\"},\"filerRelation\":\"\",\"shares\":{\"raw\":413,\"fmt\":\"413\",\"longFmt\":\"413\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"Bought at price 41.14 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1563926400,\"fmt\":\"2019-07-24\"},\"value\":{\"raw\":49491,\"fmt\":\"49.49k\",\"longFmt\":\"49,491\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1203,\"fmt\":\"1.2k\",\"longFmt\":\"1,203\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"Bought at price 41.14 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1563926400,\"fmt\":\"2019-07-24\"},\"value\":{\"raw\":54963,\"fmt\":\"54.96k\",\"longFmt\":\"54,963\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1336,\"fmt\":\"1.34k\",\"longFmt\":\"1,336\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"Bought at price 41.14 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1563926400,\"fmt\":\"2019-07-24\"},\"value\":{\"raw\":16579,\"fmt\":\"16.58k\",\"longFmt\":\"16,579\"},\"filerRelation\":\"\",\"shares\":{\"raw\":403,\"fmt\":\"403\",\"longFmt\":\"403\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"Bought at price 41.14 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1563926400,\"fmt\":\"2019-07-24\"},\"value\":{\"raw\":18471,\"fmt\":\"18.47k\",\"longFmt\":\"18,471\"},\"filerRelation\":\"\",\"shares\":{\"raw\":449,\"fmt\":\"449\",\"longFmt\":\"449\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 40.93 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1562889600,\"fmt\":\"2019-07-12\"},\"value\":{\"raw\":17518,\"fmt\":\"17.52k\",\"longFmt\":\"17,518\"},\"filerRelation\":\"\",\"shares\":{\"raw\":428,\"fmt\":\"428\",\"longFmt\":\"428\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 40.94 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1555027200,\"fmt\":\"2019-04-12\"},\"value\":{\"raw\":22025,\"fmt\":\"22.02k\",\"longFmt\":\"22,025\"},\"filerRelation\":\"\",\"shares\":{\"raw\":538,\"fmt\":\"538\",\"longFmt\":\"538\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1551398400,\"fmt\":\"2019-03-01\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1551398400,\"fmt\":\"2019-03-01\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1551398400,\"fmt\":\"2019-03-01\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1551398400,\"fmt\":\"2019-03-01\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1551398400,\"fmt\":\"2019-03-01\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"Bought at price 39.27 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1549411200,\"fmt\":\"2019-02-06\"},\"value\":{\"raw\":41233,\"fmt\":\"41.23k\",\"longFmt\":\"41,233\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1050,\"fmt\":\"1.05k\",\"longFmt\":\"1,050\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"Bought at price 39.27 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1549411200,\"fmt\":\"2019-02-06\"},\"value\":{\"raw\":54978,\"fmt\":\"54.98k\",\"longFmt\":\"54,978\"},\"filerRelation\":\"\",\"shares\":{\"raw\":1400,\"fmt\":\"1.4k\",\"longFmt\":\"1,400\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"Bought at price 39.27 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1549411200,\"fmt\":\"2019-02-06\"},\"value\":{\"raw\":16571,\"fmt\":\"16.57k\",\"longFmt\":\"16,571\"},\"filerRelation\":\"\",\"shares\":{\"raw\":422,\"fmt\":\"422\",\"longFmt\":\"422\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"Bought at price 39.27 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1549411200,\"fmt\":\"2019-02-06\"},\"value\":{\"raw\":18496,\"fmt\":\"18.5k\",\"longFmt\":\"18,496\"},\"filerRelation\":\"\",\"shares\":{\"raw\":471,\"fmt\":\"471\",\"longFmt\":\"471\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"Bought at price 40.62 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1523491200,\"fmt\":\"2018-04-12\"},\"value\":{\"raw\":150781,\"fmt\":\"150.78k\",\"longFmt\":\"150,781\"},\"filerRelation\":\"\",\"shares\":{\"raw\":3712,\"fmt\":\"3.71k\",\"longFmt\":\"3,712\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1519948800,\"fmt\":\"2018-03-02\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1519948800,\"fmt\":\"2018-03-02\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Glimcher (Laurie H)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1519948800,\"fmt\":\"2018-03-02\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Goodman (Jesse)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1519948800,\"fmt\":\"2018-03-02\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1519948800,\"fmt\":\"2018-03-02\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Barron (Hal V)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1510099200,\"fmt\":\"2017-11-08\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1488499200,\"fmt\":\"2017-03-03\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1488499200,\"fmt\":\"2017-03-03\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Burns (Stephanie)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Maughan (Deryck C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Podolsky (Daniel K)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Slaoui (Moncef M)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Slaoui (Moncef M)\",\"transactionText\":\"Bought at price 46.73 per share.\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1425945600,\"fmt\":\"2015-03-10\"},\"value\":{\"raw\":520432,\"fmt\":\"520.43k\",\"longFmt\":\"520,432\"},\"filerRelation\":\"\",\"shares\":{\"raw\":11137,\"fmt\":\"11.14k\",\"longFmt\":\"11,137\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Burns (Stephanie)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Elsenhans (Lynn Laverty)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Lewent (Judy C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Maughan (Deryck C)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Podolsky (Daniel K)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Slaoui (Moncef M)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1},{\"filerName\":\"Ulrich (Jing L)\",\"transactionText\":\"\",\"moneyText\":\"\",\"ownership\":\"D\",\"startDate\":{\"raw\":1424304000,\"fmt\":\"2015-02-19\"},\"filerRelation\":\"\",\"shares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"filerUrl\":\"\",\"maxAge\":1}],\"maxAge\":1},\"insiderHolders\":{\"holders\":[{\"maxAge\":1,\"name\":\"Bancroft (Charles A)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"positionDirect\":{\"raw\":1971,\"fmt\":\"1.97k\",\"longFmt\":\"1,971\"},\"positionDirectDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"}},{\"maxAge\":1,\"name\":\"Barron (Hal V)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1629676800,\"fmt\":\"2021-08-23\"},\"positionDirect\":{\"raw\":224427,\"fmt\":\"224.43k\",\"longFmt\":\"224,427\"},\"positionDirectDate\":{\"raw\":1629676800,\"fmt\":\"2021-08-23\"}},{\"maxAge\":1,\"name\":\"Burns (Stephanie)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Annual Return\",\"latestTransDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"},\"positionDirect\":{\"raw\":20584,\"fmt\":\"20.58k\",\"longFmt\":\"20,584\"},\"positionDirectDate\":{\"raw\":1457568000,\"fmt\":\"2016-03-10\"}},{\"maxAge\":1,\"name\":\"Capital Group Companies, Inc.\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Increase\",\"latestTransDate\":{\"raw\":1605571200,\"fmt\":\"2020-11-17\"},\"positionDirect\":{\"raw\":24146025,\"fmt\":\"24.15M\",\"longFmt\":\"24,146,025\"},\"positionDirectDate\":{\"raw\":1605571200,\"fmt\":\"2020-11-17\"}},{\"maxAge\":1,\"name\":\"Conrad (D)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1624579200,\"fmt\":\"2021-06-25\"},\"positionDirect\":{\"raw\":14450,\"fmt\":\"14.45k\",\"longFmt\":\"14,450\"},\"positionDirectDate\":{\"raw\":1624579200,\"fmt\":\"2021-06-25\"}},{\"maxAge\":1,\"name\":\"Dodge & Cox\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Holding\",\"latestTransDate\":{\"raw\":1613692800,\"fmt\":\"2021-02-19\"},\"positionDirect\":{\"raw\":77043117,\"fmt\":\"77.04M\",\"longFmt\":\"77,043,117\"},\"positionDirectDate\":{\"raw\":1613692800,\"fmt\":\"2021-02-19\"}},{\"maxAge\":1,\"name\":\"Elsenhans (Lynn Laverty)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"positionDirect\":{\"raw\":40085,\"fmt\":\"40.09k\",\"longFmt\":\"40,085\"},\"positionDirectDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"}},{\"maxAge\":1,\"name\":\"Glimcher (Laurie H)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"positionDirect\":{\"raw\":15347,\"fmt\":\"15.35k\",\"longFmt\":\"15,347\"},\"positionDirectDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"}},{\"maxAge\":1,\"name\":\"Goodman (Jesse)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"},\"positionDirect\":{\"raw\":7685,\"fmt\":\"7.68k\",\"longFmt\":\"7,685\"},\"positionDirectDate\":{\"raw\":1627430400,\"fmt\":\"2021-07-28\"}},{\"maxAge\":1,\"name\":\"Lewent (Judy C)\",\"relation\":\"\",\"url\":\"\",\"transactionDescription\":\"Bought\",\"latestTransDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"},\"positionDirect\":{\"raw\":28269,\"fmt\":\"28.27k\",\"longFmt\":\"28,269\"},\"positionDirectDate\":{\"raw\":1595980800,\"fmt\":\"2020-07-29\"}}],\"maxAge\":1},\"netSharePurchaseActivity\":{\"period\":\"6m\",\"netPercentInsiderShares\":{\"raw\":0,\"fmt\":\"0.00%\"},\"netInfoCount\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"totalInsiderShares\":{\"raw\":350560,\"fmt\":\"350.56k\",\"longFmt\":\"350,560\"},\"buyInfoShares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"sellInfoCount\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"maxAge\":1,\"buyInfoCount\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"},\"netInfoShares\":{\"raw\":0,\"fmt\":null,\"longFmt\":\"0\"}},\"majorHoldersBreakdown\":{\"maxAge\":1,\"insidersPercentHeld\":{\"raw\":0.00014,\"fmt\":\"0.01%\"},\"institutionsPercentHeld\":{\"raw\":0.13193,\"fmt\":\"13.19%\"},\"institutionsFloatPercentHeld\":{\"raw\":0.13194,\"fmt\":\"13.19%\"},\"institutionsCount\":{\"raw\":882,\"fmt\":\"882\",\"longFmt\":\"882\"}},\"financialData\":{\"ebitdaMargins\":{\"raw\":0.30697,\"fmt\":\"30.70%\"},\"profitMargins\":{\"raw\":0.12942,\"fmt\":\"12.94%\"},\"grossMargins\":{\"raw\":0.6777,\"fmt\":\"67.77%\"},\"operatingCashflow\":{\"raw\":8040000000,\"fmt\":\"8.04B\",\"longFmt\":\"8,040,000,000\"},\"revenueGrowth\":{\"raw\":0.05,\"fmt\":\"5.00%\"},\"operatingMargins\":{\"raw\":0.24776,\"fmt\":\"24.78%\"},\"ebitda\":{\"raw\":10229999616,\"fmt\":\"10.23B\",\"longFmt\":\"10,229,999,616\"},\"targetLowPrice\":{\"raw\":41.55,\"fmt\":\"41.55\"},\"recommendationKey\":\"buy\",\"grossProfits\":{\"raw\":23209000000,\"fmt\":\"23.21B\",\"longFmt\":\"23,209,000,000\"},\"freeCashflow\":{\"raw\":8766000128,\"fmt\":\"8.77B\",\"longFmt\":\"8,766,000,128\"},\"targetMedianPrice\":{\"raw\":47.02,\"fmt\":\"47.02\"},\"currentPrice\":{\"raw\":42.6345,\"fmt\":\"42.63\"},\"earningsGrowth\":{\"raw\":-0.065,\"fmt\":\"-6.50%\"},\"currentRatio\":{\"raw\":0.814,\"fmt\":\"0.81\"},\"returnOnAssets\":{\"raw\":0.06466,\"fmt\":\"6.47%\"},\"numberOfAnalystOpinions\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"targetMeanPrice\":{\"raw\":47.02,\"fmt\":\"47.02\"},\"debtToEquity\":{\"raw\":117.735,\"fmt\":\"117.74\"},\"returnOnEquity\":{\"raw\":0.23622999,\"fmt\":\"23.62%\"},\"targetHighPrice\":{\"raw\":52.5,\"fmt\":\"52.50\"},\"totalCash\":{\"raw\":3513999872,\"fmt\":\"3.51B\",\"longFmt\":\"3,513,999,872\"},\"totalDebt\":{\"raw\":25604999168,\"fmt\":\"25.6B\",\"longFmt\":\"25,604,999,168\"},\"totalRevenue\":{\"raw\":33326000128,\"fmt\":\"33.33B\",\"longFmt\":\"33,326,000,128\"},\"totalCashPerShare\":{\"raw\":1.403,\"fmt\":\"1.4\"},\"financialCurrency\":\"GBP\",\"maxAge\":86400,\"revenuePerShare\":{\"raw\":13.34,\"fmt\":\"13.34\"},\"quickRatio\":{\"raw\":0.526,\"fmt\":\"0.53\"},\"recommendationMean\":{\"raw\":2.2,\"fmt\":\"2.20\"}},\"quoteType\":{\"exchange\":\"NYQ\",\"shortName\":\"GlaxoSmithKline PLC\",\"longName\":\"GlaxoSmithKline plc\",\"exchangeTimezoneName\":\"America/New_York\",\"exchangeTimezoneShortName\":\"EST\",\"isEsgPopulated\":false,\"gmtOffSetMilliseconds\":\"-18000000\",\"quoteType\":\"EQUITY\",\"symbol\":\"GSK\",\"messageBoardId\":\"finmb_275442\",\"market\":\"us_market\"},\"institutionOwnership\":{\"maxAge\":1,\"ownershipList\":[{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Dodge & Cox Inc\",\"pctHeld\":{\"raw\":0.035,\"fmt\":\"3.50%\"},\"position\":{\"raw\":88017914,\"fmt\":\"88.02M\",\"longFmt\":\"88,017,914\"},\"value\":{\"raw\":3363164493,\"fmt\":\"3.36B\",\"longFmt\":\"3,363,164,493\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Capital International Investors\",\"pctHeld\":{\"raw\":0.009,\"fmt\":\"0.90%\"},\"position\":{\"raw\":22660211,\"fmt\":\"22.66M\",\"longFmt\":\"22,660,211\"},\"value\":{\"raw\":865846662,\"fmt\":\"865.85M\",\"longFmt\":\"865,846,662\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Fisher Asset Management, LLC\",\"pctHeld\":{\"raw\":0.0070999996,\"fmt\":\"0.71%\"},\"position\":{\"raw\":17830400,\"fmt\":\"17.83M\",\"longFmt\":\"17,830,400\"},\"value\":{\"raw\":681299584,\"fmt\":\"681.3M\",\"longFmt\":\"681,299,584\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"organization\":\"FMR, LLC\",\"pctHeld\":{\"raw\":0.0067000003,\"fmt\":\"0.67%\"},\"position\":{\"raw\":16977229,\"fmt\":\"16.98M\",\"longFmt\":\"16,977,229\"},\"value\":{\"raw\":676033258,\"fmt\":\"676.03M\",\"longFmt\":\"676,033,258\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"organization\":\"Price (T.Rowe) Associates Inc\",\"pctHeld\":{\"raw\":0.0058,\"fmt\":\"0.58%\"},\"position\":{\"raw\":14668615,\"fmt\":\"14.67M\",\"longFmt\":\"14,668,615\"},\"value\":{\"raw\":584104249,\"fmt\":\"584.1M\",\"longFmt\":\"584,104,249\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Black Creek Investment Management Inc.\",\"pctHeld\":{\"raw\":0.0041,\"fmt\":\"0.41%\"},\"position\":{\"raw\":10329349,\"fmt\":\"10.33M\",\"longFmt\":\"10,329,349\"},\"value\":{\"raw\":394684425,\"fmt\":\"394.68M\",\"longFmt\":\"394,684,425\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Renaissance Technologies, LLC\",\"pctHeld\":{\"raw\":0.0037,\"fmt\":\"0.37%\"},\"position\":{\"raw\":9414421,\"fmt\":\"9.41M\",\"longFmt\":\"9,414,421\"},\"value\":{\"raw\":359725026,\"fmt\":\"359.73M\",\"longFmt\":\"359,725,026\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"Hotchkis & Wiley Capital Management, LLC\",\"pctHeld\":{\"raw\":0.0036000002,\"fmt\":\"0.36%\"},\"position\":{\"raw\":9125932,\"fmt\":\"9.13M\",\"longFmt\":\"9,125,932\"},\"value\":{\"raw\":348701861,\"fmt\":\"348.7M\",\"longFmt\":\"348,701,861\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1632960000,\"fmt\":\"2021-09-30\"},\"organization\":\"State Street Corporation\",\"pctHeld\":{\"raw\":0.0036000002,\"fmt\":\"0.36%\"},\"position\":{\"raw\":9079035,\"fmt\":\"9.08M\",\"longFmt\":\"9,079,035\"},\"value\":{\"raw\":346909927,\"fmt\":\"346.91M\",\"longFmt\":\"346,909,927\"}},{\"maxAge\":1,\"reportDate\":{\"raw\":1625011200,\"fmt\":\"2021-06-30\"},\"organization\":\"UBS Group AG\",\"pctHeld\":{\"raw\":0.003,\"fmt\":\"0.30%\"},\"position\":{\"raw\":7440966,\"fmt\":\"7.44M\",\"longFmt\":\"7,440,966\"},\"value\":{\"raw\":296299266,\"fmt\":\"296.3M\",\"longFmt\":\"296,299,266\"}}]},\"calendarEvents\":{\"maxAge\":1,\"earnings\":{\"earningsDate\":[{\"raw\":1485964740,\"fmt\":\"2017-02-01\"},{\"raw\":1486400400,\"fmt\":\"2017-02-06\"}],\"earningsAverage\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"earningsLow\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"earningsHigh\":{\"raw\":0.62,\"fmt\":\"0.62\"},\"revenueAverage\":{\"raw\":12587600000,\"fmt\":\"12.59B\",\"longFmt\":\"12,587,600,000\"},\"revenueLow\":{\"raw\":12350200000,\"fmt\":\"12.35B\",\"longFmt\":\"12,350,200,000\"},\"revenueHigh\":{\"raw\":12755600000,\"fmt\":\"12.76B\",\"longFmt\":\"12,755,600,000\"}},\"exDividendDate\":{\"raw\":1637193600,\"fmt\":\"2021-11-18\"},\"dividendDate\":{\"raw\":1642032000,\"fmt\":\"2022-01-13\"}},\"summaryDetail\":{\"previousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"regularMarketOpen\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"twoHundredDayAverage\":{\"raw\":39.97489,\"fmt\":\"39.97\"},\"trailingAnnualDividendYield\":{\"raw\":0.018845702,\"fmt\":\"1.88%\"},\"payoutRatio\":{\"raw\":0.935,\"fmt\":\"93.50%\"},\"volume24Hr\":{},\"regularMarketDayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"},\"navPrice\":{},\"averageDailyVolume10Day\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"totalAssets\":{},\"regularMarketPreviousClose\":{\"raw\":42.45,\"fmt\":\"42.45\"},\"fiftyDayAverage\":{\"raw\":40.445,\"fmt\":\"40.44\"},\"trailingAnnualDividendRate\":{\"raw\":0.8,\"fmt\":\"0.80\"},\"open\":{\"raw\":42.26,\"fmt\":\"42.26\"},\"toCurrency\":null,\"averageVolume10days\":{\"raw\":3903542,\"fmt\":\"3.9M\",\"longFmt\":\"3,903,542\"},\"expireDate\":{},\"yield\":{},\"algorithm\":null,\"dividendRate\":{\"raw\":2.2,\"fmt\":\"2.20\"},\"exDividendDate\":{\"raw\":1637193600,\"fmt\":\"2021-11-18\"},\"beta\":{\"raw\":0.402824,\"fmt\":\"0.40\"},\"circulatingSupply\":{},\"startDate\":{},\"regularMarketDayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"priceHint\":{\"raw\":2,\"fmt\":\"2\",\"longFmt\":\"2\"},\"currency\":\"USD\",\"trailingPE\":{\"raw\":18.633959,\"fmt\":\"18.63\"},\"regularMarketVolume\":{\"raw\":2414934,\"fmt\":\"2.41M\",\"longFmt\":\"2,414,934\"},\"lastMarket\":null,\"maxSupply\":{},\"openInterest\":{},\"marketCap\":{\"raw\":107263279104,\"fmt\":\"107.26B\",\"longFmt\":\"107,263,279,104\"},\"volumeAllCurrencies\":{},\"strikePrice\":{},\"averageVolume\":{\"raw\":4064776,\"fmt\":\"4.06M\",\"longFmt\":\"4,064,776\"},\"priceToSalesTrailing12Months\":{\"raw\":3.2186065,\"fmt\":\"3.22\"},\"dayLow\":{\"raw\":42.21,\"fmt\":\"42.21\"},\"ask\":{\"raw\":0,\"fmt\":\"0.00\"},\"ytdReturn\":{},\"askSize\":{\"raw\":4000,\"fmt\":\"4k\",\"longFmt\":\"4,000\"},\"volume\":{\"raw\":2414934,\"fmt\":\"2.41M\",\"longFmt\":\"2,414,934\"},\"fiftyTwoWeekHigh\":{\"raw\":43.61,\"fmt\":\"43.61\"},\"forwardPE\":{\"raw\":13.32328,\"fmt\":\"13.32\"},\"maxAge\":1,\"fromCurrency\":null,\"fiveYearAvgDividendYield\":{\"raw\":5.24,\"fmt\":\"5.24\"},\"fiftyTwoWeekLow\":{\"raw\":33.53,\"fmt\":\"33.53\"},\"bid\":{\"raw\":0,\"fmt\":\"0.00\"},\"tradeable\":false,\"dividendYield\":{\"raw\":0.051,\"fmt\":\"5.10%\"},\"bidSize\":{\"raw\":1400,\"fmt\":\"1.4k\",\"longFmt\":\"1,400\"},\"dayHigh\":{\"raw\":42.71,\"fmt\":\"42.71\"}},\"symbol\":\"GSK\",\"esgScores\":{},\"upgradeDowngradeHistory\":{\"history\":[{\"epochGradeDate\":1636107518,\"firm\":\"Barclays\",\"toGrade\":\"Equal-Weight\",\"fromGrade\":\"Underweight\",\"action\":\"up\"},{\"epochGradeDate\":1616499320,\"firm\":\"SVB Leerink\",\"toGrade\":\"Market Perform\",\"fromGrade\":\"Outperform\",\"action\":\"down\"},{\"epochGradeDate\":1612455203,\"firm\":\"Deutsche Bank\",\"toGrade\":\"Sell\",\"fromGrade\":\"Hold\",\"action\":\"down\"},{\"epochGradeDate\":1610714470,\"firm\":\"Deutsche Bank\",\"toGrade\":\"Hold\",\"fromGrade\":\"\",\"action\":\"init\"},{\"epochGradeDate\":1574334807,\"firm\":\"UBS\",\"toGrade\":\"Buy\",\"fromGrade\":\"Neutral\",\"action\":\"up\"},{\"epochGradeDate\":1573482581,\"firm\":\"Argus Research\",\"toGrade\":\"Buy\",\"fromGrade\":\"\",\"action\":\"main\"},{\"epochGradeDate\":1571234887,\"firm\":\"New Street\",\"toGrade\":\"Hold\",\"fromGrade\":\"Reduce\",\"action\":\"up\"},{\"epochGradeDate\":1570793572,\"firm\":\"Cantor Fitzgerald\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1567526873,\"firm\":\"Societe Generale\",\"toGrade\":\"Buy\",\"fromGrade\":\"Sell\",\"action\":\"up\"},{\"epochGradeDate\":1547469333,\"firm\":\"Exane BNP Paribas\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Outperform\",\"action\":\"down\"},{\"epochGradeDate\":1544799489,\"firm\":\"Morgan Stanley\",\"toGrade\":\"Underweight\",\"fromGrade\":\"\",\"action\":\"init\"},{\"epochGradeDate\":1544795906,\"firm\":\"SunTrust Robinson Humphrey\",\"toGrade\":\"Hold\",\"fromGrade\":\"\",\"action\":\"init\"},{\"epochGradeDate\":1544097200,\"firm\":\"Barclays\",\"toGrade\":\"Equal-Weight\",\"fromGrade\":\"Overweight\",\"action\":\"down\"},{\"epochGradeDate\":1534766245,\"firm\":\"Argus\",\"toGrade\":\"Buy\",\"fromGrade\":\"Buy\",\"action\":\"main\"},{\"epochGradeDate\":1509024130,\"firm\":\"Bank of America\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Buy\",\"action\":\"down\"},{\"epochGradeDate\":1499283191,\"firm\":\"Citigroup\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Buy\",\"action\":\"down\"},{\"epochGradeDate\":1474613155,\"firm\":\"PiperJaffray\",\"toGrade\":\"Overweight\",\"fromGrade\":\"\",\"action\":\"init\"},{\"epochGradeDate\":1473828820,\"firm\":\"Exane BNP Paribas\",\"toGrade\":\"Underperform\",\"fromGrade\":\"Neutral\",\"action\":\"down\"},{\"epochGradeDate\":1525527134,\"firm\":\"Argus\",\"toGrade\":\"Buy\",\"fromGrade\":\"\",\"action\":\"main\"},{\"epochGradeDate\":1468477846,\"firm\":\"Jefferies\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1456467560,\"firm\":\"Cantor Fitzgerald\",\"toGrade\":\"Hold\",\"fromGrade\":\"\",\"action\":\"init\"},{\"epochGradeDate\":1453882841,\"firm\":\"Bryan Garnier\",\"toGrade\":\"Buy\",\"fromGrade\":\"Neutral\",\"action\":\"up\"},{\"epochGradeDate\":1445326459,\"firm\":\"Credit Suisse\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Underperform\",\"action\":\"up\"},{\"epochGradeDate\":1444650215,\"firm\":\"JP Morgan\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Underweight\",\"action\":\"up\"},{\"epochGradeDate\":1433418170,\"firm\":\"Morgan Stanley\",\"toGrade\":\"Equal-Weight\",\"fromGrade\":\"Overweight\",\"action\":\"down\"},{\"epochGradeDate\":1421918353,\"firm\":\"New Street Research\",\"toGrade\":\"\",\"fromGrade\":\"\",\"action\":\"down\"},{\"epochGradeDate\":1406549489,\"firm\":\"Mainfirst\",\"toGrade\":\"Underperform\",\"fromGrade\":\"\",\"action\":\"down\"},{\"epochGradeDate\":1525527134,\"firm\":\"Argus\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1398153600,\"firm\":\"Panmure\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1390838400,\"firm\":\"S&P Capital IQ\",\"toGrade\":\"Hold\",\"fromGrade\":\"Sell\",\"action\":\"up\"},{\"epochGradeDate\":1390579200,\"firm\":\"Berenberg\",\"toGrade\":\"Hold\",\"fromGrade\":\"Buy\",\"action\":\"down\"},{\"epochGradeDate\":1390406400,\"firm\":\"Cowen & Co.\",\"toGrade\":\"Market Perform\",\"fromGrade\":\"Outperform\",\"action\":\"down\"},{\"epochGradeDate\":1389256200,\"firm\":\"UBS\",\"toGrade\":\"Neutral\",\"fromGrade\":\"\",\"action\":\"init\"},{\"epochGradeDate\":1387296000,\"firm\":\"Deutsche Bank\",\"toGrade\":\"Hold\",\"fromGrade\":\"Buy\",\"action\":\"down\"},{\"epochGradeDate\":1384241377,\"firm\":\"Panmure\",\"toGrade\":\"Hold\",\"fromGrade\":\"Buy\",\"action\":\"down\"},{\"epochGradeDate\":1381386471,\"firm\":\"Credit Suisse\",\"toGrade\":\"Underperform\",\"fromGrade\":\"Neutral\",\"action\":\"down\"},{\"epochGradeDate\":1381215228,\"firm\":\"MainFirst\",\"toGrade\":\"Outperform\",\"fromGrade\":\"Underperform\",\"action\":\"init\"},{\"epochGradeDate\":1379317355,\"firm\":\"Barclays\",\"toGrade\":\"Equal-Weight\",\"fromGrade\":\"Overweight\",\"action\":\"down\"},{\"epochGradeDate\":1377076654,\"firm\":\"Cowen & Co.\",\"toGrade\":\"Outperform\",\"fromGrade\":\"Market Perform\",\"action\":\"up\"},{\"epochGradeDate\":1376555723,\"firm\":\"Morgan Stanley\",\"toGrade\":\"Underweight\",\"fromGrade\":\"Equal-Weight\",\"action\":\"down\"},{\"epochGradeDate\":1376466095,\"firm\":\"JP Morgan\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Underweight\",\"action\":\"up\"},{\"epochGradeDate\":1376465309,\"firm\":\"JP Morgan\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Underweight\",\"action\":\"up\"},{\"epochGradeDate\":1375781457,\"firm\":\"Citigroup\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Buy\",\"action\":\"down\"},{\"epochGradeDate\":1370590478,\"firm\":\"Liberum\",\"toGrade\":\"Hold\",\"fromGrade\":\"Underweight\",\"action\":\"up\"},{\"epochGradeDate\":1369730533,\"firm\":\"Credit Suisse\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Outperform\",\"action\":\"down\"},{\"epochGradeDate\":1369724565,\"firm\":\"Deutsche Bank\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1362031924,\"firm\":\"Morgan Stanley\",\"toGrade\":\"Underweight\",\"fromGrade\":\"Equal-Weight\",\"action\":\"down\"},{\"epochGradeDate\":1360317237,\"firm\":\"Kepler Cheuvreux\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1359447816,\"firm\":\"Barclays\",\"toGrade\":\"Overweight\",\"fromGrade\":\"Equal-Weight\",\"action\":\"up\"},{\"epochGradeDate\":1355328509,\"firm\":\"Credit Suisse\",\"toGrade\":\"Neutral\",\"fromGrade\":\"Underperform\",\"action\":\"up\"},{\"epochGradeDate\":1355306415,\"firm\":\"Panmure\",\"toGrade\":\"Buy\",\"fromGrade\":\"Hold\",\"action\":\"up\"},{\"epochGradeDate\":1345616820,\"firm\":\"JP Morgan\",\"toGrade\":\"Underweight\",\"fromGrade\":\"Neutral\",\"action\":\"down\"},{\"epochGradeDate\":1344837180,\"firm\":\"Jefferies\",\"toGrade\":\"Hold\",\"fromGrade\":\"Buy\",\"action\":\"down\"}],\"maxAge\":86400},\"pageViews\":{\"shortTermTrend\":\"UP\",\"midTermTrend\":\"UP\",\"longTermTrend\":\"UP\",\"maxAge\":1}}\n"
     ]
    }
   ],
   "source": [
    "url = \"https://apidojo-yahoo-finance-v1.p.rapidapi.com/stock/v2/get-summary\"\n",
    "\n",
    "querystring = {\"symbol\":\"gsk\",\"region\":\"uk\"}\n",
    "\n",
    "headers = {\n",
    "    'x-rapidapi-host': \"apidojo-yahoo-finance-v1.p.rapidapi.com\",\n",
    "    'x-rapidapi-key': \"9cd97ba3camsh244cbd2e3e420a4p1e83c0jsne0fdd0787f8e\"\n",
    "    }\n",
    "\n",
    "response = requests.request(\"GET\", url, headers=headers, params=querystring)\n",
    "\n",
    "print(response.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
